The best investment category

AppLovin belongs to my favorite type of investment: a category definer, temporarily beaten down by the market on a below-expectations print.

A category definer is a company that created a new category and occupies the leadership seat in it, crushing the competition in its segment through its products and services.

I’m sure you already have a few names in mind, and here are some examples.

Investing in such companies offers one of the best risk-reward ratios you can find in the market. Because if a company crushes the competition, is loved by its customers, does more volume, and keeps improving relentlessly — who’s going to threaten it?

Generally, these companies are recognized by the market as very good investments and trade at a premium. The most financially interesting moments to invest in them come during a passing scare.

The tricky part is telling apart a company in decline from a giant going through a moment of doubt.

And sure enough, on August 5th 2026, AppLovin disappointed. Its Q2 revenue landed slightly below guidance, and the stock fell 19.66%. The stock has kept sliding since its all-time high of $745.61 in November 2025. Yet performance remains remarkable, with 53% annual revenue growth and net income up 78% on a trailing-twelve-month basis.

AppLovin is a great example of the virtue of patience, where waiting a year before investing would have paid off. As for me, I hesitated to enter the position back in February near its lows in case it kept falling, but the market decided to hand back part of its loss.

A few words on method and plan

I’m a former project manager with 7 years of experience (PMP certified), and I formalize my fundamental analyses like a project trajectory, from point A (starting point) to point B (destination).

Point A, in our case, is what the company does, together with its environment (competitors, suppliers) and its competitive advantage, then the financial and management side. This is a static study, and if you already know the company, you can skim through it quickly.

Point B is a forward-looking study. I don’t claim to know the future, nor what the company is worth. So instead I look for the different scenarios that could play out for the company, the way you’d run a qualitative and quantitative risk analysis on a project.

This takes the shape of weighing opposing theses — why the stock fell, the arguments for the bear thesis, and the arguments for the bull thesis. I try to make both sides as objective as possible using quantifiable criteria.

I then lay out a map of possible prices at a given target date, without a discount rate, crossing fundamental trajectories with valuation levels — stating my starting assumptions each time. Knowing which valuation multiple to apply at a given date comes down to knowing what the risks, opportunities, and therefore the narrative of the company will be. For convenience and by convention, this section is called “Valuation” even though that’s not really the right word for it.

The whole article is long because it covers a lot of ground, and short because I try to give you a synthesis of the points. So I start with a “short version” for those of you in a hurry — here it is, without further ado.

The Short Version

After falling more than 50% from its highs, notably due to a quarterly print below expectations, one can reasonably think this is an air pocket, and that growth — spectacular so far (Q3 guidance still sits at +46-48% YoY) — will trend toward 30% a year according to management. The market is punishing this result all the more because AppLovin had never posted below its own expectations since its 2021 IPO.

This looks like a classic buy-the-dip setup on a quality company momentarily tormented by the market. The results due November 11th should confirm this for us. The company could be disrupted, but that seems fairly unlikely in the near term and isn’t showing up in the numbers.

Subscribe now

1. What AppLovin does

Business model

When a company wants to find customers (gamers who’ll buy inside its game, buyers on its e-commerce site), it goes to AppLovin and states its goal (“I want X users who spend at least Y”), and AppLovin’s AI places its ads wherever that’s most profitable.

This model doesn’t require an intermediary ad agency: the company itself is in the driver’s seat, and AppLovin supplies the tool and the algorithm. AppLovin gets paid by taking a commission on what the company spends.

This business model is built on four pillars:

AppLovin Ads — the core of the business. I would have liked to give you a number, but AppLovin sticks to “substantially all of our revenue” in its 10-Q and 10-K filings. The company (the advertiser) sets its campaign goal, and the AI optimizes the placement. AppLovin pays the publisher of the app where the ad was shown and keeps the rest as margin. Pricing is dynamic (as opposed to fixed, like “10 cents a click”): the algorithm adjusts in real time how much to charge based on the advertiser’s goal. Nearly all of revenue comes from mobile apps, and mostly from mobile games.

Since Q2 2026, AppLovin Ads has been available in self-service. Before that, you had to go through an ad rep.

MAX — used by app publishers to auction off their ad inventory. AppLovin takes its commission on the winning bid before passing the rest to the publisher. As with the previous product, nearly all of revenue comes from mobile apps, and mostly from mobile games.

Adjust — a measurement tool for advertisers (how many installs, fraud detection). The only product billed as an annual subscription, unlike the others which run on commission.

Wurl — distribution of video programming across streaming/connected-TV platforms, with ad sales on top. Billed on usage and/or CPM (cost per mille: the price the advertiser pays for 1,000 impressions of its ad, regardless of whether anyone clicks or buys afterward).

Suppliers

AppLovin is hosted on Google Cloud and uses its associated services. Beyond that, AppLovin is structurally dependent on the Apple App Store and Google Play for distributing its content, collecting payments, and targeting rules — and both of these players hold significant market power.

Clients

AppLovin has three customer groups, ranging from the largest companies to small independent operators:

• Advertisers who use the platform to find users.

• Advertising networks who use AppLovin’s mediation solution to buy inventory.

• The community of mobile app publishers who use the mediation tool to monetize their ad inventory.

Having a broad customer base is an advantage from a risk standpoint. Worth noting: the advertising sector is cyclical, and all customers tend to cut spending at the same time during a downturn.

Competitors

The 10-K explicitly names Meta, Google, Amazon, and Unity Software, while making an important point: some of these “competitors” are also partners and clients of AppLovin (“several of which are also our partners and clients”) — the line between competitor and customer isn’t clean. The company also states: “We operate in a fragmented advertising ecosystem composed of divisions of large, well-established companies as well as privately-held companies.”

Here’s an illustration of the three preceding sections:

Competitive advantage

The main competitive advantage lies in the quality of the company’s products and the quality of its management.

The presence of network effects and switching costs helps reinforce the company’s lead and insulate it from competition.

On the network effect, the 10-K describes it this way:

“As more advertisers use our advertising solutions to market and monetize their content, we gain access to more data regarding users and user engagement, further strengthening our scaled distribution. As our distribution grows, we gain better insights for Axon AI, which then further enhances the efficiency and effectiveness of the Axon Ads Manager.”

This is primarily a data-scale barrier. Anyone with the same level of data would erase the competitive advantage — which isn’t currently the case.

I lack information on the company’s switching costs, and therefore on how easy it is to change advertising provider. It doesn’t strike me as especially complicated, especially since it seems possible to bring on a second provider, run comparisons based on a pilot, then progressively migrate ad campaigns over. We’re not in a Microsoft-style situation where entire teams’ workflows are so embedded that they can’t switch overnight. All the more so since the company’s contracts include clauses allowing cancellation at any time.

2. Financials

Key financial metrics

Commentary

The numbers are staggering. Decelerating, sure, but staggering nonetheless — especially for a TTM PE of 26. No sign of inflation from financial shenanigans after reviewing AppLovin.

Revenue

Growth has decelerated continuously and steadily over the last five periods, going from 75% (FY ’24) to 55% (H1 ’26 YoY). AppLovin states that the composition of growth has changed in nature, and breaks its own revenue down into two factors — install volume and net revenue per install (MD&A):

• FY2024: installs +50%, net revenue per install +22% → growth driven by volume.

• FY2025: installs +3%, net revenue per install +72% → shift toward price/monetization.

• H1 2026: installs -10%, net revenue per install +75% → volume is declining, and all growth now comes from monetization per install.

• Q2 2026 alone: installs -2%, net revenue per install +58% → same read, slightly softer.

Net revenue per install is the net amount of money earned over a period divided by the total number of installs generated. The number of installs tends to mechanically shrink (you only install once), and on that shrinking base, net revenue per install climbs (which can happen repeatedly, by nature).

Worth remembering, still: continuing to grow like this at these revenue levels isn’t sustainable over time. A cumulative growth rate of 50% a year gives you roughly 57x the initial amount after 10 years. So what to make of a doubling, or 75% a year?

Operating margin

With revenue growth outpacing cost growth, AppLovin’s business is scalable and shows significant operating leverage. The rise in GAAP operating margin from 42% (FY ’23) to 78% (Q2 ’26) is spectacular. Unfortunately, since the ceiling is 100%, there isn’t much more improvement to hope for on this front going forward. Holding at these levels remains impressive in itself.

Net income and free cash flow

AppLovin’s net margin is boosted by a low tax rate — 13.1% in 2025, well below the 21% federal rate. AppLovin benefits from an FDII (Foreign-Derived Intangible Income) tax break, a US tax provision created in 2017 (the Tax Cuts and Jobs Act).

I like comparing net income and free cash flow to spot variations that might reveal hidden issues. Here, they converge toward the same figure, around 65%, which is excellent. For net income, growth outpaces revenue growth in every period, driven by a scissor effect (opex shrinking as a percentage while revenue doubles).

For FCF, I usually strip out SBC, which is a non-cash charge. Growth in this metric looks larger since it starts from a smaller base.

Balance sheet

The company is financially very solid, with a debt-minus-cash to equity ratio of 0.15x. AppLovin is holding onto its long-term debt; the ratio is shrinking through the accumulation of cash and equity, which are growing faster than everything else.

3. Management

Adam Foroughi — CEO (co-founder, since 2011)

Foroughi holds only 9% of the economic capital but 61.6% of the voting power (Class B shares carry 20 votes each), 66.9% including the voting agreement tying him to Herald Chen. This makes AppLovin legally a “controlled company,” although it doesn’t make use of the governance exemptions that status allows.

According to Forbes and Bloomberg estimates, this would represent 66% to 85% of his net worth. In terms of incentives, his salary has been capped at $400k since the IPO, with no increase since.

The fact that the CEO is also the founder is a very good sign, one that typically generates outperformance.

More broadly across the leadership team, the variable portion of compensation plans is paid in equity, not cash — a notable point of alignment.

Capital allocation

No dividend is currently paid. There are share buybacks, but they primarily serve to offset dilution from SBC. Beyond that, the amount repurchased remains marginal — 0.5% over 2025, and 0.9% over H1 2026. The declining share price will mechanically push this share higher.

4. The two theses

I believe the best way to decide whether an investment is sound is to pit the bullish and bearish theses against each other. That way, I know what could happen, and knowing your position well helps you endure downturns and protects you psychologically. Considering only the bear thesis is alarmism; considering only the bull thesis is wishful thinking. This section includes both the arguments and the catalysts for each version of the story.

Why did the stock fall?

Starting in February 2025, a series of short-seller reports — Fuzzy Panda Research, Culper Research, then Muddy Waters Research in March 2025 — accused AppLovin’s AXON ad system of circumventing Apple’s App Tracking Transparency framework. These allegations fed an SEC investigation that weighed on the stock in early 2026, down to a low reached around February 12th 2026 — nearly 50% below the late-2025 peak.

Next, doubts about the durability of growth. As the market re-rated software names exposed to AI disruption risk, analysts considered the ~30% long-term growth assumption against a stock still priced for more and chose to lower their price targets.

Finally, and most recently: the August 5th 2026 earnings release. Q2 2026 revenue slightly missed consensus, and AppLovin issued guidance slightly below expectations. The stock then fell 19.66% intraday, wiping out roughly $40 billion in market cap — even as the SEC closed its AXON investigation that same day with no action taken. Several downgrades and price-target cuts followed (Wells Fargo, Piper Sandler, Goldman Sachs, BofA Securities).

Bear thesis

Growth is slowing

Revenue growth has declined over the last four periods (75% → 70% → 56% → 53% YoY), and Q2 2026 marks the first guidance miss since the 2021 IPO. The market can read the combination of the two as the signal of the beginning of the end of growth.

As Peter Lynch put it, “small company, big moves, big company, small moves.” Growth is bound to mechanically shrink over time.

As growth declines, it will inevitably revert to its natural, and more cyclical pace: the model depends on the ad budgets of mobile/gaming advertisers — a sector historically more discretionary, as AppLovin doesn’t require multiannual contracts.

In gaming, a significant share of revenue, the segment is mature: growth there already comes more from existing users. Nothing rules out this slowdown continuing into Q3.

Disruption risk

Analysts explicitly cite a risk that AI tools could erode AppLovin Ads’ competitive edge, wondering if 30%+ long-term growth can hold.

Indeed, the R&D headcount remains modest given the stakes. 380 R&D employees, or 42% of the workforce, are tiny compared to the AI resources of Meta, Google, or OpenAI. The current model is mainly based on a data flywheel. If a competitor with stronger AI R&D managed to replicate AppLovin Ads with less data (via more efficient techniques), the moat could give way faster than a simple data-volume catch-up would suggest. But I don’t think it will happen in the next quarter, and the competitors have shown before a propensity to fail outside of their core products.

This point matters even more given that AppLovin’s revenue depends on essentially a single line, AppLovin Ads. Disruption is all the more likely for a single-product company.

Capital allocation

$2.19 billion was repurchased in FY2025, a year that includes the all-time high (late 2025), without a quarterly breakdown of the average price paid to confirm whether the capital was deployed in a disciplined way. This should be put in perspective, though, since the question mainly matters near highs and doesn’t really apply here.

Ongoing lawsuit

Two US law firms (Schall Law Firm and Bragar Eagel & Squire) have announced they are investigating/soliciting shareholders for a possible class action against AppLovin, over allegedly false statements or omissions of information material to investors, regarding purchases between May 10, 2023 and March 26, 2025. This is a private civil action, separate from the SEC investigation, which has just been closed.

What if the bear case were true?

In that case, management would lower its guidance and report below its own internal forecasts and analyst expectations. The indicators to watch then are revenue and net margin. Moreover, products from competitors could emerge, and claim similar results.

Bull thesis

1. A strong growth with normal deceleration

The market seems to be forgetting that the company still posted 53% revenue growth. I personally estimate this is a simple air pocket. Though I say this, it is without certainty and the decline could continue over the coming quarters.

My confidence comes from the company’s track record and from its previous margin expansion, which remains impressive.

To hit these targets, the company has a growth relay in consumer/e-commerce : a self-service platform opened to the public in 2025. Revenue is seasonal, and Q2 is usually the slow quarter. Even so, advertiser spend rose 28% versus the Q4 2025 seasonal peak. The web/e-commerce vertical now runs at a record ~$1 billion annual run-rate, and management estimates this market at 5-10x the size of mobile gaming.

2. Management commentary

The miss came from an execution problem. The CEO states that the shortfall came from the timing of AI model improvements on the gaming side — “we know what happened, and it’s already been addressed.” Advertiser appetite remained healthy during the quarter.

Management maintained its long-term outlook on the August 5th call of ~30% combined annual growth for gaming + consumer.

3. A highly profitable business

The company generated $863.3 million in FCF in Q2 2026 alone, and 32% FCF growth after deducting SBC — still well above nearly the entire software/AdTech sector, with a balance sheet carrying almost no net debt. Incremental costs are minimal, since this is a scalable business.

One of my favorite indicators, the ROIC, indicates a steady growth in profitability, which remains impressive for a company of that size. Every invested dollar is producing almost a third in cash. A declining company would show a fall in this metric.

4. Only one shortfall so far

Even though the company had a miss, it’s a single occurrence since the IPO. They’re only human, after all. By nature, this kind of stumble remains a weak signal, especially when it’s being closely watched by management itself heading into next quarter.

What would invalidate the bull case

Would a new quarter below guidance do it? No — because it’s always possible that a simple air pocket produces a continued decline in install volumes without offsetting price gains.

The real signal would be a confirmed slowdown in consumer/e-commerce growth, since that’s the growth relay put forward to justify the thesis beyond mature gaming.

5. Valuation

The numbers only make sense if you’ve read the two theses section. A valuation without a thesis is just a spreadsheet.

The valuation requires an important assumption, being the continuity of a normal economic environment, i.e. without recession, major credit event, market crash. Any of these could push the stock below the bear case shown here, temporarily, independent of the company’s underlying performance. All figures in the scorecard are pre-tax and pre-fees. Run the numbers for your own situation before drawing conclusions.

The assumptions are the following:

• For all the cases, the margin stays flat.

• For the revenue, it goes from 10% per year in the base case, to 30% per year in the central case, and 40% per year in the bull case.

The valuation scorecard map

My conviction sits on the $1,549 scenario or higher.

I’d imagine that if the gap closes next year, AppLovin could once again trade at a PE of 50, under the effect of irrational exuberance — but not by 2030, if the company holds at 30% annual revenue growth.

The re-rating will mainly depend on the catalysts covered in the next section.

6. Momentum

Overall, crossing fundamentals (covered above) with momentum is an excellent way to improve your returns. You’re never right on your own, especially since a significant share of valuation comes from the multiple.

Catalysts

Q3 results (the major point):

• If AppLovin reports below expectations: this would break confidence in the guidance more durably than an isolated accident. E-commerce would slow if management’s “it takes time” turns into disappointment rather than acceleration.

• It’s possible the air pocket continues into next quarter, or even across a run of quarters with a focus on long-term indicators — producing a scenario similar to MercadoLibre (falling share price alongside renewed long-term prospects).

• If AppLovin reports in line with expectations: the market will likely want a quarter or two of confirmation, and will gently begin a re-rating.

• If AppLovin reports above expectations: the market will forget its fear, and the stock could gain 20% in a single session and keep re-pricing higher over the following weeks.

• Analyst revisions will follow the Q3 results and amplify the move up or down in the share price. The sell-side consensus remains heavily bullish despite the miss: 29 buy / 0 sell / 3 hold across 30 analysts (S&P Global), with an average price target of $575 — roughly 66% above the current price ($347). The market has punished the stock more harshly than the analysts who follow the story closely. That’s generally a good signal for a buy-the-dip.

On the shareholder lawsuit: its dismissal could trigger a modest bounce in the share price, while its continuation would weigh on it.

A re-rating could also come if a superinvestor (Pat Dorsey or Steve Mandel) builds a stake, or if buybacks continue. The company could also decide to increase its allocated buyback amount as a signal of confidence.

When to enter the stock?

The market hates uncertainty and has already started a significant decline in the share price. So you need to track the price to see where it bottoms. I see three possible strategies:

Buy the dip:

• I would wait for analysts to stop cutting their outlooks. The likely target zone is a PE of 20-25.

• It’s hard to give a PE ratio as a support level, since the company has broken through its last support on the way down.

• This works if AppLovin surprises to the upside next quarter, and fails if AppLovin disappoints or worries the market for a second quarter.

Capitulation:

• It’s possible we head toward a very bearish scenario if the company reports below expectations. In that case, you have to wait for capitulation, which shows up through several signals, such as above-average volume, or RSI <20.

• So far, AppLovin hasn’t shown signs of capitulation.

• DCA: the way to reduce risk (the non-choice) is to run a DCA every month, if that’s your approach. As for me, I prefer to enter in one or two tranches.

As for me, I plan to open a position once the price stabilizes, and I’ll let my subscribers know when I do. I’m prepared to add to the position on further weakness or capitulation. There’s no rush — the thesis playing out will probably take 2-3 years. In Fortinet’s case, which shows some similarities, it took a year between the August ’25 decline and the re-rating over April-July ’26.

Final Thoughts

I think that starting at a PE of 22, AppLovin becomes a great buy, and starting at a PE of 16, a screaming buy. Who knows where the share price will end up falling? It depends heavily on investor sentiment. I plan to enter soon, because I’m convinced the company has only hit an air pocket. It’s possible, but in my view unlikely, that next quarter comes in below expectations. It should legitimately either be in line or beat expectations. As mentioned earlier, buying the dip can be either the best or the worst investment decision there is. I published this deep dive ahead of my investment decision, unlike with Booking and Microsoft, to give you time — and to give myself time — to properly weigh every element before making a call.

Subscribe now

Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author DO NOT HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

As you can deduce from the name, the central thesis is that harmonic reducers (HDS) and planetary roller screws (THK) are in short supply, with demand exceeding supply. It gives us every aspect we want as investors: prices increases, production and guidance increases, and multiple expansion (PE ratio, Price to Sales, etc.).

I wanted to make an update since both companies beat expectations, both raised guidance and both fell after their results. This article will provide you an update on:

1. Why they fell

2. The bull vs bear part I made in the previous article

3. The valuation scorecard

Subscribe now

1. Why HDS and THK fell

Sector rotation and macro

The market feared an intervention on the yen, as the currency was weakening. The government would sell dollars and buy yen: a stronger currency would weaken the industrials such as THK and HDS.

Moreover, there was a broad AI/semiconductor selloff on August 6-7. Other names in the sector, such as Kioxia, Taiyo Yuden, Murata and Tokyo Electron, were all down on the same days. THK and HDS got dragged along with the rest of the sector.

Pre-earnings rally

THK was up roughly 23% in the week before its own results, and roughly doubled over the past year. HDS was sitting near its 52-week high, already a 3-bagger YoY.

Results were below expectations

Here is a quick update on the results:

As the market rallied before the results, the expectations were obviously stronger.

THK’s net income is up 805% YoY. It was mostly a one-off gain from the divestiture of its automotive unit. The truth lies in a normalized net income closer to +364%.

There was no explicit mention of take-off in humanoid robotics, so the market feared the AI thesis wasn’t there: HDS’s guidance hike came with just “industrial robots and semiconductor manufacturing equipment”, and THK’s growth is also concentrated in “electronics and semiconductor” demand.

2. Bull vs bear update

I made a bull vs bear in the previous article, some points may have changed. It’s worth noting THK’s cost-to-sales ratio improved 4.6 points year over year. HDS’s operating margin for a single quarter already exceeds its full-year FY2027 guidance. It goes into the good direction.

Bear argument #1: China competition

Goldman Sachs conducted a field survey of 9 suppliers in China in November 2025. They planned an increase in capacity, from 100,000 to 1M units. Moreover, the direct competitor of HDS, LeaderDrive, mentioned booked capacity through 2027, with production expected to reach 1M units in 2026.

Bear argument #2: Price rally and cyclicality instead of robotics

As said before, both stocks went up significantly. The market is still cautious about evidence of bottleneck pricing, regarding the first bear point. Neither company has mentioned humanoid-specific segments. What is sure for the moment is the capex and the increase of competition on the supply side. If there is a bottleneck, nobody knows when it can stop.

Bull argument #1: Demographic tailwind / labor shortage

This point is unchanged from the previous article and certainly won’t be any different throughout the investment period. Demographics aren’t in quarters, but in decades.

Bull argument #2: Operational execution

Both companies raised the guidance, a good signal for the continuation of the thesis. The sustained execution is a necessary condition for the whole bull thesis to materialize.

Bull argument #3: Real barriers to entry

This point is unchanged from the previous article and certainly won’t be any different throughout the investment period. The qualification cycle for a new supplier is usually several quarters: by that time, the thesis will be played out.

Bull argument #4: The fragmentation of the world into blocs

I said in the previous article “each bloc (Western, and within the West, the EU, the US and Japan taken separately) will want to keep strategic suppliers tied to its own bloc rather than depend entirely on an outside supplier. This isn’t just a price or volume argument: it’s a supply-security logic that structurally leaves room for a “trusted” bloc supplier — even at a higher price, even with less volume than the cheapest Chinese option. Both HDS and THK benefit from this mechanism, independent of their pure price competitiveness. “

This argument has another confirmation in other compartments of semiconductors:

• On rare earth elements, China restricted access to Japan for dual use and permanent magnets over Taiwan tensions

• On chipmaking equipment, U.S. export controls target American toolmakers themselves, while Japan’s Tokyo Electron and the Netherlands’ ASML negotiated carve-outs letting them keep selling into China.

The logic is the following: if possible and for strategic sectors, the US companies would get a Tier 1 group of US companies, then a Tier 2 group of western companies (EU, Japan, Korea, etc.) and then a Tier 3 group of companies (China, rest of the world) with a focus on price.

New: Bull argument #5: The main competitor of HDS, LeaderDrive, is full until 2027

The other side of the first bear argument is that if LeaderDrive is in a supply shortage and there is room for western companies, then HDS should also be in a supply shortage for the coming quarters.

New: Bull argument #6: Despite growing capacities, the Total Addressable Market is growing significantly

HDS is adding 33% more capacity at its Beverly, Massachusetts plant by December 2026, on top of 13% already added in December 2025. In Japan, roughly ¥10bn is going specifically into humanoid-reducer production at the Ariake plant, targeting ¥10-20bn of revenue from that line in FY2027.

Goldman Sachs has also revised its humanoid market-size estimate upward since the original article: from roughly $3-5bn today to $15-19bn by 2030, and $38bn by 2035. The insight I want from this is that the runway until market saturation is longer than expected, allowing HDS and THK to compound for longer.

3. Valuation scorecard

Despite revenue growth running below the +50% YoY assumption from the previous article, the net margin of THK is already running above the scorecard’s Bull case. HDS’s Q1 margin is climbing faster than expected toward the Central case. I updated the valuation scorecard to reflect the shorter horizon now that we're getting closer to 2030. I expect the price to increase several times based on sentiment in the coming quarters, then I would sell the news before the price drop. The tricky part is to know when to sell cyclical stocks: you’ll never get the perfect tops and bottoms.

Conclusion

There’s still no clean evidence of a bottleneck, but both companies are tracking their bullish-scenario margins already — what the coming quarters should settle is how much of that holds up. The low weighting of stocks in the portfolio reflects this lack of predictability, although the balance between upside and downside potential remains positive. I would consider increasing my position in both if I had additional capital to deploy, given that the fundamentals have improved faster than the price.

Subscribe now

Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the companies analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

Despite fears of AI disruption, tourists are still booking with Booking. Room nights grew 5% YoY, the operating margin improved from 33.1 to 34%. Free cash flow minus SBC is up 17%. A pretty solid quarter, beating expectations across the board.

Verdict: I would love to add content on it, but nothing to see here, folks. Everything is fine.

My reaction

Booking is up today because such a juggernaut with a PE less than 25 times makes no sense. The numbers in the valuation section are lower to Novo Nordisk, but Booking has more love from the market, and the fears are easier to dissipate.

I think I will make a 100% return in the coming quarters and sell it for another GARP in a downturn.

As a client, I like Booking, and I really like it as a shareholder with its impressive net margin and no clear competition. Airbnb’s prices increased, so I perceive less value from it.

Booking is a clear example of “Invest in what you know” and an easy business to understand. Investing feels sometimes like an intellectual race, but the reward lies mostly in the simplest businesses.

2. The Numbers

2.1 At a glance

This table summarizes the key metrics from Booking’s Q2 FY2026 earnings release: https://ir.bookingholdings.com/overview/default.aspx

2.2 Commentary

Revenue :

Total revenue grew 8% YoY to $7.35B (7% FX neutral):

• Merchant revenues (Booking directly bills the final client, and afterwards pays the merchant) grew 15%.

• Agency revenues (Booking takes a commission on the reservation) fell 7%.

• Ads : +8%

The opposite direction between merchant and agency is following the Booking business model transition. So it is going as expected, and room nights are in line with the global increase.

Margins:

Net income margin grew to 26.5% from 13.2%. The number is overrated, since a non-cash FX gain on euro-denominated debt of $195M (vs a loss of $962M a year ago) occurred this quarter. The best metric to follow is the GAAP operating margin at 34.0% (vs. 33.1%, +0.9pt) driven by fixed-cost leverage (total operating expenses +7% vs revenue’s +8%) and cost reduction.

The Transformation Program expects an annual run-rate savings raised from $550M to ~$650M, targeted by end of 2027 — confirms the deep dive’s “more capacity to invest” thesis.

Net income and free cash-flow

As mentioned above, the FX gain on the debt is distorting the net income: 118% YoY. I prefer to track the free cash-flow (with subtraction of SBC), which grew 17% YoY.

The company bought back $3.7B in shares (vs. $3.6B in Q1 2026) and paid a $0.42/share dividend.

3. Key Takeaways from the Earnings Call

AI dominated the Q&A — 5 of 9 analyst questions were AI-related. Still a concern for most.

AI disintermediation: management put a number on it. Asked directly about AI’s impact on the top line, CFO Ewout Steenbergen volunteered the most concrete data point of the call: traffic arriving from large language models — paid and unpaid combined — is “still significantly below 1% of our room nights,” and “that hasn’t moved so much recently... no material change over the last few months or quarters.”

This is the first time management has quantified the AI-referral contribution, and it lands squarely in favor of the deep dive’s bull case: the disintermediation threat remains a future risk only.

A new crack worth watching: SEO pressure, mentioned for the first time. Management acknowledged declining organic search traffic: “I do believe that some of the changes that were made in the display at Google definitely put some pressure on SEO. Putting in that AI overview probably has done it. Now, here’s an important thing to keep in mind. So, our direct, our direct mid-60s, hasn’t gone down at all.”

Management is citing Q3 as the key quarter to watch: peak European summer, the first full quarter of Transformation Program savings, and the point where Middle East headwinds finally lap their own anniversary, normalizing the base effect.

4. Theses Update

4.1 Bear Thesis Signals

Room nights declining in absolute terms on core Booking.com. Not triggered. 325M, up 5% YoY, a record.

Direct booking rate below 60% and falling. Not triggered, though the sources disagree on the number. The 10-Q says mid-fifties, flat versus last year. Fogel said mid-60s on the call, also flat versus last year. Pick whichever number you trust more, but none of them is falling.

Customer acquisition cost rising specifically on accommodation. Inconclusive. No segment-level disclosure exists. Marketing spend as a share of gross bookings ticked up 10 basis points, to 4.7%. But is going from 4.6% to 4.7% significant?

An AI agent completing hotel bookings at scale outside an OTA. Not triggered. Management put a number on it this quarter for the first time: LLM referral traffic is below 1% of room nights, and that share hasn’t moved in months.

4.2 Bull Case

FCF minus SBC growing. Confirmed. $3.50B this quarter, up 17%. Pretty solid.

Operating margin expansion. Confirmed with the GAAP Operating margin at 34.0%, up 90 basis points.

Transformation Program flowing to the bottom line. Confirmed, and moving faster than expected. The savings target rose from $550M to roughly $650M this quarter. Another $100M got identified on top of that, from B2B consolidation.

Genius as an anti-disintermediation moat. Confirmed, strengthening. Level 2 and 3 members now account for a high-50s share of room nights and more than 30% of the active customer base. Both figures are up year over year.

Aggressive buybacks at depressed prices. Confirmed, unchanged pace. $3.7B this quarter. $14.5B of authorization still on the table.

Direct channel above 60% and rising. The exact level is disputed between the 10-Q and the call. It is the same argument as bear signal #2.

5. Valuation

I’m sticking with the original deep dive assumptions. I updated the current date and the EPS. The end date stays fixed, which mechanically inflates the annualized figures, since the same target price is now spread over a shorter time horizon.

The normalized P/E is 21.6x, based on normalized earnings of $7.11B, driven by 1) adding back the $457M KAYAK impairment recognized in Q3 2025, 2) removing the $581M non-cash FX gain on euro-denominated debt that artificially inflates TTM GAAP earnings, and 3) the $25M tax benefit associated with these two adjustments.

CAGR calculated from $204.1 to June 5, 2028 (1.83 years), dividends included.

How to read this table: in the central scenario at PE 30x, the price target reaches 358$ by December 31, 2028, a total return of +75% from current price, or a CAGR of 36.0% including dividends. It is the floor of my conviction, since 30 is still a quite conservative PE ratio for a business of this quality.

I’d consider selling above 35x.

Subscribe now

Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

The central point of this quarter is the guidance raise for 2026, with adjusted sales now expected to grow from flat to -6% at CER, vs. -4% to -12% previously. Management gave us two reasons to adjust sales: one good, a provision reversal, and one semi-good, with impairment of terminated drugs.

The main growth is made by the obesity segment, and inside it, by the Wegovy pill (almost none by the injectable Wegovy). I expect the worldwide launch of Wegovy HD to provide additional revenue and operating profit.

Verdict: The volume effect, which is positive, is now outweighing the price effect. In front of us, I see the upside; behind us is the downside.

Subscribe now

My reaction

I published a note yesterday about how much I dislike the word adjusted. Here I don’t see any partial presentation of the truth. The ‘adjusted’ framing asks readers to do extra work to assess the current situation. That’s part of what I do here, and it’s normal for me to provide it to you. Management is right to give us this presentation, as it delivers the most precise picture of the business health.

With Novo Nordisk, being contrarian feels like a long path of patience, and any bottom-sell could cost you a lot, just as being too early could. It was a market darling, and then a fallen angel.

The only things that could resolve its situation are time and work (from the company). They are on track: the downside is certainly behind us, and the upside is coming.

The numbers, the bear thesis status, and the bull thesis are here to validate these points.

As a personal view, somebody from my family is taking a GLP-1 drug. It turns out she was prescribed Zepbound, presented to her as ‘more effective.’ I have to admit I didn’t take that news particularly well, as a Novo shareholder. I’m fairly convinced that going forward, Novo’s prescriptions will pick up again with Wegovy HD.

2. The Numbers

2.1 At a glance

This table summarizes the key metrics from Novo Nordisk’s Q2 FY2026 earnings release: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916590.

2.2 Commentary

Adjustments

Management provided adjusted numbers relative to 2 one-time events.

• Impairment of DKK 6B, with DKK 4B to the sole monlunabant drug. Even though it is a non-cash expense, it carries a real cost. Additional impairment could occur in the coming quarters, depending on the results (and terminations) of the pipeline. I see it as something you should be prepared for as a pharmaceutical company shareholder.

• Rebate provision reversal: Under the U.S. 340B Drug Pricing Program, manufacturers must give discounts on drugs sold to hospitals and clinics serving low-income patients. Novo booked a provision in ‘25, which turned out, this quarter, to have been too conservative. The release of this provision gives a one-time boost to reported sales and profit. The underlying performance of the company is best read without this adjustment.

In my opinion, the best number for profit analysis is without rebate provision reversal and with impairment, as it is a “recurring” expense in the life of such a pharmaceutical company.

Revenue

Q2 2026 reported sales increased by 3% at CER (Constant Exchange Rate), and adjusted sales increased by 7% at CER. The volume effect, which is positive, is now outweighing the price effect, which had been reduced due to U.S. government decisions.

As expected, Obesity care accelerated, with +16% CER YoY, vs 3% for the diabetes segment. I wrote in the deep dive that this second segment is mature and commoditized, so there is no surprise here.

Inside Obesity:

• The injectable Wegovy is only growing 1% CER.

• The heavy lifting is done by the Wegovy pill.

• With the worldwide launch of Wegovy HD, I expect clear traction to return for the injectable (for Q3 in the EU). As said previously, the drug efficacy gap with Zepbound resolved with Wegovy HD.

• International Operations (unadjusted) sales grew 10% CER, whereas US Operations (unadjusted) sales shrank 2% CER.

Margins

The adjusted gross margin is shrinking from 82.7% in Q2 2025 to 78.2% in Q2 2026, due to “lower realised prices, one-time costs of around DKK 3 billion related to right-sizing of manufacturing capacity agreements, as well as a negative currency impact. This was partly countered by productivity gains and a positive product mix.“ (information from Novo Nordisk).

The adjusted operating margin is improving from 41.8% to 42.5% YoY, as Novo reduced its workforce and made efforts on cost to maintain its profitability.

Any additional price drop could lower the margin. As shareholders, we hope that the US government will move to another topic.

Without any change on this subject, we can expect the margin to be near its bottom with volume increase, price stability and additional variable cost reductions.

Net income and free cash-flow

Financial charges increased from DKK 1.95bn to DKK 2,76bn, with a higher interest rate on the debt. Worth mentioning, but nothing alarming here.

Net income fell 21% due to the adjustments, and free cash-flow increased by 57% YoY since the capex fell 14% CER YoY due to a higher base effect in 25. Investments are still strong as the future needs way more GLP1 drugs.

3. Key Takeaways from the Earnings Call

Novo’s management stays conservative in its assertions, as Novo Holdings Foundation controls 77% of the voting rights, so management has no structural incentive to overpromise to put the stock price higher. It is reinforced by a danish corporate culture of humility and trust. That’s my opinion and I’m not Danish, but I come from Central Europe and people tend to behave like that.What is a good point for trust is a bad point for rerating.

As the thesis is focused on obesity, I won’t elaborate on the pipeline.

Guidance. Framed as “a better than expected start to the year.” Management confirmed the outlook stays conservative on the Medicare Bridge program, even after a direct push from an analyst noting a competitor has been more bullish on volume inflection. This is consistent with the “guidance was sandbagged” read.

Access. “From an access perspective, quality of access for obesity GLP-1s remains poor and is a key focus area. While we see uptake for the pill in the reimbursed commercial channel, the majority of total prescriptions are self-pay.”

Manufacturing capacity. On the new API facilities: “validated the first product in the first facility... very low utilization from these facilities... bullish in terms of being able to supply significant volumes in the years to come.” Early innings on the capacity ramp. The moat is intact. It’s not yet monetized.

Cost savings, ahead of plan. The Q3 2025 restructuring is tracking ahead of its DKK 8 billion savings target. Headcount down to 66,700. That’s a cut of roughly 12,000 people, 15%, over the past year. Harder than the 9,000 figure originally announced.

Wegovy pill, international. UK: 300,000 patients in the first three weeks, versus 48,000 in the US over a comparable window. UAE: Novo’s obesity market share jumped from 30% to 45% after the pill launch. The pill already holds roughly 50% of the oral segment there, despite a competitor’s oral drug launching about a month earlier (surely Eli Lilly…). Germany launches in September. Around 80% of pill patients are GLP-1-treatment-naive. Limited cannibalization of injectable Wegovy.

What’s next. Capital Markets Day, September 2026. Formal 2027 guidance waits until February. The CFO already flagged two swing factors: the CagriSema US regulatory decision, expected by year-end, and the “mim8” decision, in H2 2026.

4. Theses Update

Anchored to the deep dive published 26/05/2026 (”Novo Nordisk: A GLP-1 Banger”).

4.1 Bear Thesis Signals

• No guidance beyond 2026. Nothing in this report addresses 2027 and beyond. The raise only narrows the 2026 range, from -4% to -12% CER down to 0% to -6% CER.

• Lilly winning the GLP-1 market (57% share). Lilly reports Q2 2026 the same day as Novo. One data point does stand out: Wegovy remains the U.S. market leader by new patient starts among branded obesity drugs, even as Zepbound leads on total prescriptions. I will provide content about Lilly vs Novo later.

• Structural margin compression (MFN). Confirmed, but smaller than the headline number suggests. Adjusted gross margin fell, indeed, but Novo discloses that roughly DKK 3 billion of that hit is a one-time cost tied to right-sizing manufacturing capacity agreements, layered on top of lower realised prices and a negative FX effect. Strip out the one-off and the clean MFN-driven compression is well under the headline -4.5pp.

• New this quarter: pipeline disappointment. Monlunabant’s development was terminated, “due to portfolio considerations,” triggering a DKK 4.0 billion impairment. ZEUS (ziltivekimab, cardiovascular) missed its primary endpoint. Neither touches the core obesity thesis directly. Both are new data points on non-GLP-1 pipeline execution that didn’t exist in May.

• New this quarter: quality of growth. Trade receivables grew 25.5% since year-end, DKK 70.9 billion to 88.9 billion, roughly twice the pace of H1 revenue growth. Plausibly just the ~60-country Wegovy rollout. Still, a working-capital line to watch next quarter.

4.2 Bull Case Prerequisites

• Efficacy gap with Zepbound closes, via Wegovy HD. In progress. Launched in the US in April, in the UK in June alongside the single-dose pen. No comparative prescription data yet.

• Valuation gap vs. Lilly (PE 10x vs. 36x) is an anomaly. Still wide open. At ~308.7 DKK, the stock prices closer to the Bear and low-Central scenarios than the Bull case. See the updated scorecard in section 5. The market is rewarding today’s execution without re-rating the multiple.

• Prices fell, volume hasn’t followed. Yet. This is the prerequisite that finally shows up in the numbers. Obesity care accelerated to +16% CER. Wegovy pill scripts kept climbing past 265,000 weekly by mid-July. Volume is now outweighing price at the net-sales level: +7% adjusted CER, despite ongoing MFN cuts.

• Guidance was sandbagged. Confirmed again. It is the second consecutive raise under Doustdar.

• Production moat: 14 fill-finish sites, 5 to 7 years to replicate. Reinforced by the same capex and net-debt evidence above. The moat is largely built and starting to convert into cash rather than absorbing it.

• Market stays a duopoly through 2028. No new information either way this quarter.

• CagriSema delivers in Phase 3. Mixed. REDEFINE 9, the lower-dose trial, showed statistically superior weight loss vs. placebo. It also lands in the same quarter as the monlunabant termination and the ZEUS failure.

5. Valuation

I’m sticking with the original deep dive assumptions. The only update is the current price. The end date stays fixed, which mechanically inflates the annualized figures, since the same target price is now spread over a shorter time horizon.

CAGR calculated from 308.7 DKK to December 31, 2028 (2.4 years), dividends included.

How to read this table: in the central scenario at PE 22x, the price target reaches 572 DKK by December 31, 2028, a total return of +95% from current price, or a CAGR of 32.0% including dividends. It is the floor of my conviction.

The assumptions depending on the PE:

• PE 15x — The market sees a mature pharma under pressure, losing market share to Lilly, facing patent cliff in 2031. Just a dividend stock.

• PE 22x — The market recognizes a quality compounder, solid second in a structural duopoly, with a manufacturing moat. GARP territory.

• PE 30x — The market prices leadership potential. Wegovy HD closes the efficacy gap, the oral pill scales, CagriSema delivers. Novo challenges for pole position.

Subscribe now

Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

EverQuote delivered on revenue, growing 25% year-over-year. Operating margin expanded from 9% to 12%, and operating income grew 65%. EPS growth was muted by a tax headwind, but the underlying results are solid.

Nothing here shows any sign of disruption to the business today.

EverQuote delivered another quarter of growth and profitability.

The investment thesis has always rested on a simple observation: a platform like EverQuote already exists and works in Europe — MoneySuperMarket and GoCompare in the UK, CHECK24 in Germany, LesFurets in France — and the US is simply following the same path with a lag. This is a genuinely good business that the market has beaten down.

With a PE of 11.4 and a PFCF-SBC of 12.5 on a price of $24 (premarket), EverQuote is a quality small-cap that should re-rate toward double its current price

Verdict: Another quarter, another fear of disruption that is still not showing up. Re-rating will come.

Subscribe now

My Reaction

Management is talking extensively about its EBITDA Adjusted.

To focus on this point, I dislike the usage of EBITDA, as it doesn’t reflect the true health of the company.

But Adjusted EBITDA? It is something I strongly dislike:

• The term isn’t standardized and its definition can be adjusted to whatever management wants to show you.

• If the GAAP term were good, they would present it.

• It gives me a seductive vision from management, showing you the parts of the truth they are willing to and not the actual situation. I cannot feel trust in such conditions.

In this kind of situation, I usually check for financial shenanigans, to see if the partial vision provided by management is also distorted in the financials.

Management defines it as: “net income (loss), excluding the impact of stock-based compensation expense; depreciation and amortization expense; restructuring and other charges; acquisition-related costs; legal settlement expense; interest income; and income taxes. “

Luckily, the numbers for EverQuote are still strong and the net cash position tells you the company generates enough cash to fund itself and still return some of it to shareholders

But still, I won’t comment on any Adjusted EBITDA metrics.

I have held EverQuote since April 30, 2026 and I’m up 60% at the time of writing, a pretty solid result.

The company is heavily profitable, and priced like it’s dying. I still don’t see any disruption. Management is able to take advantage of the undervaluation to buy back as many shares as possible, a good point for the long term. I can clearly see the company trading around $100 within a few quarters

When? The main question is when the market will consider that EverQuote is a winner, and won’t be disrupted anytime soon.

2. The Numbers

2.1 At a Glance

This table summarizes the key metrics from EverQuote’s Q2 FY2026 earnings release: https://investors.everquote.com/news/news-details/2026/EverQuote-Announces-Second-Quarter-2026-Financial-Results/default.aspx

2.2 Commentary

Revenue: 15% year-over-year in Q1, 25% in Q2. Those are good numbers, as they usually increase the operating leverage. But it cannot be found yet in the increase of earnings. This is the reason, in my opinion, why management is talking about EBITDA Adjusted.

The main activity is in the Auto segment (+23.3%, $172.1M), but the Home & Renters segment is gaining more traction +35.2% ($23.0M). A good signal, as it isn’t their core activity and they take market share from their competitors - online: MediaAlpha and offline: TV, display advertising, physical agents (i.e., in-person/traditional insurance agents).

Operating Margin : 12% in Q2 vs 12.3% in Q1, vs 9% in Q2 ‘25. The operating income grew 65% YoY for just 25% growth of revenue. The leverage is the key to the rerating and earning growth I am looking for. It went from a small basis, though.

Net income and Free cash flow: Free cash flow - Stock-based compensation dipped sequentially, $22.8 million versus $28.1 million in Q1. The dip reflects a working-capital timing effect.

Income before income taxes is up from $15.1M to $24.5M (+62% YoY), but the tax rate went from 2% to 21%, due to a one-time tax credit last year. It was a one-time event that won’t occur next quarter.

Cash position : $192.3 million in cash, zero debt, $50 million bought back since last August. Net cash as a share of market cap fell from 32.1% in Q1 to 23.0% in Q2. This number is pretty satisfying, as this “lowers” the effective PE ratio by 23%, and management will be able to buy shares back and push the share price higher.

3. Key Takeaways from the Earnings Call

Management spent a lot of the call on AI — a new bidding tool called Smart Campaigns, internal AI agents, early work on capturing traffic from AI search and what they called “agentic commerce.” It’s a real shift in framing: AI used to come up as a threat to comparison platforms like this one, and now it’s being pitched as EverQuote’s own weapon.

Management follows a metric, the Variable Marketing Dollars (VMD), which is Revenue minus the expense for traffic acquisition from Meta, Google, etc. It tracks the true value the company adds. The ratio of this metric is the Variable Marketing Margin (VMM).

The most-asked question on the call, more than once, was whether the margin would compress as the company invests in AI. CFO Joseph Sanborn kept steering it back to dollars, saying the company does “not solve for VMM margin, we solve for VMD,” and reiterated a target in the high 20s. That’s a defensible way to run the business, and keeps a focus on operational leverage.

The AI story moved from a defensive talking point to an offensive one. For the moment, only the story changed: it is still to be found in the VMM.

Combined ratios stayed healthy — “in the 80s,” per management — which is the clearest evidence available that the 2023 collapse was cyclical, not structural.

On capital allocation, management laid out three priorities in order: organic growth, buybacks ($50 million cumulative), and M&A as a lever toward the $1 billion target. No sign of a deal happening soon.

4. Where the Investment Thesis Stands

I had no time to formalize a deep dive yet, although I meticulously checked the company on a checklist I have.

4.1 Bear Thesis Signals — Triggered or Not

- AI disintermediation (Google/Meta build native insurance comparison tools) → not triggered. Management is positioning EverQuote as an AI infrastructure partner instead, though that’s a claim only and not a measured outcome yet.

- Traffic dependency (rising Google/Meta click costs compress margin) → not triggered. VMM held at 29.2%, in line with last year.

- Rising carrier combined ratios cutting marketing budgets → not triggered. Combined ratios described as healthy, in the 80s.

- Stock-based compensation dilution → partially active. SBC is real ($10.8 million year-to-date) but partly offset by $29 million in buybacks over the same period.

- Product concentration in Auto insurance → still structurally true (88% of Q2 revenue), though Home is growing faster and slowly diluting it.

4.2 Bull Case Prerequisites — Status

- Recovery of the auto insurance cycle → confirmed. Healthy combined ratios, accelerating Auto growth.

- Operating leverage from AI and scale → confirmed and strengthening. Operating income growth nearly tripled revenue growth.

- Disciplined capital return → confirmed. $50 million bought back, consistent pace.

- Diversification into Home insurance → in progress. Home grew 35.2% against Auto’s 23.3%.

- Path to $1 billion in revenue → reaffirmed by management this quarter.

- VMM expansion above 35% → not observed. Still at 29.2%.

Subscribe now

Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

1.1 Synthesis

Atos is coming back from a near-bankruptcy: at the end of 2024, a commercial court ordered the restructuring of its balance sheet. Today, the firm is progressing toward its 2028 objectives:

• €9-10 billion in revenue

• 10% operating margin

• An investment-grade credit rating profile

The first chapter is the cost-reduction phase of the Genesis plan, delivered ahead of schedule. The initial target was achieved within a year and has since been raised to €800M.

The second chapter is the improvement in operating margin: €190M in H1, up 43% year-on-year, from 3.7% in H1 2025 to 5.7% in H1 2026.

Management indicates that the actions behind these two chapters are complete and will continue to deliver results over the coming quarters.

The next chapter is commercial expansion, where management’s focus is now shifting.

The balance sheet is expected to improve significantly by year-end, supported by continued progress on debt refinancing.

None of the bear thesis’s warning signs have been triggered, and the bull thesis is gradually playing out.

Verdict: The company is progressing through its turnaround. The market still applies a discount, and management is advancing relentlessly toward resolving it. The price does not yet reflect the positive developments of the first half.

Subscribe now

1.2 My Reaction

Management has been heavily focused on cost-cutting measures and will continue acting to protect the margin of the business. I’m still very bullish on Atos, and I think the market is still pricing it as though the company will remain a broken IT services business.

They have succeeded on the cost-cutting front, are well on their way to improving operating margin, and are removing black contracts wherever they can — the ones that generate extra revenue but kill the margin.

They are now focusing on revenue: the commercial pipeline is growing significantly, and the 91% book-to-bill ratio, while it looks disappointing, doesn’t include framework agreements. Some of their clients were forced to end their contracts because of Atos’s previous sub-investment-grade status, and are keen to come back as soon as they can.

I’m a bit puzzled by the -7% move on results day. Turning around a company like Atos isn’t easy, and the bull thesis is playing out in the right direction — just not as fast as the market seems to expect.

I’m still confident the stock will move upward over the coming quarters. One day, management could raise guidance, and the stock will re-rate. And I’ll be there. I don’t mind waiting two years for a 5-20x return, because I’m convinced Atos will turn around.

2. This Quarter’s Numbers

2.1 At a Glance

This table summarizes the key metrics from Atos’s Q2 FY2026 earnings release: https://www.atosgroup.com/en/investors/financial-results-reports/h1-2026-results

2.2 Commentary

Numbers are those of ’26 vs. ’25.

Revenue (go-forward perimeter): €3,304m vs €3,626m and operating margin: 5.7% vs 3.7%

Management is “cost-killing” and removing black contracts with two effects: the revenue goes south and the margin goes north. Revenue will improve in the next quarter, as will the operating margin. The revenue decline is decelerating every quarter since ’25.

Organic growth: -8.9% vs n/a
H1 total organic growth rate, calculated by Atos at constant scope and FX. Not applicable to H1 2025 since it’s the comparison base.

Underlying EBIT: €190m vs €133m
+43% (+€57m) year-on-year. Every improvement in revenue will drastically increase EBIT.

GAAP net income: -€504m vs -€695m
Loss narrowing by €191m year-on-year, but still heavily weighed down by one-off refinancing costs (call premium, accelerated IFRS9 depreciation) and restructuring charges — not a clean read on underlying profitability yet. Management targets a “clean” P&L by year-end 2026.

Operating cash flow: -€120m vs +€28m (published, not comparable basis)
The -€120m figure includes €127m of restructuring cash-out — strip that out and underlying cash generation is close to flat to slightly positive. The H1 2025 published figure isn’t calculated at the same current perimeter, so it’s not a clean comparison; treat both cautiously.

Total liquidity: €1,805m vs N/D (30 June 2025)
Comfortably above the €650m covenant floor. Next payments are in 2030, giving management the time it needs to turn the company around.

Book-to-bill (global): 89% H1 / 91% Q2 vs N/D (Q2 2025: 84%)
Below 100% at face value, but methodologically conservative — framework agreements (the €187m European public sector deal, the Dutch police contract) aren’t counted. The +7pt year-on-year improvement, and >100% book-to-bill in France, UK and Eviden specifically, tell a stronger story than the headline number.

Renewal rate: 94% vs 91%
Confirms the “back to normal” narrative management pushed on the call — this is roughly where renewal rates sat before the 2024 restructuring shock hit client confidence.

3. Earnings Call Key Takeaways

Genesis ahead of schedule: Phase 1 (€650M) completed in one year, by Q1 2026. Phase 2 launched, horizon 2027-2028, total target raised to >€800M. Total restructuring cost envelope confirmed at ~€700M (~€200M spent in 2026).

Margin/revenue mechanism openly acknowledged by management:

Philippe Salle, CEO:

• “Whatever happen on the top line, we will deliver the bottom line”

• “I have just adjusted Genesis to protect the margin”

A nice way to say that he will reduce workforce whether or not it’s needed.

Official book-to-bill is conservative: 91% (+7 pts YoY), but framework agreements (the €187M European public sector contract, Dutch police, European Patent Office) aren’t counted. France, UK and Eviden all above 100% in Q2.

Qualified pipeline: +€900M in Q1, +€760M in Q2 = roughly +€1.7bn cumulative over H1.

No net client losses in H1 2026 — a contrast with 2024-early 2025.

Management posture shift: “refocus the mind of the management to the top line” — an explicit pivot from survival to growth.

Management is now explicitly focusing on revenue expansion. It is the last chapter of the turnaround story. I’m bullish that management will make it happen.

No price deflation on renewals: margin on signed contracts close to 25%, presented as evidence against broad-based pricing pressure.

Black accounts: down from several problematic contracts to just two today; one of the two loses ~€10M/year, with a maximum remaining duration of 2 years.

Debt structure: no maturity before the 1.5L tranche (2029-2030) following the May refinancing. Debt buybacks already underway: €109M on the open market + €38M linked to the South America disposal.

4. Where the Investment Thesis Stands

The objective of this section is to confront the quarter / half against the deep dive bear and bull thesis.

4.1 Warning Signs of the Bear Thesis — None Triggered

The three signals that would have invalidated the thesis (original deep dive, “Points of failure” section):

• FCF vs. reported EBIT divergence: Not triggered — the gap is almost entirely explained by the restructuring cash-out

• Book-to-bill sustained below 90%: Not triggered — 91% official, likely understated (frameworks excluded)

• Flat or rising Genesis charges: Not triggered — declining trajectory confirmed for H2 (€127M in H1 → guidance of ~€70M max in H2)

4.2 Bull Case Prerequisites — Status

As laid out in the original deep dive, the bull case rests on fourteen independent arguments. Most haven’t moved this quarter. Below are only the ones that have evolved since the deep dive:

• Argument 2 (contract rationalization → hidden operating leverage) — confirmed: EBIT +43% on declining revenue across two consecutive half-years.

• Argument 3 (judicial shield + 2031 refinancing) — confirmed. No debt maturity before 2029-2030 following the completed refinancing steps. The existential risk this argument addressed is now closed.

• Argument 4 (counterparty-risk unlocking) — in progress, strengthening. Zero net client losses in H1 2026, a clear contrast with 2024-early 2025. North America book-to-bill at 115%. Management’s own posture shift — explicitly refocusing on the top line.

• Argument 5 (deleveraging flywheel) — in progress, strengthening. Debt buybacks already executed (€109M open market + €38M from the South America disposal), and oversubscription of the refinancing from the bond market in May. I see it as the main point playing out.

  

• Arguments 7-8 (AI doesn’t destroy the IT services model / regulated sectors need Atos) — qualitatively reinforced. New contracts with sovereignty-sensitive institutional clients (European public sector agency, Dutch police, European Patent Office) support the thesis, though this remains anecdotal.

5. Valuation

The following images provide the different scenarii embedded in the deep dive

The deep dive laid out a nine-scenario scorecard, I don’t provide a unique valuation, merely scenarii . The market is still pricing Atos close to S2, the market-crash scenario, at a current price of ~€33 against an S2 target of €28. That’s roughly where the implied EV/EBIT of ~5.6-6x has sat since the deep dive was written — essentially no re-rating despite the quarter’s execution.

Out of this quarter, the price should reasonably start moving to reflect:

• margin convergence over two consecutive half-years

• the book-to-bill once framework agreements are counted

• black-account stabilization (down to two, from several)

• the absence of net client losses in H1 2026

• the improving commercial pipeline (+€1.7bn qualified pipeline over H1)

• any AI/sovereign optionality (MogwAI, Sovereign Cloud, AI Studios)

The rerating will certainly take place once management increases the guidance and when the market realizes that IT services won’t be disrupted by AI any time soon. It is a core assumption of the thesis that should be emphasized.

Subscribe now

Important Disclosure & Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

1. Quarterly Verdict

1.1 The Engines Are Running, The Bill Is Getting Heavier

Nothing in the published numbers contradicts Alphabet’s growth trajectory. Search is up 17%, YouTube up 13%, and above all Cloud is accelerating to 82% with an operating margin that has nearly doubled year over year (20.7% → 35.6%). Twelfth consecutive quarter of double-digit growth for the group.

What has changed, on the other hand, is the scale of the investment effort management is now committing to. Leadership raised its annual capital expenditure guidance from $180-190B to $195-205B — a jump of more than $15B decided mid-year, justified by a faster pace of AI capacity delivery than previously planned, in the face of demand that still outstrips supply. The immediate consequence: negative free cash flow of -$5.9B for the quarter, a first in several years.

It’s this last point, more than growth itself, that drove the stock down after the release. The market read “cash pressure” where management is presenting a calculated bet on the future return of this investment, notably through TPU system sales, the bulk of which won’t be recognized as revenue until 2027.

Bottom line. Nothing in this quarter undermines the underlying thesis on Alphabet, but the market remains hesitant about the profitability of the investments being made. How long is it willing to fund this phase before demanding concrete proof of return? Q3, with the first effects of the shift toward third-party capacity, will give a first indication.

Subscribe now

1.2 My Reaction With a 10% Alphabet Portfolio

I remain very bullish on Alphabet given the quality of their world-class products, and their impressive growth given their size. Search, YouTube and Cloud are each, taken individually, dominant positions in their category — few companies can claim three engines of this scale at once, let alone growing them simultaneously at this pace (17%, 13%, 82%) with a revenue base already above $400B annualized. It’s this combination — product quality, addressable market size, and speed of growth despite the size already reached — that in my view justifies staying invested despite short-term volatility in the stock.

The TPU business looks like a solid growth driver. The first deliveries started being recognized this quarter, but remain deliberately marginal: management is clear that the bulk of revenue from these contracts won’t arrive until 2027, which gives visibility into a growth engine that hasn’t even started running at full capacity yet. Management frames this as an expansion of the addressable market rather than cannibalization of Cloud, which is consistent with the “full stack” strategy: the more layers Alphabet controls (chips, models, infrastructure, distribution), the more value it captures at each layer.

Investing in hyperscalers seemingly requires trusting management on the profitability of these investments — which has held true so far. As a minority shareholder, you can’t audit the return on every dollar of capex poured into a data center yourself; you can only watch whether the indirect signals point the right way (Cloud margin expanding, backlog growing, a consistent narrative quarter after quarter) and note that, so far, these investments have translated into margin expansion rather than dilution. That’s no guarantee going forward, but it’s a track record that deserves credit rather than default suspicion.

If profitability were to decline, they can halt investments, sell off assets, and the income statement and cash flows would mechanically improve. That’s a safety net you don’t necessarily get with other types of businesses: Alphabet’s capex is largely discretionary and spread over time, without being locked in irreversibly for decades. If AI capacity demand were to soften, management could slow server orders, pause new data center builds, or even offload assets to third parties (as it’s already partly doing with leased capacity) — and free cash flow, negative today, would turn positive again fairly quickly.

2. This Quarter’s Numbers

2.1 At a Glance

This table summarizes the key metrics from Alphabet’s Q2 FY2026 earnings release: https://s206.q4cdn.com/479360582/files/doc_financials/2026/q2/2026q2-alphabet-earnings-release.pdf

2.2 Commentary

Revenue. At $119.8B, the quarter beats consensus by nearly 3%. The 24% growth marks a clear acceleration versus Q2 2025 (+14%) — no sign of fatigue in the core advertising business.

Off-balance-sheet purchase commitments and other contractual obligations — $332.4B total (of which $138.0B short-term). This figure comes from the Q1 2026 10-Q — the Q2 10-Q hasn’t been filed yet, so this is included here as a tracking reference rather than a Q2 data point. It’s an important number to flag: it sits entirely off the balance sheet (these are future commitments, not booked liabilities), yet it dwarfs the quarterly capex figures dominating the headlines and gives a sense of just how much additional spending is already contractually locked in beyond what shows up in the P&L or cash flow statement each quarter.

— of which long-term supply agreements (>1 year), including energy and content licenses: $232.7B. Also from the Q1 10-Q. This is the bulk of the $332.4B total and covers technical infrastructure and inventory components, energy take-or-pay contracts (with payments running through 2047), and content licensing — in other words, the multi-year backbone of Alphabet’s AI buildout that sits alongside, and arguably dwarfs, the headline capex guidance figures.

Cloud, the main engine. This is the segment driving most of the positive surprise: revenue up 82%, operating margin jumping from 20.7% to 35.6%, backlog up more than $50B in the quarter alone. The first TPU system sales to customers have started being recognized, but remain marginal — management explicitly states that the majority of revenue tied to these contracts won’t show up until 2027.

Operating margin. At 34.0% versus 32.4% a year earlier, it improves year over year despite rising depreciation charges linked to capex. Viewed sequentially, the picture is different: margin declines versus Q1 2026’s 36.1%. Part of this decline is seasonal — Alphabet structurally posts a higher margin in Q1 than in Q2, as it already did in 2025 (-1.5 pt on the same transition). But the scale of the decline this year (-2.1 pt) exceeds this pure base effect: other cost of revenues (technical depreciation, YouTube content) is rising as a share of revenue, a structural effect tied to the ramp-up in capex, compounded by one-off G&A charges (compensation, litigation) that inflate that line by +50% for the quarter. Management also warns of additional pressure in Q3, tied to increased use of third-party leased compute capacity while internal infrastructure ramps up.

Free cash flow, the sensitive point. Negative for the quarter for the first time in a long while, entirely attributable to the capex level. On a trailing-twelve-month basis it remains positive at $53.3B but is down 20% year over year. This line, more than the income statement, is what dominated analyst attention on the call.

Financing — the opposite of a buyback. Rather than reducing its share count, Alphabet did the opposite this quarter: raised $49.6B in equity and convertible notes, made no repurchases (versus $13.2B a year earlier), and diluted shares outstanding rose from 12,198M to 12,309M year over year. That’s a clean reversal from the stock’s usual dynamic, entirely dedicated to funding capex.

Quality of net income. Operating income gives a faithful picture of the quarter’s real performance; reported net income, on the other hand, is massively inflated by an accounting revaluation of equity stakes, largely illiquid and unverifiable by the market.

Operating income — the part reflecting the company’s actual business — grew 30% to $40.8B. That’s a solid signal, consistent with revenue growth (24%) and Cloud margin expansion: nothing to flag there.

The portion of income coming from gains on equity securities, on the other hand, is a largely accounting artifact disconnected from operations: $98.0B in unrealized gains, which explain most of the gap between operating income (+30%) and reported net income (+298%). The detail available for Q1 2026 (the Q2 release only publishes the aggregate total) shows that this type of gain comes almost entirely from non-marketable securities — stakes in private companies, valued not at market price but revalued only occasionally upon observable transactions (typically new funding rounds). In Q1, the net gain on non-marketable securities was $36.3B versus just $105M on marketable securities — a ratio of more than 300 to 1. Of the $101.3B carrying value of non-marketable securities as of March 31, 2026, $73.6B had been remeasured during that single quarter.

For Q2, Alphabet does not break down the composition of its $98.0B in securities gains, but financial media (Fortune, among others) attribute it to two stakes in particular: Anthropic, which remained private, whose valuation rose from $350B to $965B over the quarter following a $65B funding round, and SpaceX, which went public in early June 2026 at a $1.77T valuation (versus roughly $400B at its last private valuation), and is therefore now sitting on the marketable side. This specific attribution is not confirmed by Alphabet itself — the 10-Q never names its stakes — but it’s consistent with the pattern observed in Q1: most of the gain comes from a private-stake revaluation, not a market move on listed shares.

3. Earnings Call Key Takeaways

Opening / growth. Twelfth consecutive quarter of double-digit growth; Pichai says Alphabet is still in the “very early innings” of an AI-driven secular shift. Cloud backlog at $514B (+$50B for the quarter), Gemini Enterprise adopted by ~90% of the Fortune 100. Model APIs now processing 22 billion tokens per minute (up from 16B last quarter), Gemini app at 950 million MAU.

Models / product roadmap. Gemini 3.6 Flash and 3.5 Flash-Lite launched just ahead of the call; Gemini 3.5 Pro in testing. Gemini 4 is in training — described as the “most ambitious effort yet,” needed to stay at the frontier. Management is targeting a near-monthly release cadence going forward. Coding/agentic coding flagged as a current weak spot, being actively closed (3.6 Flash: +10 points on DeepSuite vs. 3.5 Flash).

TPUs (the most-probed topic in Q&A). Allocation priority: frontier model development (AGI) first, then Search/YouTube/Cloud, particularly Vertex AI and Gemini Enterprise. Third-party capacity deals (e.g. SpaceX, Blackstone) act as a pressure valve to absorb demand without diverting internal TPUs. The CFO explicitly declined to disclose TPU sale margins specifically — only saying it “expands the TAM” rather than cannibalizing Cloud. Revenue from TPU sales to customer data centers will mostly land in 2027, not 2026.

Capex and financial structure. The guidance increase (to $195-205B) is framed as an acceleration in capacity delivery, not a change in philosophy. Funding waterfall: operating cash flow first, then debt (up from ~$16B to ~$100B in a year), then equity — the recent equity raise isn’t expected to repeat (aside from the ATM program for SBC-related taxes). Anat Ashkenazi: “we will continue to invest as long as we see an attractive return.”

Competition / moat. Pichai emphasizes the “full stack” approach (chips + models + cloud + distribution) as the differentiator rather than any single model. On the “model war” question, explicit positioning across the full price spectrum (Flash-Lite through frontier), not just the high end.

Other Bets. Waymo launched a new vehicle (”Oasis”); Pichai stayed evasive on a possible spin-off, prioritizing execution instead. Isomorphic Labs raised over $2B for its drug discovery pipeline.

Search/YouTube monetization (Philipp Schindler). Retail and finance were the largest contributors to Search growth. AI Max (out of beta): +15% average conversions for advertisers who adopt it. YouTube: 1.7B unique World Cup viewers, new “Buy with Google Pay” format on CTV.

Overall tone of the analyst Q&A: nearly every exchange came back to capex, TPUs, and ROI — relatively few questions on advertising or core Search, a sign that capex/ROI is what the market is trying to understand right now.

4. Where the Investment Thesis Stands

This kind of analysis is usually built on a full deep dive — easy to sketch in broad strokes, but very time-consuming to do properly (segment-level modeling, scenarios, precise invalidation criteria). I haven’t yet had the time to do one for Alphabet. In the meantime, here’s the thesis in summary.

I opened the position in May 2025, at a time when Alphabet, despite world-class products, was trading in “Value” territory — the market was pricing the risk of disruption from generative AI (ChatGPT and the like threatening Search) more than the underlying quality of the business. The original idea: given its financial resources and the quality of its teams, Alphabet remained one of tech’s juggernauts, capable both of reclaiming AI market share and of staying the leader in Search. The quarters since then, and this one in particular, have leaned in that direction — but absent a formalized deep dive, the points below remain a coarse-grained assessment rather than a rigorous checklist.

4.1 Warning Signs — None Triggered

• Structural slowdown of Search below 10% growth → not observed (17%)

• Stagnation or decline in Cloud margin → not observed (35.6%, expanding sharply)

• Slowdown in Cloud backlog → not observed (+$50B for the quarter)

4.2 Bull Case Prerequisites — Status

• Search and YouTube resilience against external generative AI competition → confirmed, record engagement during the World Cup

• Google Cloud market share gains → confirmed, growth well above the sector’s

• Ramp-up of proprietary TPU monetization → in progress, effect expected mainly in 2027

• Return on capex as the business scales → to be watched closely, this is precisely what the guidance increase raises

4.3 What Changes This Quarter

The new element isn’t the strategy — the integrated chips/models/cloud approach was already known — but its pace of execution. By raising its capex guidance by more than $15B in one go, Alphabet is accepting negative free cash flow in the short term to secure capacity faster, in the face of demand it describes as durably exceeding supply. The coherence of the strategy isn’t in question; it’s the speed of execution and its immediate cash cost that are the variable to watch. In short, Alphabet is borrowing against its future cash flows to grow its present.

5. Valuation: A Gap to Watch Rather Than Resolve

The stock closed the regular session at $341.91 before giving up ground after hours to around $327. This move responds to a specific announcement — the capex increase — not to a reassessment of the quarter’s commercial momentum. This type of reaction, where the market penalizes a spending commitment before seeing its results, is typical during heavy investment phases and doesn’t prejudge the outcome.

Over ten years, Alphabet’s PE has generally ranged between 17 and 33, depending on investor sentiment through the cycle. At the time of writing, the PE sits around 26 — nothing particular to flag at this level, neither expensive nor cheap relative to history. Given the quality of the business, I’d be tempted to sell if the PE were to climb above 40.

The quarter confirms the operational trajectory. The market, for its part, chose to focus on the cost of the strategy rather than on results already visible. The next concrete checkpoint will be the materialization, over the course of 2026 and 2027, of revenue tied to the Cloud backlog and already-signed TPU contracts.

Subscribe now

Important Disclosure & Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

Subscribe now

1. What the Nebius release says

Nebius ($NBIS) is launching a new model: “infrastructure partners.” The split of responsibilities is clear-cut.

The partner finances and owns 100% of the infrastructure — the building, the GPUs, the hardware. It sources powered land, handles construction (mechanical, electrical, plumbing), imports the hardware (customs included), operates the site, secures it physically, and obtains regulatory and export approvals.

Nebius provides the reference design (NVIDIA-validated, from HGX H200 to GB300 NVL72), supply-chain access, a certified assembly partner, deploys and validates the full cloud platform, keeps the SLA, and sells the partner’s capacity to its own global customer base.

The partner owns the hardware. Nebius owns the software running on top of it and the customer relationship.

The precise economics of the deal (revenue share, licensing fees, commissions) are only disclosed under NDA, after an initial qualification call. No partner has been named publicly — the release refers to “initial arrangements” already signed, without detail on who or how much.

Here is the link: https://nebius.com/infrastructure-partners

2. Interpretation

Nebius continues its massive direct capex in parallel — agreements with Meta and Microsoft, a commitment with NVIDIA to deploy more than 5 gigawatts of capacity by 2030. The partner model adds a new growth driver on top of that trajectory.

The underlying logic: Nebius saw hardware commoditization coming before the rest of the sector. Any player with capital and access to the power grid can now build a GPU facility. What doesn’t commoditize is the customer contract, the brand, the software layer, and the SLA that commits to a consistent quality of service. Nebius concentrates its resources on that layer, and delegates land, power, and local regulation to partners better positioned to handle them market by market.

The useful image here is the car manufacturer: it doesn’t make its own tires or seats, but owns the brand and the design, remains accountable for the finished product’s quality to the customer, and has its parts built by suppliers — without diluting its ability to guarantee the product. Nebius’s software layer plays that role: it ensures a customer gets “a single, consistent service” whether running on Nebius’s own infrastructure or a partner’s.

The key question for judging how solid the model is comes down to the quality of that software. If it’s genuinely better than what AWS, Azure, or GCP can offer in this segment, substitution by hyperscalers becomes difficult: they can copy the franchise concept, but they can’t instantly match a software stack built to run on heterogeneous, third-party hardware. That’s where the real defensibility of the model lies — not in the contractual structure itself, which is copyable, but in the underlying technical edge.

Each partner also brings a sector-specific advantage tied to its local position: compute stays close to the powered land and the regional demand the partner understands better than Nebius does. That proximity advantage — grid access, local relationships, regulatory knowledge of the market — is something Nebius couldn’t efficiently replicate on its own in every jurisdiction.

In a commoditized market, value concentrates on what stays scarce: the contract, the brand, and — if the technical edge is real — the software.

3. Opportunities and risks

Opportunities

• Capacity growth without weighing down Nebius’s balance sheet — compute demand already exceeds supply by their own account, so every gigawatt of incremental partner capacity finds a near-immediate outlet.

• Structurally higher margins than conventional wholesale bare-metal contracts, per the CEO’s own terms — to be confirmed once the first deals become public.

• A lock-in effect that builds fast: the more partners run on the Nebius design, the more costly switching platforms becomes for them (operational and software lock-in).

• Access to regional markets (AI sovereignty, local capital) without Nebius having to manage local regulation itself.

• If the software edge is real, the barrier to entry for hyperscalers is higher than it looks — they would need to build a stack designed for third-party hardware, not simply adapt their existing proprietary infrastructure.

Risks

• Zero named partners so far, zero verifiable margin figures beyond the CEO’s own statements. The thesis rests entirely on execution yet to be proven.

• Dependency on a given partner: local powered-land access is often hard to replace if a partner fails to deliver.

• Regulatory and export-control risk on GPUs: the partner bears this contractually, but a failure here reflects back on Nebius’s reputation through the unified SLA it guarantees to the end customer.

• The software edge has to stay real over time. If Nebius’s stack only has a limited head start, hyperscalers will eventually replicate an equivalent offering with their own capital and sales network.

• The scarcity paradox: by accelerating the arrival of new capacity on the market through third parties, Nebius contributes to closing the compute shortage that currently supports the sector’s high prices — itself included.

The metric to watch: customer contract renewal rates, and Nebius’s ability to keep its software layer’s price stable even if spot GPU prices collapse. If both hold, the “contract + brand + software” thesis is empirically validated. If customers start negotiating directly with partners around Nebius, the software edge was overstated.

Subscribe now

Important Disclosure & Disclaimer:

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

Faced with a mismatch between supply and demand, the adjustment always happens through one of two levers: volume, or price. When available volume can’t keep up — because production capacity is structurally limited, or because it takes years to build — price is what absorbs the imbalance. It’s the same mechanism as oil when available quantities tighten, or any other supply squeeze: a rise in demand follows exactly the same logic as a drop in supply, the effect on price is identical. That’s the mechanism that drove up the price of memory in the previous article, and it’s the one we’re trying to spot here in the reducer and linear-motion space.

The trigger is never the product itself: it’s the change in status, from a commodity bought at the best price to a strategic asset whose access gets secured at almost any reasonable price. The question this article asks is where HDS and THK stand on that path — and the answer, as we’ll see, isn’t the same for both.

1. The short version

Two Japanese companies each carry the flag for their segment: Harmonic Drive Systems (HDS) for the reducer, THK for linear motion. My valuation view on both is simple to state, even though it’s hard to pin down precisely — there’s no consensus on which assumptions to use, and I’m setting some myself for lack of anything better: broadly, these companies are already too expensive in the absence of a bottleneck, and undervalued in the presence of one. As I am very bullish on the robotics and the probability of a bottleneck on these segments, I’m staring a position on HDS at 2% of my portfolio and 1% on THK.

Subscribe now

2. Why I think there is a bottleneck in these segments

I came across a table from Goldman Sachs listing the possible bottleneck segments in humanoid robotics. I’ve reclassified it into three tiers below: real scarcity, real leverage but fragmented, or essential with no humanoid-specific alpha.

The ten categories from the Goldman table reclassified into three tiers: real scarcity, real but fragmented leverage, or essential with no humanoid-specific alpha.

Three items in the left-hand column deserve a fuller explanation, because the whole article rests on them.

The harmonic reduction gear is the part that converts a motor’s fast, weak rotation into slow, precise, high-torque motion — without the mechanical play (”backlash”) found in a conventional gear. In practice, a motor on its own spins far too fast and pushes far too weakly to move a robotic arm; the harmonic reducer does this conversion work inside the joint itself, in a compact housing. Its manufacture relies on a thin special-steel part (the “flexspline”) that flexes millions of times without fatiguing — a metallurgical know-how that’s hard to replicate quickly, which explains the scarcity of suppliers.

The planetary roller screw does the same job as the harmonic reducer, but for linear rather than rotary joints: it converts rotation into straight-line displacement, with load capacity and precision far superior to a standard ball screw. It’s the part typically found in the hips or knees of a humanoid robot, where you need to push hard in a straight line rather than pivot a joint.

The dexterous hand module brings together all the miniature motors, sensors and transmission mechanisms that let a robotic hand grip and manipulate objects with the finesse of a human hand. It’s a concentrate of every other component in the body (motors, reducers, sensors) miniaturized down to finger scale — which mechanically makes it the most complex and most expensive part of the robot.

3. The central debate: bull vs bear

The bear case common to both names

• Price competition from China (for HDS) and from China/Taiwan via Hiwin (for THK) — an established fact for both companies, not a deduction.

• Both stocks have already run up a lot: HDS is up nearly 3x in a year (roughly +200%), THK has doubled (roughly +100%, including +79% since the start of the year alone). Part of the margin of safety that existed a year ago has therefore already been consumed — entering today isn’t entering at the same price as whoever identified the thesis in 2025.

• Strong cyclicality in both businesses, each dependent on semiconductor capex and industrial-automation cycles — not a guaranteed linear growth path.

The bull case common to both

• A real demographic tailwind: the labor shortage is a structural driver of automation demand for both companies — not just a research-desk estimate.

• Operational recovery already visible in recent numbers, not just in the narrative: HDS orders +16.2%, THK’s cost-to-sales ratio down 4.2 points in Q1 2026.

• Real barriers to entry on both sides: long qualification cycles at robotics OEMs once a component is “designed-in,” and metallurgical know-how that’s hard to replicate quickly.

• The fragmentation of the world into blocs: each bloc (Western, and within the West, the EU, the US and Japan taken separately) will want to keep strategic suppliers tied to its own bloc rather than depend entirely on an outside supplier. This isn’t just a price or volume argument: it’s a supply-security logic that structurally leaves room for a “trusted” bloc supplier — even at a higher price, even with less volume than the cheapest Chinese option. Both HDS and THK benefit from this mechanism, independent of their pure price competitiveness.

• Momentum itself is a bull argument, not just a caution flag: the rally already realized in both stocks draws attention, flows, and media/analyst coverage, which tends to be self-reinforcing over the short and medium term. A stock that’s rallying hard attracts the next marginal buyer more easily than one that’s flat — that’s no guarantee of continuation, but it’s a genuine technical factor in favor of it continuing, to be weighed against the already-consumed margin of safety noted above.

Companies ruled out

a. China

LeaderDrive (Suzhou Green Harmonic, 688017.SH) is clearly a serious competitor to HDS on the harmonic reducer, at roughly half HDS’s product cost, and is gaining ground quickly (its share of Chinese robotics production has gone from near-zero in 2018 to over 30-35% in 2024-2025). I’m not investing in this segment for geographic reasons already laid out at the start of the series (Chinese A-shares, access, governance). That choice has a cost I’d rather name than stay silent about: it’s possible that price competition turns out to be tougher on the Chinese side than this thesis captures, if LeaderDrive and others keep gaining ground at the same pace.

b. Nabtesco

This is a company where the reducer (Component Solutions segment) accounts for only about a quarter of its revenue (~26% of FY2025 revenue, ¥307.9bn).

c. Schaeffler

A more classic case of diversification: the bulk of its revenue comes from automotive (bearings and transmission systems for combustion and electric vehicles), and its humanoid exposure is buried inside a much larger whole.

4. Harmonic Drive Systems

4.1 What the company does

HDS makes and sells precision reducers and mechatronic products, split into two families: harmonic reducers (77.8% of FY2026 revenue, ¥46.3bn, +9.5% YoY) — the “strain wave gearing” technology the company invented — and mechatronic products (22.2% of revenue, ¥13.2bn, -0.9% YoY), actuators integrating motor, reducer and sensors. Strong product concentration: 77.8% of revenue rests on a single line.

Customers: no names are broken out, and no single customer exceeds 10% of revenue in FY2026 (Nissan Motor, the only customer above 10% in FY2025 at ¥5.7bn, has fallen below that threshold) — good customer diversification. But end applications remain concentrated in three uses: industrial robots (the dominant application), semiconductor manufacturing equipment (growing fast, driven by generative AI and data centers), and automotive applications (declining) — solid customer diversification, more limited diversification by end use. The real end customers are industrial and collaborative robot OEMs (Fanuc, Yaskawa, ABB, KUKA, Universal Robots and Chinese manufacturers), semiconductor equipment makers, and medical/aerospace integrators — a “designed-in” component, very hard to substitute once built into a customer’s design.

Suppliers: no names identified. Gross margin depends heavily on the cost of raw materials (special steel alloys for the flexspline, which must withstand cyclical deformation without fatigue) and on labor — material and labor costs remain elevated, with an internal cost-reduction program underway.

Competitors: Nabtesco (the most significant, but positioned on RV reducers — a competing rather than directly substitutable technology, ~60% share of that sub-segment), and Sumitomo Drive Technologies. Harmonic Drive LLC (US) is not a competitor but HDS’s own local distribution/production subsidiary — not to be double-counted in the competitive analysis. The most significant competitor is actually Chinese: LeaderDrive (Suzhou Green Harmonic, 688017.SH), which produces at roughly half HDS’s unit cost and is gaining ground quickly — its share of Chinese robotics production has reportedly gone from near-zero in 2018 to over 30-35% in 2024-2025, alongside Beijing CTKM Harmonic Drive, Zhongda Leader and Zhenkang. It’s specifically this name, not a Western competitor, that represents the real competitive risk to the thesis — but it stays outside my investable universe (Chinese A-shares, per the geographic filter set out at the start of the series). In the overall precision-reducer market (RV plus harmonic combined), HDS remains a follower; on the harmonic reducer segment specifically, HDS is the category definer of its own technology, not the leader of the total market.

Moat: decades of patents and real-world reliability data, metallurgical know-how on the flexspline that’s hard to replicate quickly, and above all a high switching cost once the component is “designed-in” to a customer’s robotic arm architecture (1-2 year qualification cycles before series integration).

Balance sheet (gearing): gross financial debt of ¥13,219m against equity of ¥80,390m, a debt-to-equity ratio of 16.4% (22.5% including lease liabilities of ¥4,846m). Debt/EBITDA of roughly 1.3x (1.8x with leases) — comfortably manageable. HDS is in a net cash position (~¥6bn excluding leases).

Geographic revenue split (FY2026, by customer location): Japan ¥24,388m (41.0%), Europe ¥16,777m (28.2%, of which Germany alone 10.1%), North America ¥12,108m (20.3%, of which the US alone 18.0%), China ¥4,047m (6.8%), other regions (Korea, Taiwan, Oceania) ¥2,239m (3.8%). 59.1% of revenue is generated outside Japan — genuine geographic diversification, with a notable dependence on Germany within Europe. Like any company that exports the majority of its revenue, HDS remains mechanically sensitive to currency swings (USD/JPY, EUR/JPY): a weak yen mechanically inflates consolidated results in yen terms regardless of actual operating performance, and vice versa.

4.2 HDS valuation

The scorecard below crosses a flat 50%/year revenue growth assumption over four years (FY2026 → FY2030) with three net-margin scenarios (Bear 5%, Central 15%, Bull 30%), the same method as in the Memory article. Useful reference point: HDS’s current net margin is 2.7% (FY2026) — below the Bear scenario (5%) itself, which shows how far there is to go even to reach the bottom of the table.

HDS is clearly too expensive in the absence of a bottleneck: under the Bear scenario (5% net margin, the scarcity thesis doesn’t pan out and Chinese competition captures pricing power), the stock is overvalued by 40-80% depending on the multiple used. It is, on the other hand, clearly a great price if the bottleneck is confirmed: under the Bull scenario (30% net margin, the harmonic reducer’s scarcity genuinely translates into pricing power), the stock is undervalued by 19% to 258%. The whole thesis comes down to that bet.

A word of context, so as not to dismiss the Bull scenario as unrealistic out of hand. In the Memory article, Micron and SanDisk genuinely saw a net-margin expansion of several dozen percentage points, driven by revenue growth well above 50% per year during the period when the memory bottleneck was biting — so the idea that a real bottleneck can produce this kind of trajectory isn’t a made-up scenario, it’s a verified precedent within this same series of articles. The asymmetry is therefore real. But Micron and SanDisk delivered that margin expansion with numbers already booked at the time of purchase, whereas HDS’s current guidance (FY2027 revenue barely +14.2%) is well short of a 50%/year pace. A bearish scenario therefore remains very much possible for HDS — the favorable asymmetry exists, but for now it’s only a possibility, not a precedent already confirmed on this stock.

4.3 Sizing

I’m keeping the series’ overall envelope: 5-10% of the total portfolio for all bottleneck bets combined, not on a single name, not all at once. I plan to add other companies in other bottleneck segments (optics, energy, power semiconductors in particular) in upcoming installments of the series — reallocation between names already in the portfolio and these newcomers can happen based on projections and how each one’s price-to-value ratio evolves, not on a fixed basis.

On Harmonic Drive Systems: I’m buying in, with 20% of the bottleneck sub-total allocation, i.e. 2% of the total portfolio. This isn’t a full position: the scorecard shows the current price only makes sense if the bottleneck is genuinely confirmed (Bull scenario), and stays frankly expensive otherwise (Bear scenario). The remaining allocation stays open for a top-up if the stock moves closer to the Bear/Central scenarios in the table, or if the China segment stabilizes over at least two consecutive quarters.

5. THK

5.1 What the company does

THK makes precision linear-motion components: the LM Guide (its founding product, invented in 1972), ball screws, linear actuators, cross roller rings, and seismic isolation/damping products as a diversification. Strong technological concentration: a single technology family (”rolling motion”) underlies the whole portfolio — a shock to that base technology would hit the entire group. Application diversification, on the other hand, is broad: machine tools, semiconductors, robotics, medical, aerospace. The automotive & transportation business (steering, suspension, and braking components) is being divested to AP87/Advantage Partners (closing expected June 1, 2026) and reclassified as a discontinued operation — the FY2026 figures (¥276bn of guided revenue) therefore cover only the continuing industrial business.

Customers: no customer named and no concentration data (top 10) available. Geographic and sector diversification mechanically limits dependence on any single customer, but this isn’t a verified figure, only a structural inference. Direct sales in Japan (plus agents) and through local subsidiaries in 5 regions (Japan, Americas, Europe, China, Other — with India/ASEAN expanding).

Suppliers: a diversified global supply base, not limited to Japan. No key supplier named. Likely critical inputs (special steel, bearing balls, precision grinding equipment) aren’t disclosed publicly — not a documented vulnerability point.

Competitors: NSK and IKO/Nippon Thompson (Japan), Bosch Rexroth and Schaeffler/INA (Germany), and above all Hiwin Technologies (Taiwan) — the low-cost competitor moving upmarket, particularly in China. No precise market share is available; as an unverified indicative point, THK and NSK are generally cited in trade press as the two largest global players in LM Guides.

Moat: precision-machining know-how built up over more than 50 years, historical patents on rolling technology, long OEM qualification cycles (a “designed-in” component, hard to dislodge once specified into a machine’s design), a global service and application-engineering network, economies of scale. Low-end competitive pressure is intensifying, driven by the rise of Chinese and other emerging-market products — real barriers, but not absolute ones, particularly against Hiwin and Chinese entrants.

Balance sheet (gearing): a debt-to-equity ratio of roughly 31% — noticeably higher than HDS’s (16.4%, 22.5% with leases), but still at a moderate level for an industrial company, no warning sign in itself. Consistent with other observations: short-term borrowings doubled in Q1 FY2026 (¥33bn → ¥60bn), partly to fund the buyback and the automotive divestiture; confirmed credit lines of ¥50bn are in place; cash stayed positive throughout the 2021-2025 cycle (¥120-160bn) and operating cash flow stayed positive even at the low point of the cycle (¥15.6bn in 2021). The point to watch is therefore not the absolute level of leverage, but its recent trajectory (short-term debt doubling in a single quarter) against a backdrop of already-generous shareholder returns (record dividend plus a completed buyback).

Geographic revenue split (FY2025, consolidated basis before the automotive reclassification): Japan ¥110.9bn (30%), Americas ¥90.2bn (25%), China ¥76.0bn (21%), Europe ¥67.5bn (18%), Other ¥21.6bn (6%) — a similar split in Q1 2026. Note that this breakdown covers the historical total business (automotive included); it isn’t directly comparable to the guided FY2026 revenue of ¥276bn, which excludes the divested automotive unit. Like HDS, THK remains mechanically sensitive to currency moves across its four export regions — a weak yen inflates consolidated results in yen terms regardless of actual operating performance.

5.2 Valuation

Same assumptions as for HDS, to keep things comparable: FY2030 horizon (4 years), a flat 50%/year revenue growth rate, and the same three net-margin scenarios (Bear 5%, Central 15%, Bull 30%) applied to guided FY2026 revenue for the continuing business (¥276bn) and to 112.02 million shares outstanding (derived from guided FY2026 EPS of ¥202.64 and guided net income of ¥22.7bn). Useful reference point: THK’s current net margin comes out at roughly 17% TTM — already above the Central scenario (15%) and close to the Bull scenario (30%), the reverse situation from HDS.

Like HDS, THK is too expensive in the absence of a bottleneck and a great price if the bottleneck is confirmed — but the tipping point is different: even under the Bear scenario (5% net margin), the stock is already undervalued by 23% to 143% depending on the multiple. That mostly reflects the smaller size of the revenue base used (¥276bn, smaller than HDS’s) relative to the same 50%/year growth assumption — a signal that should be read with caution, see the caveat below.

An important methodological caveat, even more so than for HDS: looking at the past, THK’s revenue growth runs more in the range of 10-15%/year over a full cycle (consistent with its own FY2026 guidance of +14.8%), not a sustained 50%/year — over 2021-2025, its revenue went from ¥318bn to ¥223bn depending on the machine-tool/semiconductor capex cycle phase, a cyclical pattern rather than a structural trend at that pace. For the 50%/year assumption to become coherent, it would take a genuine bottleneck effect combining both a price effect (pricing power regained on linear motion) and a volume effect (humanoid demand adding to the existing industrial cycle rather than replacing it) — not just a normal cyclical rebound in semiconductor capex. The table above should therefore be read as a methodological comparability exercise with HDS, not as a reference projection for THK: on a growth assumption closer to its own history (12-15%/year), the current price would remain considerably more stretched, as the earlier calculation showed (forward PE of ~38x versus a historical 15-18x).

5.3 Sizing

The name has cleared the quality bar (a disciplined refocusing via the automotive divestiture, sound governance, aligned incentives, real tailwinds) but the price question remains entirely dependent on which growth assumption is used — on the shared 50%/year assumption, the valuation looks cheap; on a realistic assumption based on its own history (12-15%/year), it stays stretched (forward PE ~38x versus a historical 15-18x).

On THK: I’m buying in at 1% of the total portfolio (when the momentum will get better) — a more cautious size than HDS (2%), consistent with the gap between the two growth readings still being too wide to fully resolve. Adding to the position will depend on confirmation, over two consecutive quarters, that growth is moving closer to the humanoid/AI pace rather than the historical semiconductor/machine-tool pace; failing that, a price pullback toward a PE near 15-18x (THK’s normal historical range) or toward its 200-week moving average would be the alternative trigger.

Subscribe now

Sources

I have no formal obligation to disclose my sources, but I want to express that my articles are inspired by Ren’s articles and ideas, which I strongly recommend: https://substack.com/@renstocks

As well as Micron’s and SanDisk’s 10-Q and 10-K filings.

Important Disclosure & Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the companies analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers

The first in the series is about memory, with company proposals tied to this trade. It builds on elements already present in my portfolio, based on supply/demand asymmetries — the same logic as in my article on Strategy Inc. (MSTR): an asset whose supply is constrained, a demand that can’t route around it, and a price that eventually stops drifting and snaps instead.

This article is structured in seven parts: first the building blocks of memory, to lay down the vocabulary; then the Nvidia supercycle pattern, transposed to memory; the state of the market today; the companies where to play this thesis; the central debate over whether the cycle is over; valuation; and finally sizing. Each part builds on the previous one.

The Short Version

Supply and demand indicators say the memory cycle isn’t over. But Micron’s and SanDisk’s prices already behave as if the peak had passed. Today, Micron trades around $948.80, down more than 24% from its mid-June high of $1,255. SanDisk trades around $1,727.18, down nearly 27% from its 52-week high of $2,354, with a good chunk of that lost in just a few sessions. Both stocks remain extremely volatile day to day — these levels will move fast, and that’s not the point.

The point: it’s this gap between price and fundamentals that interests me — reinforced by an almost mechanical effect: with gross margins of 78-85%, as long as prices hold, every extra dollar of revenue falls almost entirely to the bottom line.

Subscribe now

The building blocks of memory: what it’s for, and why AI can’t do without it

Before going further, the definitions need to be laid out. Memory isn’t a single block — it’s several families of products, each playing a different role in an AI machine. The most useful distinction to keep in mind is between volatile memory (which loses its content without power) and non-volatile memory (which retains its data).

The premise of this section: being able to understand the mechanics at play in broad strokes, with even a very limited technical interest. Judging the precise relative value between products requires being a specialist in the field — that’s not what’s being asked here. The goal is to understand enough vocabulary to follow the rest of the article, not to become a memory engineer.

Volatile memory

Dynamic RAM (DRAM) is fast, volatile memory: it loses all of its content the moment power is cut. It’s the working memory used by data centers, PCs, mobile devices, and cars. It comes in several flavors depending on use: DDR5 is the workhorse of standard servers and PCs; LPDDR is the low-power variant that powers every smartphone, and increasingly AI servers where energy efficiency matters at rack scale; GDDR is the graphics variant, soldered next to GPUs in gaming cards and certain inference accelerators.

HBM (High-Bandwidth Memory) is the flagship DRAM product for AI: a 3D-stacked architecture, directly fused onto the processor. It’s the piece that answers the real problem of AI compute: a GPU starved of data to process is the most expensive and most useless machine in the data center. Compute is worthless if memory can’t feed the processor fast enough — that’s exactly HBM’s job. It’s also why only three companies in the world are capable of making it.

Non-volatile memory

NAND is rewritable non-volatile storage — the kind that keeps data even without power (SSDs, memory cards, USB drives). Historically, its role in AI was secondary to DRAM’s. That’s changing: recent inference architectures now rely on large NAND pools to offload the “KV-cache” (the context memory a model holds onto mid-generation) and store long context — a use case that barely existed a year ago and could, on its own, add substantial demand by 2027-2028.

NOR handles reliable code storage (system boot-up, embedded automotive/industrial applications) — a more minor segment, less central to this thesis.

HBF (High Bandwidth Flash) aims to combine flash density with DRAM-like bandwidth — co-developed by SanDisk and SK Hynix. Important point to keep in mind: it’s still at the design and prototype stage, not commercial production. None of this is in current revenue or in analyst models yet — it’s optionality, not a given.

One idea to take away from this section: memory isn’t a simple accessory to AI compute, it’s what decides whether compute can actually run at full capacity. That’s why it deserves its own place in a series on bottlenecks.

---

1. The Nvidia supercycle pattern

Three years ago, Nvidia followed a precise pattern. It wasn’t just “the stock went up.” It’s two engines running at the same time:

• Earnings explode, because AI compute demand far exceeds what the industry can produce.

• The multiple re-rates, because the market changes its reading grid: Nvidia is no longer a cyclical graphics card maker, it has become the mandatory infrastructure of an entire industry.

Two engines running together doesn’t produce an additive gain. It produces a squared gain: earnings ×, multiple × —> price ײ.

The trigger for the re-rating is never the product itself. It’s the change in status: from a commodity you buy at the best price, to a strategic asset whose access you secure at almost any reasonable price. That’s the status shift that has to be spotted before it gets priced.

I think we’re watching exactly this pattern replay in memory, with a two-to-three-year lag on Nvidia.

---

2. The state of the memory market today

Memory has become AI’s new wall. The “memory tax” — memory’s share of AI capex — now represents roughly a third of the total, and that share is growing.

What’s really changed is long-term contracts (LTAs / NBMs depending on the company). Historically, memory sold like any commodity: produce, stockpile, sell on a spot market and short contracts that adjusted violently. LTAs change the mechanics: multi-year agreements, prepayments, committed volumes, take-or-pay penalties. It increasingly looks like what a semiconductor foundry does — not what a commodity seller does.

The bulls’ argument: if memory pulls off the same business-model transition as foundries or hard drives after 2011, it deserves the same valuation transition.

One nuance worth keeping in mind: these contracts dampen cyclicality, they don’t eliminate it. A precedent exists and it stings: in 2017, similar commitments held exactly until they were tested by a real slowdown, then got renegotiated back toward spot prices within a few quarters.

The difference with 2017 is the demand engine. In 2017, the tension came from a classic smartphone/server upgrade cycle. Today, it’s generative AI that needs unprecedented compute power — and therefore memory — with multi-year investment budgets committed by players who historically never had to haggle over memory prices. This article rests on the hypothesis that this demand engine constitutes a genuine investment supercycle, not a classic cycle peak that will unwind at its usual pace. If that hypothesis is wrong, so is the rest of the thesis.

---

3. Segments and companies: where to play the thesis

In this supercycle, not everyone is exposed the same way. Two worlds need distinguishing: HBM, on the GPU side, serving model training at Nvidia — and “classic” high-capacity memory (DRAM, NAND, and tomorrow HBF), serving inference instead.

**Micron** is the American generalist pure player — DRAM and NAND, with a clear geopolitical positioning: it’s the only one of the three big memory players that answers to the United States, with CHIPS Act-backed fabs in Idaho, New York, and Virginia. Strategic contracts signed with hyperscalers, HBM capacity sold out in advance.

**SanDisk** is the NAND/flash pure-play. It’s developing HBF, co-developed with... SK Hynix — still at the prototype stage, as noted above. But the nuance needs to stay clear: SanDisk does one thing, flash, while SK Hynix remains structurally focused on HBM for Nvidia GPUs — on the training side, not the inference-memory side that’s the core of this thesis.

**Samsung** is deliberately not covered in detail here. It’s a generalist conglomerate — memory, foundry, consumer electronics — whose memory exposure is too diluted within a much larger empire to make it a pure vehicle for this specific narrative.

One nuance not to forget: flash itself isn’t fully sheltered. HBM, CXL-attached memory, and new non-volatile architectures could eventually shrink flash’s role in AI pipelines. SanDisk is developing HBF precisely to stay ahead of that risk — but incumbents historically don’t always see disruption coming in time.

---

4. The central debate: is the memory cycle over?

This is the question that decides everything else. And the answer doesn’t depend on opinion — it depends on two things that can be observed: supply/demand fit, and price as the normalization gauge for the shortage.

**The bear camp** says: capacity is coming. New fabs and production lines are set to come online starting 2027-2028. Historically, every memory margin peak has eventually attracted the capacity that floods the market and breaks prices. The classic mechanism, once the shortage clears: prices normalize, earnings normalize along with them, and the market doesn’t discover it all at once — the P/E drifts down slowly ahead of time, as investors anticipate the end of the cycle before it even shows up in the results. 2028 is when the music stops.

**The bull camp** answers with arithmetic rather than pattern-matching: bit demand is growing in the mid-20s percent per year. The HBM conversion ratio (it takes roughly three commodity wafers to produce the bit-equivalent of one HBM wafer) means the current capex wave isn’t excessive — it’s the bare minimum required to keep the shortage from becoming absurd.

My read: the real test arrives in 2028. I don’t calculate beyond that date — as they say in chess, long variation, bad variation. If a thesis needs a chain of assumptions stretching indefinitely into the future to hold up, that’s a sign it’s already fragile. Before 2028, the thesis of supply ruining the market has no physical grip. After that date, anything is possible, and I’d rather reassess the position at that point than pretend I can calculate it today. This is a position with a limited shelf life, not a conviction held forever.

Metrics to watch ahead of earnings

The problem with this debate is the temptation to wait for the next quarter to find out who’s right. Mistake: the market gives signals beforehand, provided you look in the right place.

Signal #1, The spot/contract spread

Memory sells on two parallel markets. The contract is where most of the volume gets negotiated — quarterly, between manufacturers and large buyers. That’s the price that actually generates companies’ revenue. Spot is the marginal market — small volumes traded day-to-day between distributors and brokers. It represents only a fraction of bits sold, but it moves instantly with sentiment, while the contract adjusts with a lag.

In a shortage, spot trades at a premium above contract, and that premium pulls the contract up the following quarter. In oversupply, it’s the reverse: spot drops below contract, buyers wait, and the contract eventually falls too. The most honest turning-point signal is exactly this crossover — spot dropping back below contract while inventories build. That’s happened before every historical peak of the memory cycle.

Spot is easy to track: public indices, widely relayed by trade press, free in broad terms — tracking its trend over time is already enough as an early warning. Contract is less immediate — three ways to approach it:

1. Monthly assessments from industry pricing services, built from surveys of market participants.

2. The average selling price each manufacturer reports on earnings calls — an implicit contract price, calculated after the fact, so available only on a quarterly cadence.

3. The anchor price written into the LTAs themselves, referenced to a given quarterly average — revealed only when deal announcements are made.

Signal #2: competing capacity announcements

Fully public — press releases, earnings calls, trade press. This isn’t theoretical: it’s precisely this kind of announcement (Samsung and SK Hynix signaling plans to expand capacity) that triggered the recent correction across the entire memory sector. The real test isn’t the announcement itself, it’s whether it translates into actual volumes that loosen the supply/demand ratio.

Signal #3: the 2027-2028 production timeline.

Known through manufacturers’ guidance and investor presentations, updated every quarter. As long as these sites aren’t producing yet, the capacity announcement remains an anticipated signal, not a consumed fact.

The other signals worth tracking — wafer reallocation between HBM and commodity DRAM, actual renewal of LTA contracts, inventory levels at manufacturers — are useful for understanding the mechanism, but in practice, they only confirm on a quarterly cadence. Better to know that than to believe everything can be tracked continuously.

**This dashboard — spot/contract spread first — is what serves as the exit or position-reduction signal, not a fixed price target.** As long as these indicators don’t move, the gap between current pricing and physical fundamentals remains the core of the thesis.

---

5. Valuation scorecard: does the price already reflect an end of cycle?

The question isn’t “is it expensive or cheap” in the abstract. The question is: what cycle scenario does the current multiple imply, and does that scenario match what’s actually observed in the supply and demand data?

• Micron trades at a single-digit multiple on next-twelve-months earnings, even as it just posted record results. A multiple that low on such elevated profits means one thing: the market is betting these profits won’t last, that this is a peak and not a new floor. Set against the data from part 4 — a shortage that structurally shouldn’t clear before 2028 — this pricing looks ahead of the facts.

• SanDisk trades at a hefty premium on this year’s earnings, but that premium collapses sharply when looking at 2027, provided long-term contracts hold. This is a different setup from Micron’s: here, the market isn’t pricing pessimism about the length of the cycle, it’s pricing optimism about the duration of the contracts — with little room for error in case of disappointment.

Scorecard — Micron (MU), current price $948.80

The table below applies 50%/year revenue growth through 2028 (a quite conservative assumption IMO) across all three scenarios — only net margin varies, between a cycle trough (10%), mid-cycle (30%), and a hold near the current peak (60%). Each cell gives the implied price, the change versus the current price, and the 2-year CAGR.

How to read this: the current price already sits between Central/PE 10 and Central/PE 20. In other words, it takes neither a Bull scenario nor a generous P/E to justify today’s price — a simple hold at mid-cycle with a modestly re-rated multiple is enough. Only the Bear scenario, at any P/E, is clearly a loss. That’s a favorable risk setup: the current price doesn’t require believing in the best-case scenario to be breakeven.

Scorecard — SanDisk (SNDK), current price $1,727.18

Same growth (50%/year) and margin (10/30/60%) assumptions as for Micron, to make the comparison direct.

How to read this: here, the current price sits between Central/PE 20 and Central/PE 30 — it already takes a rich P/E applied to a mid-cycle scenario to be breakeven, and the Bear scenario stays a loss at any P/E in this table. That’s a less favorable risk setup than Micron’s: the current price leaves much less room for error before flipping into a loss.

The point linking both tables: at the 2027-2028 horizon, it’s the same parameter — the margin assumed — that decides everything, far more than the P/E applied. But the asymmetry between the two stocks is clear once the assumptions are harmonized: Micron needs fewer things to go right, SanDisk needs more things to go right just to avoid going wrong.

The argument that makes this bet interesting despite the uncertainty: the fixed-cost structure of the memory industry means that, as long as prices stay elevated, a revenue increase converts almost entirely into a net income increase, with current gross margins of 78-85%. It’s this mechanical gap — not a market opinion — that justifies taking the bet. The risk is symmetric: that same leverage works in reverse if prices turn.

My conviction: I’m not going in for now. I’m waiting for a price pullback, ideally through a genuine sector-wide sell-off, before entering — see part 6. That pullback might never come and I might miss the move. Fine by me: in that case I’d rather focus on other bottlenecks in the series, earlier in their own re-rating cycle.

6. Sizing

I plan to allocate between 5% and 10% of my portfolio to the full set of ‘bottleneck’ stocks in this series, across upcoming articles — not all at once, and not on a single name.

For Micron and SanDisk specifically, I’m passing for now. Both scorecards in part 5 show a real thesis, but both stocks have already rallied hard from their recent lows, and I’d rather wait for a genuine price pullback before entering. By “pullback,” I mean a temporary price panic — a sentiment purge like the one already documented in part 4 (sector rotation, scary capacity announcements, profit-taking after an extreme rally) — not a signal that the cycle is genuinely over. It’s precisely because nothing in the fundamentals changed during those episodes that a price plunge becomes an entry opportunity, not a reason to run.

That pullback might never come and the price might keep climbing without me. Fine by me. In that case I’d rather stay focused on other bottlenecks in the series, earlier in their own re-rating cycle, where the risk/price-paid ratio is more favorable today. Nothing stops me from coming back to Micron or SanDisk later if the price comes to me.

The dashboard from part 4 — spot/contract spread, capacity announcements, production timeline — remains the right filter for telling a genuine cycle turn apart from a simple sentiment purge, whether now or on a future entry attempt.

Conclusion

The same pattern that made Nvidia is replaying in memory, with a lag. Supply and demand data say the shortage holds at least through 2028. The price, meanwhile, already behaves as if it were all over — on Micron through pessimism about the length of the cycle, on SanDisk through a premium that leaves no room for error. Between the two, a simple mechanism: as long as prices hold, operating leverage makes earnings explode much faster than revenue. That’s the gap worth watching, with the dashboard from part 4 as the signal.

A new article is currently in the works on another bottleneck.

Subscribe now

Sources

I have no formal obligation to disclose my sources, but I want to express that my articles are inspired by Ren’s articles and ideas, which I strongly recommend: https://substack.com/@renstocks

As well as Micron’s and SanDisk’s 10-Q and 10-K filings.

Important Disclosure & Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author DON’T HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers

Non of this is happening with the stock I suggest you. A perfect niche quality stock in a defensive sector, temporarily undervalued.

Plan

This article starts with the business — what Interparfums actually does, how the licensing model works, who its clients and suppliers are, and what the brand portfolio looks like today. From there, it examines whether this model constitutes a genuine competitive advantage or a contractual dependency dressed up as one, and how Interparfums sits against both the licensed players and the integrated luxury houses that dominate the category.

Financials and management follow, with particular attention to how the business absorbed a currency- and tariff-battered 2025 without breaking stride.

The article then presents the two competing theses in full, a valuation scorecard, and portfolio considerations.

I know you’re busy, so I always start with a summary called The short version. If that’s all you have time for, that’s fine. The rest of this article explains why.

The Short Version

Interparfums is a forty-year-old licensing operator trading like its growth engine broke. It didn’t. A currency move and a tariff shock cost real money in 2025 and Q1 2026, and the stock repriced as if the damage were structural — PE compressed from a historical 30-40x range to roughly 15-16x on a normalized basis, the cheapest this business has traded in years.

Nothing in the numbers supports that read. Net cash, no leverage. A dividend maintained through the worst of the slowdown. Tariff-adjusted net income actually grew in 2025, once the one-off €7.6 million tariff cost is stripped out. The Boucheron license the market priced as lost in November 2025 was renewed in February 2026 — the clearest real-time test of the renewal track record this business has run for forty years, and it passed.

My conviction is the bull case: EPS compounding at roughly 14% a year as Lacoste matures and the 2027 brand launches (Off-White™, Annick Goutal, Longchamp) start contributing, with the multiple re-rating to 25x as the market re-reads this as a temporary air pocket rather than a structural decline. That scenario puts the stock near €58 within 2.5 years — +126% from current levels, a 38.4% CAGR. It doesn’t require heroic assumptions. It requires the licensing model to keep doing what it’s done for four decades, priced today as if it might stop.

This isn’t the loudest position in the portfolio. It’s a defensive business, temporarily priced like a declining one, sitting completely outside the AI narrative that moves everything else I hold. That’s the trade.

Subscribe now

Understanding Interparfums’ business, supply chain and environment

History

Interparfums was founded in 1982 in Paris, by Philippe Benacin and Jean Madar. From the start, the structure was split in two: an American parent company, Interparfums Inc., listed on the Nasdaq in 1988, and a French subsidiary, Interparfums SA, listed in Paris starting in 1994. That dual listing is not a footnote — it gives the group two separate access points to capital markets and two distinct shareholder bases, an architecture it still carries today.

The core business has not changed in over forty years: sign licensing agreements with fashion, leather goods, or jewelry brands, and develop fragrances on their behalf. The first agreement, in 1988, was for the Régine’s brand. Others followed — Burberry (1993, terminated in 2012), S.T. Dupont, Paul Smith, Lanvin, Van Cleef & Arpels, Jimmy Choo (2009), Montblanc and Boucheron (2010), Balmain and Repetto (2011), Karl Lagerfeld (2012), Coach (2015), Kate Spade (2019), Moncler (2020), Lacoste (2022). Some licenses end — Burberry is the clearest example. Others last for decades and get renewed repeatedly, like Montblanc, extended through 2031.

Two breaks from the pure-licensing model stand out. In 2015, Interparfums acquired the Rochas brand outright — its first owned brand. Then, starting in 2024, the group accelerated acquisitions: Off-White™ in 2024, Annick Goutal in 2025, alongside a new licensing agreement signed with Longchamp. The company is still, first and foremost, a licensing operator. But it is building, in parallel, a second pillar made of brands it actually owns.

Segments of activity

Interparfums runs one integrated business with two revenue mechanisms attached to it.

The licensing model is the historical core. A luxury house grants Interparfums the right to use its name in exchange for an annual royalty indexed on sales. Interparfums then owns the entire execution chain: fragrance creation, component sourcing, manufacturing, packaging, marketing tools, and distribution — all built in close collaboration with the licensor’s own creative and marketing teams. The relationship is long-term by design: brands are chosen for their international recognition and their “readable” identity, and each is developed through a steady cadence of launches meant to build a full product range over years, not quarters.

The owned-brand model applies to Rochas and to the fashion side of the business acquired more recently (Off-White™, and the newly launched Solférino Paris collection). Here the group runs a hybrid setup: part of the activity is sub-licensed to specialized partners who produce and distribute certain categories, while another part is operated directly by Interparfums, which then earns both the product margin and the royalty stream from its own sub-licensees.

Brand portfolio

The brand portfolio spans three tiers of maturity: long-established franchises with predictable renewal cycles (Montblanc, Jimmy Choo, Coach, Lacoste, Boucheron), the owned Rochas fragrance and fashion lines, and a newer growth layer built through recent acquisitions and licenses — Off-White™, Annick Goutal, Longchamp — whose first product launches are scheduled for 2027 and beyond. Management describes 2026 as a year of roughly fifteen line extensions on existing fragrances, alongside early development work on the newly acquired brands.

Clients

Interparfums does not sell directly to the end consumer. Distribution runs through wholly-owned or joint-venture subsidiaries, independent distribution companies, subsidiaries of large cosmetics groups, and duty-free operators, reaching close to 120 countries. International sales represented 93.6% of group revenue in 2025 — a figure that has stayed remarkably stable (between 93.6% and 94.6%) over the last five years. The United States is the single most important market and the most exposed to currency swings.

Suppliers

Interparfums owns no factories. Manufacturing is entirely outsourced to a network of roughly a hundred specialized industrial partners spanning several distinct trades: the “noses” and concentrate producers who create the fragrance oils themselves, glassmakers who produce the bottles, component manufacturers responsible for caps, pumps, and metal parts, box and packaging makers, and packaging and logistics providers based in France. The group describes this as a deliberate choice — flexibility over vertical integration — reinforced by a diversified network of production sites capable of making the same product, which limits the risk of a single subcontractor failure. Logistics is centralized through a dedicated 36,000 sqm warehouse in France, supplemented by warehouses in the United States and South Korea.

Interparfums spent close to €192 million on marketing and advertising in 2025 — more than 21% of revenue.

Competition

The prestige fragrance market breaks into two structurally different groups of players, and the annual report itself draws that line explicitly.

The integrated houses — LVMH (Christian Dior, Guerlain, Givenchy, Kenzo, Bulgari), Estée Lauder, Chanel, Puig — own the brands they sell fragrances under. They control the entire narrative: the runway shows, the boutiques, the advertising campaigns, the pricing architecture. Fragrance for them is one expression of a brand they already own outright, not a licensed activity.

The licensing operators — L’Oréal, Coty, Shiseido, Euroitalia, and Interparfums — do not own most of the brands on their shelves. They rent the name, execute the fragrance, and pay a royalty back to the house that owns the identity. Within this group, L’Oréal, Coty and Shiseido operate at a completely different scale, with fragrance divisions posting several billion euros in revenue each. Interparfums sits in the second tier alongside roughly ten other mid-size players, with revenue in the €100 million to €2 billion range.

That’s the direct competitive set. Indirectly, Interparfums also competes for licenses themselves — a fashion or jewelry house choosing between Interparfums, Coty, Euroitalia or an in-house fragrance division when a contract comes up for renewal or a new brand looks for a partner. Losing that competition doesn’t cost market share on a shelf. It costs the license outright, as happened with Burberry in 2012.

Category definers. Chanel and LVMH’s owned brands — Dior, Guerlain — are the closest thing this market has to category definers. They don’t need a licensing partner, they set the pricing ceiling, and much of what “prestige fragrance” means as a category is built on their positioning. No licensing operator, including Interparfums, occupies that role. The category is defined elsewhere, and Interparfums operates underneath it.

Market share. Interparfums holds around 4% of the French selective distribution market, and between 2% and 5% in other key countries — the United States, the United Kingdom, Mexico, China. In the US specifically, the report places Interparfums as the 7th-largest player, with a 4.5% share, and its three flagship brands (Jimmy Choo, Coach, Montblanc) sit among the top 30 fragrance franchises in the market. The global selective fragrance market is estimated at roughly $40 billion. On any of these numbers, Interparfums is a meaningful but clearly secondary player — never the largest, always present.

What the report is careful to point out is that the company doesn’t try to compete on the same terms as the leaders. The stated approach is explicit: a methodical, long-term development strategy, “not focused on volume and advertising, but rather on creation and consumer loyalty.” Whether that’s a genuine structural difference or a polite description of operating at a smaller scale is a question worth holding onto — it belongs in the competitive advantage section, not here.

Geographic revenue

North America alone accounted for €347.1 million of the €899.4 million in group revenue in 2025 — 38.6% of the total, and the only country the group is required to flag individually under IFRS 8, since the United States crosses the 10% threshold on its own. One US customer represented 12.6% of total group revenue in 2025. That’s a meaningful single point of dependency for a company whose whole model is built on distribution breadth.

The rest of the map: Western Europe €162.7 million, Asia €115.0 million, Eastern Europe €79.1 million, South America €78.7 million, France €57.9 million, Middle East €52.2 million, Africa €6.8 million. Asia actually declined year-over-year (from €125.2 million in 2024), a reversal that runs against the growth narrative used elsewhere in the report for the region.

The practical read: Interparfums is not a diversified basket of comparable-sized markets. It’s a US-led business with a long tail of smaller regions attached, and the dollar exposure that comes with it — the same currency dynamic management pointed to as the main drag on 2025 profitability.

Competitive advantage

Porter, Mauboussin, and most moat frameworks converge on the same question: why can’t a well-funded competitor simply replicate what this business does? For Interparfums, the honest answer starts with an admission — the most obvious asset in this business, the brand name on the bottle, isn’t one Interparfums owns or controls. That has to be dealt with directly before anything else.

What looks like a moat and isn’t one. A licensing contract is not a durable competitive advantage. It’s a lease. Burberry proves the point: thirteen years into the relationship, the license was terminated in 2012, and Interparfums lost the brand entirely — not gradually, just a contract that ended. Any investor tempted to treat the brand portfolio as a permanent asset base needs to hold that example in mind. The Maisons chose Interparfums once. They can choose someone else next time the contract comes up.

What might actually be durable. Three things, in order of how convincing they are.

Renewal behavior over four decades. Contracts ending is the exception, not the rule. Montblanc has just been extended to 2031. Boucheron to 2027. Coach’s latest renewal added five more years. Across roughly forty licensing relationships signed since 1988, the group has lost very few outright — Burberry is close to the only clean example in the report. That’s not proof of a moat, but it is evidence of a switching cost that runs in Interparfums’ favor: a Maison that terminates a working relationship has to rebuild an entire fragrance operation — creative process, manufacturing partners, global distribution — either in-house or with a competitor, and accept the multi-year gap in launches while that happens. Rebuilding is expensive and slow for the licensor, not just for Interparfums.

Contractual minimums that work both ways. In a standard licensing deal, Interparfums pays the Maison (Montblanc, Coach, and so on) a royalty calculated as a percentage of the sales Interparfums generates from that brand’s fragrances — more sales, more royalty owed to the Maison; fewer sales, less owed. On top of that, the group discloses €308.7 million in minimum guaranteed royalty commitments: fixed floor payments that Interparfums owes its licensors even if actual sales fall short. The direction of the money is always the same — from Interparfums to the Maison — the minimum guarantee just sets a floor under it.

That floor is a liability for Interparfums: a bad year on a given brand doesn’t reduce what’s owed. But it’s also worth reading the other way. A Maison agrees to a multi-year minimum-guarantee structure, instead of a simple percentage-of-sales royalty, because fragrance licensing is a narrow market with specific, hard-to-replace expertise — a handful of operators (Interparfums, Coty, L’Oréal, a few others) who can actually run the twelve-to-eighteen-month development cycle, the manufacturing network, and the global distribution. The Maison isn’t choosing from a deep bench of interchangeable vendors it can threaten to replace next quarter. Locking in a guaranteed minimum is what a licensor does when it has already accepted that switching partners would be slow and costly on its own side too — not just a gesture of trust, but a rational response to a market with few credible alternatives.

Operational depth that’s hard to buy quickly. Forty years of relationships with fragrance houses, glass manufacturers, and packaging suppliers; a twelve-to-eighteen-month development cycle run in close coordination with each Maison’s own creative team; a deliberately diversified production network so no single subcontractor failure can halt a launch. None of this is unique in the abstract — Coty and L’Oréal have the same kind of infrastructure, at greater scale. But it is genuinely difficult for a new entrant, or for a Maison trying to bring fragrance in-house, to replicate quickly. That barrier belongs to the handful of established licensing operators as a group, not to Interparfums specifically against Coty or L’Oréal.

The honest conclusion. This is not a moat in the strict sense — no network effect, nothing that gets structurally harder to dislodge as the company gets bigger. It’s a set of relationship-based, contractually-reinforced barriers that are real and have held up for decades, but that depend on Interparfums continuing to execute well for every Maison, every renewal cycle, indefinitely. The competitive position is defended continuously, not automatically. What should reassure an investor is not the existence of a moat — there isn’t one — but the track record of a company that keeps winning the renewal anyway, cycle after cycle, for forty years.

Financials

Key metrics

Comments

On revenue growth (2021-2025) — the deceleration is the single most important line in this table. Growth ran at 26%, 13%, and 10% in the three years through 2024, then dropped to 2.1% in 2025. Management attributes the slowdown to two external, largely non-repeating factors: an unfavorable EUR/USD move that cost roughly €20 million in sales, and a 15% US tariff introduced mid-2025 that forced pricing flexibility on the group’s largest market. The brand-level picture is more mixed than that framing suggests, though — Coach and Lacoste both grew in 2025, while Jimmy Choo and Montblanc, two of the three historical pillars, actually declined. Whether 2026 confirms this as a one-year currency-and-tariff air pocket or the start of a genuine deceleration is the question the valuation section has to answer.

On operating margin — the trend peaked in 2023 at 20.7% and has declined two years running, to 19.5% in 2025. That’s a smaller move than the revenue deceleration, but it’s moving in the same direction, and it should be watched rather than dismissed as noise.

On net income — the headline number looks like a decline: €129.9m to €126.6m, -2.5%. But that’s the unadjusted figure, and it’s misleading on its own. Interparfums discloses a tariff-adjusted net income of €132.3 million for 2025 — stripping out the one-off €7.6 million cost from the 2025 US tariff introduction — which comes in +2% versus 2024. Once that single external policy shock is removed, net income didn’t shrink in 2025. It grew, modestly, in line with a business absorbing a temporary cost rather than losing structural profitability.

On cash generation — operating cash flow rose from €107.7 million in 2024 to €150.0 million in 2025, even as reported IFRS net income dipped slightly. The driver is working capital: inventory swung from building up (-€19.3m in 2024) to being drawn down (+€23.3m in 2025). Cash conversion improved in the same year earnings stagnated — either disciplined inventory management going into a slower year, or a one-off destocking that won’t repeat. Capex roughly doubled to €40.5 million in 2025 (from ~€20.5m in 2024), which limits how much of that cash flow gain shows up as free cash flow, but estimated FCF still grew from roughly €87 million to €109 million.

On ROE — calculated directly from the reported figures, group-share ROE was approximately 17.3% in 2025 and 18.6% in 2024. Down slightly, consistent with the earnings deceleration already discussed, but still well above what’s typical for a consumer staples business of this size. Some third-party sources cite a higher range, closer to 19-21% — the figure used here comes from a direct calculation on the group’s own reported net income and equity.

On the balance sheet — net cash has grown every year except 2022, and stands at €63.3 million. There is no leverage overhang to monitor here, which matters when weighing this business against the two other positions in the portfolio that do carry meaningful debt structures.

Management

The founders are still in charge

Interparfums has had the same two people at the top since it was founded in 1982. Philippe Benacin and Jean Madar co-founded the company, and forty-plus years later they still control it — together holding 44% of Interparfums Inc., the Nasdaq-listed US parent, which in turn owns 72% of Interparfums SA, the Paris-listed operating entity. That’s not a symbolic stake. It’s a controlling one, structured through two layers, held by the same two founders since day one.

Benacin holds the Chairman-CEO role combined (Président-Directeur Général) — a concentration of power worth naming directly. In most governance frameworks that combination draws scrutiny, and it should here too: there is no independent chair providing a check on the CEO’s decisions. What offsets this to some extent is tenure and track record rather than structure — Benacin has run this exact business, with the same partner, through four decades of licensing cycles, without the kind of governance blow-up (auditor turnover, restated accounts, board revolt) that would normally accompany that level of concentrated control. Philippe Santi serves as Deputy CEO (Directeur Général Délégué), providing some operational counterweight day to day, but the ultimate authority sits with Benacin.

Skin in the game

A 44% combined stake in the parent company is about as direct an alignment as a shareholder can ask for — Benacin and Madar’s personal wealth moves with the stock, full stop. This is a materially different situation from a hired-in turnaround CEO with a few million euros of purchased shares. These are the two people who built the business, still holding the majority of the equity that controls it, forty years in.

Benacin’s annual variable pay is split 50% financial criteria and 50% extra-financial (qualitative and ESG) criteria — a heavier weighting toward non-financial metrics than is typical, and one investor focused purely on capital allocation might want to interrogate.

The succession

Succession planning is not addressed. For a business this dependent on long-standing personal relationships with luxury houses — built and maintained personally by Benacin and Madar over decades — the absence of a visible succession plan is a real gap, not a formality.

The two theses

Why the stock has fallen

The decline is not a single event. It’s a sequence of three, each compounding the last.

The first hit came on November 19, 2025, when Interparfums lowered its 2025 revenue guidance to €890 million and — breaking with its usual practice — declined to give any 2026 target, citing reduced visibility given the number of favorable and unfavorable variables in play. The stock fell more than 9% that morning. Analysts read the implied fourth-quarter figures as a mid-single-digit organic decline, and one research note flagged an unfavorable 2026 comparison base tied to the Boucheron license’s scheduled expiration at the end of 2025. The sector context made it worse: L’Oréal had already signaled that its own fragrance division growth had slowed sharply in the third quarter, and at least one broker described the broader prestige fragrance segment as losing momentum industry-wide.

The second hit was slower and structural: a twelve-month slide that had, by early March 2026, taken the stock down roughly 40% year-over-year, trading near €24 and testing a key technical support level.

The third hit landed with Q1 2026 results on April 22: revenue of €215.5 million against €235.5 million a year earlier, an 8.5% decline, driven by unfavorable currency effects and geopolitical disruption in the Middle East. That report landed in the middle of a broader selloff across French luxury names — Kering and Hermès both dropped sharply the same month on sector-wide concerns.

The one piece of good news buried in this sequence is easy to miss if you only read the November headlines: the Boucheron license that analysts flagged as a comparison-base risk for 2026 was, in fact, extended — not lost. In February 2026, Boucheron and Interparfums agreed to prolong their partnership on the main existing lines through December 31, 2027. The market priced in a loss in November. The actual outcome, three months later, was a renewal. That gap between feared outcome and actual outcome is worth holding onto going into the bull case.

As of early July 2026, the stock trades around €25-26, within a 52-week range of €21.78 to €35.60 — down roughly 30% over twelve months. The PE has compressed to approximately 16-17x, against a historical range that has run 30-40x in normal years. The dividend yield sits around 4-4.5%, with a payout ratio near 70%.

Bear

The revenue deceleration is broader and deeper than management’s FX-and-tariffs framing suggests. 2025’s slowdown was explained as currency and tariffs. But Q1 2026 revenue fell 8.5%, and the explanation expanded to include Middle East geopolitical disruption — a third external factor layered onto the first two. At some point, a pattern of successive external explanations for successive quarters of decline starts to look less like bad luck and more like a business that has lost some pricing power or demand resilience it used to have. Operating margin has now declined for two consecutive years, from 20.7% in 2023 to 19.5% in 2025, and margin compression doesn’t automatically reverse when a currency does.

No structural protection, only behavioral evidence. Every brand in the portfolio is rented, not owned. Burberry is proof that a decades-long relationship can still end. The renewal track record is real — Boucheron’s extension confirms it again — but it’s a pattern, not a guarantee, and a pattern can break on any given renewal date.

Customer and geographic concentration are real risks. North America is 38.6% of group revenue. One single US customer accounts for 12.6% of total group revenue on its own. A distribution shift or a renegotiation with that customer would show up immediately and materially in the numbers.

The new brands are a cost today, a promise for tomorrow. Off-White™, Annick Goutal, and the Longchamp license don’t contribute meaningfully to revenue until 2027 at the earliest. They consume management attention and development capital while the base business is already decelerating.

A Maison could stop needing a licensee at all. The Burberry precedent already covers the risk of losing a license to a competitor. There’s a more severe version of that risk the bear case hasn’t named yet: a Maison deciding to bring fragrance production in-house entirely, exiting the licensing model rather than switching partners within it. This isn’t hypothetical — LVMH, Chanel, and Estée Lauder already run fragrance divisions internally, proving the model is viable at scale. If a house the size of Coach or Montblanc concluded it now had enough marketing and industrial infrastructure of its own to justify internalizing, Interparfums wouldn’t lose a renewal negotiation to a rival licensor. It would lose the category permanently, with no contract left to compete for next cycle.

Governance concentration compounds all of the above. A combined Chairman-CEO role, held by the same person for over forty years, with no visible succession plan and licensor relationships that are, by the report’s own emphasis, personally built.

If the bear case is fully right: margin keeps drifting down through 2026-2027, external headwinds prove sticky rather than transitory, and the market settles on a lower structural growth rate for the whole licensing model — not a collapse, but a re-rating from “quality compounder” to “mature operator in slow decline,” with the PE multiple staying compressed near current levels rather than reverting toward its historical range.

Bull

The market has already priced in the worst version of this story, and the worst version keeps not happening. November 2025 priced in a lost Boucheron license. Boucheron was renewed in February. The PE has compressed from a historical 30-40x range to roughly 16-17x (unadjusted) — a compression larger than the actual deterioration in the fundamentals justifies, given that revenue is still growing, tariff-adjusted net income actually grew 2% in a year with two simultaneous external shocks, and operating cash flow improved sharply.

Forty years of renewal behavior, tested again in real time. Montblanc extended to 2031. Boucheron just extended to 2027, after the market had priced its loss. Coach added five more years. That consistency, sustained through the exact kind of pressure the market is currently pricing as terminal, is the strongest evidence available that the licensing relationships are more durable than a rented-brand framework implies.

The balance sheet gives this business time the market isn’t pricing. Net cash of €63.3 million, zero structural leverage, a dividend maintained through the slowdown, and a share buyback program approved at the April 2026 shareholder meeting — none of this is the profile of a business under financial stress. It’s the profile of a business absorbing a demand-side air pocket from a position of strength.

The next growth layer hasn’t started yet. Lacoste is still ramping. Off-White™, Annick Goutal, and Longchamp don’t show up in the numbers until 2027. A market pricing the stock on trailing growth is, by definition, not pricing what happens when that layer starts contributing.

What would need to be true for this to work: the Middle East and FX headwinds normalize rather than persist, the Boucheron pattern — feared loss, actual renewal — holds for the next major license coming up for renewal, and the 2027 brand launches deliver enough incremental revenue to restore double-digit growth. None of these are heroic assumptions. They’re a continuation of what this business has done for forty years, priced today as if it might stop.

Blind spots

Q1 2026’s 8.5% revenue decline is one data point, not a trend line. Whether it stabilizes, worsens, or reverses in H1 2026 will only be visible once that report is published. Everything in the bear and bull cases about the trajectory of the current slowdown is, for now, an extrapolation from a single quarter.

Succession planning is absent, even though the founders’ age makes it a near-term question, not a distant one. Benacin (67) and Madar (65) have run Interparfums together since 1982. No succession plan is disclosed. It will certainly be someone currently in the organization.

Valuation

The metric

TTM EPS based on IFRS net income, with one adjustment I’m making explicit rather than silently baking in: 2025 group net income of €126.6 million already absorbs a one-off €7.6 million cost from the 2025 US tariff introduction. Management’s own disclosure isolates this, giving a tariff-adjusted net income of €132.3 million (+2% versus 2024) — a genuinely comparable, recurring-basis figure rather than a number distorted by a single external policy shock. I’m using that adjusted figure as the base for the scorecard below, on roughly 80 million shares outstanding, for an adjusted EPS TTM of approximately €1.65. The unadjusted IFRS EPS, for reference, is closer to €1.58.

At a current price of roughly €25.50, the adjusted PE TTM stands at approximately 15.5x — against a historical range that ran 30-40x in normal years, and the lowest level the stock has traded at in years.

The scorecard

The table below uses adjusted EPS TTM of €1.65, a 2.5-year horizon to 2028, and three growth scenarios. Bear case assumes 3% annual EPS growth — consistent with the current slowdown persisting largely unresolved. Central case assumes 8%, roughly in line with what the licensing model has delivered across past cycles once currency and tariff effects normalize. Bull case assumes 14%, reflecting a return to something closer to the growth this business posted before 2025. Combinations that are internally contradictory — a bear earnings trajectory paired with a bull-level multiple, or vice versa — are marked Irrelevant.

One important caveat: all figures in the scorecard are pre-tax and pre-fees. The actual return in your hands will depend on your tax situation, the investment vehicle you use and any transaction costs. Run the numbers for your own situation before drawing conclusions.

How to read this. The only scenarios producing a loss combine PE 12x with either bear-case or central-case earnings — a multiple below where the stock trades even today, applied to a growth rate that’s already the pessimistic case. That’s a narrow downside window, not a broad one.

The central case at PE 20x — €40, +58%, +20.0% CAGR — requires no heroic assumption. It prices the business at barely above two-thirds of its own historical multiple, with EPS growth roughly in line with what this licensing model has delivered across past cycles. That’s what a partial re-rating looks like when a sentiment-driven discount unwinds without needing the bull case to be right.

My conviction is the Bull case with a 25-30 PE ratio, happening in less than 2,5 years.

The asymmetry

At today’s 15.5x, the market is pricing something close to the bear case already. Getting back to even a partial re-rating — not the historical 30-40x premium, just a multiple more consistent with a stable licensing operator putting a rough year behind it — produces a return profile that doesn’t require the bull case to be right, only for the current slowdown not to be permanent.

Portfolio considerations

Sizing

The safer the profile, the more room it can occupy in the portfolio

On my portfolio, it is a defensive stock with great repricing opportunities so I could allow a significant portion of my portfolio, up to 15% in the initial position. But I’m lacking of cash, and i’m confortable with my actual quality positions (booking, novo, adobe, etc.). I don’t want to reallocate massive chunks of my multibagger stocks (Nebius, Atos, Strategy) as they will provide most of my returns. So I will trim Nebius as soon as the stock goes back to its ATH, around 10%. I’m not comfortable with the current Nebius price, down because of fears of the meta competition.

Correlation

As said in the introduction, what I like in this stock is the decorrelation to the AI narrative. No bottleneck, no risk of circular funding. You can sleep on it for 2 years, just waiting for the catalysts to happen. Interparfums is a great stock in case of tension with the tech narrative: as offensive stocks will be beaten by the market, I can reallocate with a potential revaluation.

Subscribe now

Conclusion

Interparfums is not a hard business to understand. Sign a license, make a fragrance, sell it in 120 countries, collect a royalty or a margin. Forty years of doing exactly that, without a scandal, without a debt crisis, without a governance blowup.

2025 and Q1 2026 made it look harder than it is. A currency move, a tariff, a guidance cut that broke with the company’s own habit of quiet reliability. The market did what markets do with a broken habit — it repriced the stock as if the habit itself was gone, not just interrupted. The PE compressed from a historical 30-40x range to roughly 15-16x on a normalized basis. That’s not a mild discount. That’s a business priced as if the growth engine were structurally damaged.

Nothing in the numbers supports that read. Net cash. A dividend held through the worst of it. A tariff-adjusted net income that actually grew in 2025, once the one-off is stripped out. A Boucheron license the market priced as lost in November, renewed in February. Two of the three historical brand pillars declined this year, but the newer ones — Coach, Lacoste — picked up the slack, which is closer to a portfolio rotating than a portfolio failing.

The real risk isn’t a moat question — there isn’t one, and there never was. It’s a renewal question, license by license, forever. Forty years of renewals is not a guarantee. It’s a track record. The bear case only wins if that track record breaks, and nothing in this report says it has.

What this position offers isn’t the asymmetry of a turnaround or the disruption-fear unwind of a mispriced platform. It’s something plainer: a defensive business, temporarily priced like a declining one, sitting completely outside the narrative that moves the rest of this portfolio. That’s not the loudest reason to own something. It might be the most useful one.

Image credits

Product and marketing visuals sourced from the investor relations section of Interparfums. Financial charts sourced from Fiscal.ai.

Important Disclosure & Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

This question becomes considerably more interesting inside a tax-free wrapper, where the full magnitude of a re-rating compounds without erosion.

Microsoft is currently trading at a PE of 22x — its lowest valuation in a decade, last seen briefly during two narrow windows in the last ten years. The business is not showing any of the symptoms that usually accompany a multiple this depressed. Azure has accelerated for five consecutive quarters. Management is publicly admitting it cannot install GPUs fast enough — not because demand is missing, but because there isn’t enough electricity to plug them in.

And yet the stock has fallen hard. The market has a name for what’s worrying it: OpenAI. A partner Microsoft owns 27% of, has committed $13 billion to, and increasingly depends on for the AI growth story that justifies a $190 billion capital expenditure plan. No audited financial statements exist for OpenAI, and none will until an IPO whose timing remains genuinely uncertain.

This article starts with the business itself — what Microsoft actually does, how it makes money, who its customers and suppliers are, and what makes it structurally difficult to displace. From there, it examines the two competing theses: why the market is afraid, and whether that fear holds up under scrutiny. The valuation section translates those arguments into a scorecard with concrete scenarios. The article closes with portfolio considerations and a conclusion.

I know you’re busy, so I always start with a summary called The short version. If that’s all you have time for, that’s fine. The rest of this article explains why.

Subscribe now

The Short Version

Microsoft is the world’s dominant enterprise software and cloud platform — hundreds of millions of users locked into Windows, Office, and Azure not by preference but by switching costs that compound the longer they’re deployed. The stock has fallen roughly 25% from its 2025 peak. The market has one explanation: a $190 billion AI capital expenditure plan whose return isn’t yet visible in free cash flow, and a growing dependence on OpenAI — a partner Microsoft owns 27% of, has committed $13 billion to, and cannot audit, because no audited OpenAI financial statements exist.

My view: the market is pricing one real, bounded risk as though it were a structural one. Azure has accelerated for five consecutive quarters, with management openly admitting the constraint is electricity to power GPUs, not demand for them. Operating margin has expanded every year since FY2023. Two independent hyperscalers — Alphabet and Amazon — are reporting the same pattern: AI capex translating into expanding margins, not eroding them. None of that depends on OpenAI’s solvency.

EPS has compounded at roughly 18-20% a year for three years. The stock has compounded more slowly. That gap is the trade.

At a PE of 25x — still below the ten-year average of roughly 32x — the central scenario in the valuation scorecard implies a price near $795 within 3.5 years, a return of +113%. The only scenario in the scorecard that produces a loss combines a multiple below the broader software sector’s median with EPS growth cut roughly in half from its recent pace, sustained for years. That is not a base case.

Understanding Microsoft’s business, supply chain and environment

History

Microsoft was founded in 1975 and built its first fortune on a near-monopoly in desktop operating systems and office productivity software. For two decades, that dominance was nearly unchallengeable — and nearly fatal to the company’s long-term relevance. The early 2010s saw Microsoft miss the mobile transition almost entirely, dismissed by much of the market as a legacy software vendor in terminal decline.

The turnaround began in 2014, when Satya Nadella became CEO and redirected the company toward cloud computing and a cultural shift away from internal competition toward what he termed a “growth mindset.” Azure, a minor product line at the time, became the centerpiece of a decade-long transformation. By the mid-2020s, Microsoft had gone from a company written off as irrelevant to one of the most valuable companies in the world.

Two recent decisions define the current chapter. In October 2023, Microsoft completed the acquisition of Activision Blizzard for $75.4 billion, its largest deal in history, consolidating its position in gaming content. And since 2019, it has built an increasingly deep partnership with OpenAI — an investment of $13 billion in exchange for a 27% equity stake and a privileged commercial relationship that has become the centerpiece of the current market debate. That partnership was substantially restructured on April 27, 2026, a change significant enough to warrant its own section later in this article.

The engine: three segments, one platform

Microsoft organizes its business into three reportable segments, each at a different stage of maturity.

Productivity and Business Processes is the historical core: Microsoft 365 Commercial, Microsoft 365 Consumer, LinkedIn, and Dynamics 365. This segment generated $35.0 billion in revenue in the quarter ended March 2026, up 17%, with Microsoft 365 Commercial cloud revenue up 19% and LinkedIn up 12%.

Intelligent Cloud is the growth engine: Azure, server products, GitHub, and enterprise services. Revenue reached $34.7 billion in the same quarter, up 30%, with Azure itself growing 40% — its fifth consecutive quarter of acceleration, a streak that has persisted despite management repeatedly acknowledging that supply, not demand, is the binding constraint.

More Personal Computing is the most mature and most heterogeneous segment: Windows OEM and devices, gaming (Xbox, Game Pass, Activision Blizzard content), and search advertising. It was the only segment to decline in the most recent quarter, down 1%, dragged by a 2% fall in Windows OEM revenue and a 5% decline in Xbox content and services.

Layered across all three segments is Copilot — Microsoft’s attempt to embed AI monetization horizontally rather than concentrate it in a single product line. GitHub Copilot has demonstrated clear, measured value (developers documented as 55% faster on well-scoped coding tasks) and has scaled to 4.7 million paid subscribers. Microsoft 365 Copilot has grown faster in absolute seat count — over 20 million paid seats, up from 15 million the prior quarter — but penetration of the installed M365 base remains low, at roughly 4.4%, and retention appears weaker than GitHub Copilot’s. Management has already begun pivoting the product toward agentic capabilities rather than a generic assistant, an implicit acknowledgment that the first iteration underdelivered.

Customers

Microsoft’s customer base spans individual consumers, small and medium businesses, large global enterprises, public-sector institutions, service providers, application developers, and OEMs. Roughly 80% of the Fortune 500 use Azure AI Foundry. LinkedIn counts 1.2 billion members. Gaming reaches 500 million monthly active users.

One nuance worth naming explicitly, because it complicates the popular “European digital sovereignty” narrative: public-sector deviations from Microsoft are currently concentrated almost entirely in desktop software — France’s planned migration of 2.5 million government workstations to Linux, Germany’s Schleswig-Holstein region, Italy’s Ministry of Defense — not in identity infrastructure or cloud. Active Directory, Entra ID, and Azure consumption remain firmly within Microsoft’s grip even in administrations actively reducing their Windows footprint, most plausibly because the cost-benefit calculation for migrating cost-driven desktop licensing is straightforward, while migrating identity and PaaS-layer infrastructure is not.

Suppliers

Microsoft’s most consequential supplier relationship is also, structurally, its most ambivalent: Nvidia. GPU capacity is the binding constraint on the company’s entire AI growth narrative, and Nvidia is by far the dominant supplier of that capacity — a dependency Microsoft is actively working to reduce through internal silicon development (Maia, Cobalt), though that effort remains early-stage.

The second critical dependency is OpenAI itself, which occupies an unusual dual role: simultaneously a technology partner whose models power Copilot, and the single largest identified consumer of Azure’s own AI compute capacity. Independent analysis of Microsoft’s most recent 10-Q estimates that consumption tied to OpenAI represents the largest single line within Microsoft’s $37 billion AI revenue run rate — though Microsoft itself has not published an official breakdown, and this figure should be treated as a well-reasoned estimate rather than a confirmed fact.

Beyond these two, the 10-K explicitly flags concentration risk in hardware components: “there are few qualified suppliers for certain components of our servers and devices.” Azure AI Foundry also hosts models from third parties — OpenAI, Cohere, DeepSeek, Meta, Mistral, xAI — giving Microsoft a degree of model-layer diversification that reduces, without eliminating, the company’s dependency on any single AI lab.

Competition

Cloud infrastructure. Azure competes directly with Amazon Web Services and Google Cloud Platform in what is effectively a three-player oligopoly. Market share estimates converge around AWS at 30-33%, Azure at 23-28%, and Google Cloud at 11-13% — the three together capturing roughly two-thirds of the global market, with the remainder fragmented among smaller players. Azure has narrowed the gap with AWS over recent quarters rather than widened it, growing 40% against AWS’s 28% in the most recently reported periods.

Productivity software. Google Workspace is Microsoft’s only meaningful direct competitor here, and the two together control the overwhelming majority of the market — though the precise leader depends heavily on methodology. By paid enterprise seats, Microsoft 365 leads decisively, with over 450 million paid seats and roughly 75% of the Fortune 500. By raw domain or account count, Google Workspace is often cited as larger, buoyed by small businesses and education accounts where Google is free or near-free. This is a genuine duopoly with no credible third entrant.

Gaming. Sony’s PlayStation remains the dominant console platform, with Microsoft a consistent second, though Activision Blizzard content and Game Pass subscription economics have strengthened Microsoft’s position on content and recurring revenue even where hardware share lags.

Search and consumer AI. Google Search retains over 90% global market share; Bing and Copilot remain minor players in pure search terms. On the consumer AI chatbot front specifically, ChatGPT’s share of monthly active usage has declined from roughly 85% to around 45% over the past two years as Gemini, Claude, DeepSeek, and others have gained ground — though this metric measures consumer app usage, not enterprise revenue, where Anthropic’s Claude reportedly overtook OpenAI as early as mid-2025.

None of Microsoft’s direct competitors qualifies as a category-definer in the strict sense of having created an uncontested category. The closer candidate for that label sits one layer up the stack: Nvidia, whose dominance in AI compute underwrites the infrastructure all three hyperscalers depend on, and OpenAI, whose generative AI breakthrough effectively created the category Microsoft is now monetizing through partnership rather than head-on competition — a strategic choice that distinguishes Microsoft’s approach from Google’s, which is building Gemini in-house and therefore competes more directly with its own cloud customers in the AI lab space.

Competitive advantage

Most competitive-moat frameworks converge on a single question: why can’t a well-funded competitor simply replicate what this business does? For Microsoft, there are three distinct, mutually reinforcing answers — a fourth, the deepest one, is developed separately in the bull thesis below.

Economies of scale. The 10-K states plainly that the company’s datacenters “deploy computational resources at significantly lower cost per unit than smaller ones” — a direct structural barrier to entry that no new entrant can replicate without comparable capital intensity. The 2026 capital expenditure guidance of roughly $190 billion is itself a barrier: few companies on earth can fund infrastructure at this scale.

Network effects. LinkedIn’s 1.2 billion members and GitHub’s developer ecosystem both compound in the classic two-sided sense — more users make the platform more valuable to every other user.

A self-reinforcing, multi-layer lock-in system. Unlike a single-axis moat, Microsoft’s advantage is a system in which the operating system layer, the line-of-business software layer, the PaaS layer, and now the AI layer all reinforce one another rather than standing as four separate, independently defensible barriers. This is the single most important point of this analysis, and it deserves more than a paragraph — it’s developed in full in the bull thesis below.

Financials

Key financial metrics

Comments on the numbers above

On the free cash flow decline. FCF fell to $71.6B in FY2025 from $74.1B in FY2024 — not because operating cash generation weakened (it grew 15% to $136.2B) but because capital expenditure grew faster, up 45% to $64.6B. This is a capex story, not an earnings-quality story. FCF minus stock-based compensation tells the same story more starkly: $63.4B in FY2024 was the peak of the period, falling to $59.6B in FY2025, and the pressure has only intensified since — Q3 FY2026 alone saw FCF-SBC fall 26.7% year over year, the steepest decline in the series. Worth noting: this isn’t purely a recent, AI-driven phenomenon. FCF-SBC was already down 13.4% in FY2023, well before the current capex cycle began in earnest — the tension between operating cash generation and capital intensity has a longer history than the AI narrative alone would suggest.

On the volatility inside net income tied to OpenAI. Microsoft’s equity-method stake in OpenAI has produced wildly different quarterly impacts: a $4.1 billion pre-tax loss in Q1 FY2026, a $7.6 billion gain in Q2 FY2026 — driven by a revaluation following the April 2026 restructuring, not by any improvement in OpenAI’s underlying profitability — and a near-neutral $14 million loss in Q3 FY2026, down sharply from a $583 million loss in the same quarter a year earlier. This swings on Microsoft’s use of the hypothetical-liquidation-at-book-value (HLBV) accounting method, which can produce results that diverge meaningfully from a simple pro-rata share of OpenAI’s reported net income. None of this reflects a change in OpenAI’s actual cash burn, which independent estimates continue to place in the tens of billions annually.

On Azure’s acceleration despite a binding supply constraint. Azure growth has climbed in every period shown — 29% (FY2023), 30% (FY2024), 34% (FY2025), 40% (Q3 FY2026) — five consecutive quarters of acceleration, each beating prior guidance. That is the opposite of what you’d expect if AI demand were overstated. CFO Amy Hood has stated explicitly across multiple quarters that supply, not demand, remains the limiting factor, adding in the Q3 FY2026 call that the company expects to “remain constrained at least through 2026” — an admission that costs the company growth in the short term and therefore carries more credibility than a typical demand-side sales pitch.

On margin compression in the cloud segment. Microsoft Cloud gross margin fell to 66% in Q3 FY2026, which the company attributes directly to the cost of scaling AI infrastructure, partly offset by efficiency gains in Azure and Microsoft 365 Commercial cloud. Operating margin at the company level has nonetheless continued to expand throughout the period (41.5% → 44.6% → 45.6% → 46.3%), helped by declining total headcount — discipline below the gross-margin line is absorbing some of the pressure from infrastructure scaling rather than letting it flow straight through to the bottom line.

On FY2023 as the trough year. FY2023 stands out as the one period in this table where net income (-0.4%) and diluted EPS (+0.3%) were essentially flat — a pause following the post-pandemic deceleration, before the cloud and AI reacceleration that has driven double-digit growth in every subsequent year shown.

ROIC trend — a longer pattern than the AI capex story alone

The current ROIC of 19.9% is not an isolated trough created by the AI investment cycle — it is the continuation of a decline that began five years earlier. According to Fiscal.ai data spanning fiscal years 2017 through the trailing twelve months, Microsoft’s ROIC peaked at 31.4% in FY2021, held near that level through FY2022 (30.6%), then declined in successive years: 25.5% (FY2023), 24% (FY2024), 21.8% (FY2025), 19.9% (LTM). Over the same nine-year window, diluted EPS rose from $3.25 to $16.80 — a 20.0% CAGR, against a roughly flat ROIC CAGR of -0.8% over the same period.

The two-phase nature of this decline matters for how the AI capex debate should be framed. The first phase, FY2021 to FY2023, predates the current AI infrastructure buildout and likely reflects post-pandemic normalization combined with digesting the integration of the Activision Blizzard acquisition. The second phase, FY2024 onward, coincides with and likely reflects the accelerating capital intensity discussed throughout this section. Treating the entire nine-year decline as evidence that “AI investment is destroying returns on capital” overstates the case — roughly half the decline happened before the AI capex cycle began.

What the trend does confirm is the mechanism already described above: Microsoft is generating substantially more absolute profit (EPS more than doubling since FY2021) while doing so on a capital base that is growing even faster — precisely the signature of a company in a heavy investment phase, where marginal returns on newly deployed capital dilute the average ROIC even as total earnings power continues to expand.

Geographic revenue

Microsoft discloses a simple geographic split: the United States accounted for $144.5 billion, or 51.3%, of fiscal 2025 revenue, with the remaining 48.7% generated elsewhere. The company notes that no individual country outside the US exceeds 10% of revenue, so no further granularity is published.

Capital expenditure — pace and intent

Capex has compounded at a rate that materially outpaces revenue growth: $28.1B (FY2023) → $44.5B (+58%, FY2024) → $64.6B (+45%, FY2025) → roughly $190B guided for calendar 2026 (+61% on a comparable basis). Sector-wide, the four largest AI spenders (Microsoft, Alphabet, Amazon, Meta) are projected to spend a combined $505 billion in 2026, up from roughly $366 billion in 2025 — Microsoft’s acceleration is not an outlier, it’s part of an industry-wide pattern.

Roughly two-thirds of this spend goes to short-lived assets (GPUs and CPUs, depreciated over roughly two years), and one-third to long-lived assets (buildings, power infrastructure, land, increasingly financed through leases rather than direct construction). Of the $190B guided for 2026, an estimated $25B reflects component price inflation rather than incremental capacity — spend that doesn’t buy more compute, just buys the same compute at a higher price.

Capacity allocated this way is not earmarked for a single segment in Microsoft’s reporting — it is corporate spend that flows simultaneously into Azure consumption, into Microsoft’s own first-party AI products (Copilot, GitHub Copilot), and into internal R&D acceleration. Management has explicitly cautioned analysts against drawing a mechanical one-dollar-to-one-dollar link between capex and Azure revenue specifically.

Balance sheet and leverage

Total debt: $43.15B. Stockholders’ equity: $343.5B. Debt-to-equity: 0.13. Cash and short-term investments: $94.6B — exceeding total debt, putting the company in a net cash position. EBITDA (operating income plus D&A): approximately $162.7B. At this scale, total debt represents roughly 0.34 years of operating income — about four months — making leverage a non-issue for Microsoft.

A genuine off-balance-sheet item worth flagging: $92.7 billion in datacenter lease commitments not yet commenced.

Accounting notes worth flagging

The auditor is Deloitte & Touche LLP, with an unqualified opinion on both the financial statements and internal controls. Two Critical Audit Matters were identified: revenue recognition complexity (standard for a business combining licensing and cloud contracts) and uncertain tax positions (linked directly to the IRS dispute below). Neither suggests irregularity.

The IRS has assessed approximately $28.9 billion in additional tax related to transfer pricing for tax years 2004-2013, which Microsoft is contesting and has not fully provisioned. Separately, $541 million in litigation accruals are recorded, with an estimated additional $600 million in reasonably possible losses beyond what’s already booked — modest figures relative to a $619 billion balance sheet.

Management

Satya Nadella — CEO since 2014

Nadella inherited a company widely regarded as past its prime and rebuilt its growth trajectory around cloud and, more recently, AI. His public communication style is notably more measured than the typical “platform shift” rhetoric he himself favors — quarterly calls remain anchored in specific operational metrics rather than visionary abstraction, a contrast worth noting given how aggressively the company is spending on an unproven return.

The clearest data point on his character as an operator: when cybersecurity incidents drew public criticism in 2024, Nadella voluntarily reduced his own cash bonus by roughly 50% — from $10.66 million to $5.2 million. The board has since added security as a standalone compensation criterion for senior executives for the first time. This is the same instinct Microsoft’s M365 Copilot pivot reflects at the product level: naming an underperforming bet rather than quietly burying it.

Skin in the game

Nadella’s FY2025 compensation totaled $96.5 million — but the figure that matters more than the total is its composition. 87% of it, $84.2 million, came in the form of stock awards rather than cash, vesting over three to four years and tied to performance metrics including ROIC and relative shareholder return. This is a distinct, individually negotiated package — separate from the broader $12 billion in company-wide stock-based compensation expensed across the workforce — but it illustrates the same principle the board has built into its evaluation framework: pay tracks long-term capital returns and shareholder outcomes, not just short-term financial results. The board’s own scoring of his FY2025 performance reflects that blend — 117% of target on financial metrics, 151.67% on operational assessment — with security added as a standalone criterion for the first time following the cybersecurity incidents discussed above.

Capital allocation discipline

Across the criteria that typically separate disciplined capital allocators from undisciplined ones: capital is unambiguously directed toward the highest-return opportunity (Azure/AI capex dwarfs spend on flatter segments), there has been no pattern of frequent, poorly integrated acquisitions (Activision Blizzard remains the only major deal in the recent period, and it is performing), buybacks have been modest relative to free cash flow ($13.0B in FY2025 against $71.6B in FCF, with $57.3B of a $60B authorization still undeployed), and the board has demonstrably updated its own oversight criteria in response to operational failures rather than leaving them static.

The one mark against the company on this dimension: communication around the OpenAI relationship was, by external accounts, opaque in its early stages — the word “primarily” carried a great deal of unstated weight in describing the source of equity-method losses before Microsoft began isolating the figure explicitly from Q1 FY2026 onward. Transparency improved under pressure rather than arriving proactively.

Two thesis

Bear thesis

Why the stock has fallen

The decline is not explained by a deterioration in fundamentals. Revenue grew 18% in the most recent quarter, Azure has accelerated for five consecutive quarters, and operating margin has expanded every year shown in the table above. The stock fell because the market repriced the risk of a capital expenditure cycle whose return is not yet fully visible in free cash flow.

Three factors combined:

• First, capital expenditure guidance that came in well above consensus — $190 billion for calendar 2026 against a Visible Alpha estimate of $154.6 billion — with management attributing roughly $25 billion of that to component price inflation alone, not incremental capacity.

• Second, a broader market debate about whether AI infrastructure spending across the hyperscaler cohort will generate returns commensurate with its scale.

• Third, and most specifically to Microsoft, a growing dependence on OpenAI — a partner the company owns 27% of, has committed $13 billion to, and whose contractual Azure commitments now account for the majority of the deceleration gap between headline cloud growth and growth excluding that single relationship.

The OpenAI exposure gave the bears a concrete, recurring data point. It is the one argument in this section that does not unwind cleanly under scrutiny.

The bear arguments

Dependence on an unaudited, cash-burning partner. This is the central, legitimate concern, and it deserves to be unpacked as two distinct scenarios rather than one vague risk, because each implies a different magnitude of consequence for Microsoft.

OpenAI is not a public company. It has never filed audited financial statements, and won’t until an IPO whose timing remains uncertain — a confidential S-1 was filed in June 2026, but estimates of when a listing might actually happen range from late 2026 to sometime in 2027, with most analysts leaning toward the later end. In the absence of audited numbers, what’s available is a series of internal projections leaked to the press, and those projections have moved dramatically and repeatedly: cumulative revenue estimates for 2030 have been revised from roughly $85 billion to as low as $39 billion, then back up to roughly $280 billion, within the span of a few months — a swing of nearly sevenfold between the low and high figures, none of it audited, none of it confirmed by OpenAI itself. That volatility in OpenAI’s own internal forecasting is the backdrop against which both scenarios below need to be read.

In the bankruptcy scenario, the direct accounting impact is bounded — a write-down of at most the $13 billion invested, absorbable in a single quarter against net income exceeding $100 billion annually. The more consequential impact is operational: a meaningful share of the $37 billion AI revenue run rate and the 99% year-over-year growth in remaining performance obligations is tied to OpenAI’s own Azure consumption — strip that out, and RPO growth falls to roughly 26%, still healthy but a different growth story than the headline figure implies. Physical capacity would not be destroyed — the binding constraint today is electricity, not demand, meaning a queue of other customers exists to absorb freed capacity — but reallocation would not be instantaneous, and the narrative hit to Azure’s growth rate would be immediate.

In the continuous financing scenario — OpenAI survives but requires large-scale, repeated financing for years — the relevant question shifts from solvency to financing risk. OpenAI’s path to the IPO it has confidentially filed for remains genuinely uncertain in timing, and even a successful listing raising upward of $60 billion would not, on its own, close a cumulative cash burn gap that internal projections place in the hundreds of billions through 2030. Microsoft would likely continue benefiting from this relationship through royalties and Azure consumption regardless of OpenAI’s path to profitability — but the market’s confidence in the durability of that arrangement depends on financial visibility that, as things stand, does not exist.

Margin compression from infrastructure scaling. Microsoft Cloud gross margin has fallen to 66%, and the ratio of capital expenditure to operating cash flow has crossed 50% — a level that concerns analysts more than the absolute dollar figure. The bear case treats this as evidence that the capital intensity of AI-driven growth is structurally different, and structurally worse, than the software-centric model that built Microsoft’s historical margin profile.

European public-sector erosion. Several European governments — France, Germany’s Schleswig-Holstein region, Italy’s Ministry of Defense — have announced migrations away from Microsoft desktop software, framed publicly around digital sovereignty.

What if the bear thesis is really true?

If every element above plays out simultaneously — Azure’s market share gains stall, cloud margins continue eroding under the weight of infrastructure scaling, OpenAI is forced to materially scale back its Azure commitments for lack of financing, and European public-sector erosion spreads beyond the desktop into infrastructure layers — the investment thesis would shift fundamentally. Microsoft would no longer be a quality compounder temporarily mispriced; it would be a mature company in a prolonged overinvestment phase, carrying fixed costs (the $92.7 billion in datacenter leases not yet commenced) against demand that failed to materialize as planned. In that scenario, a PE of 22x would not be cheap — it would still be too expensive for a business facing structural margin erosion and a sharply slower growth trajectory than the one currently priced in.

None of the first three signals — Azure share, cloud margins, European desktop migration — currently shows evidence of this trajectory: Azure has accelerated in every one of the last five quarters, not decelerated; operating margin has expanded every year since FY2023; and European public-sector deviations remain almost entirely confined to desktop software, with identity infrastructure (Active Directory, Entra ID) and Azure consumption remaining intact even in administrations actively reducing their Windows footprint — most plausibly because the cost-benefit calculation for migrating cost-driven desktop licensing is straightforward, while migrating PaaS-layer infrastructure is not. The fourth signal, OpenAI’s financing trajectory, remains genuinely unresolved and is the one component of this bear case that current data cannot rule out.

Bull thesis

The market is pricing one fear and ignoring three independent confirmations that AI capital expenditure is profitable

CFO Amy Hood stated directly in the Q3 FY2026 earnings call, in response to an analyst question comparing AI margins to historical cloud margins, that margins on AI products and tools are already better than cloud margins were at a comparable stage of scale — a claim that is verifiable over time rather than a vague promise, and one the company has every incentive not to make if it weren’t broadly true given how closely analysts now track this exact metric.

That claim does not stand alone. Alphabet was the only one of the three major hyperscalers to “convince investors” in the most recent earnings cycle, according to financial press coverage, on the strength of a clear acceleration in Google Cloud growth that the market read as direct evidence of capex translating into results. Amazon corroborates the pattern with harder numbers: group operating margin reached a record 13.1% in the same period it announced its most aggressive capital expenditure plan in company history — $200 billion for 2026, $344 billion cumulative through 2027 — while AWS itself accelerated to 28% growth. An independent calculation based on AWS’s current margin and growth rate puts the incremental ROIC on AI capital expenditure above 25-30%, comfortably above any reasonable estimate of the sector’s cost of capital.

Three independent companies, three different competitive positions, three confirmations of the same underlying pattern: AI infrastructure investment is not destroying returns on capital at the margin — it is being deployed against demand that is currently outstripping supply, evidenced most directly by management at all three companies admitting, repeatedly and on the record, that capacity rather than demand is the binding constraint on growth. That kind of admission costs a company near-term growth and credibility with the market if it overspends on unrealized demand; it is not the kind of claim a management team makes lightly, and it is the opposite of what you’d expect to hear if the spending were not paying off.

A lock-in system that compounds across every layer of the stack — and gets stronger, not weaker, the deeper AI is embedded

Microsoft’s most durable advantage is not technological superiority at any given moment — it is the cost of leaving. That cost is best understood through specific, lived examples rather than abstraction. A notary running case-management software that only runs on Windows Server cannot migrate without rewriting mission-critical, regulator-adjacent software they did not write and cannot easily replace — the alternative isn’t switching platforms, it’s a multi-year engineering project with legal exposure attached. A systems administrator managing several thousand endpoints does not consider Linux a realistic alternative not because Linux is technically inferior, but because the tooling, the talent pool, and years of institutional muscle memory are built entirely around Active Directory — propose removing it, and the practical response is closer to resignation than migration planning. Independent software vendors who built their products on .NET and SQL Server, on-premise, propagate that same lock-in to every one of their own customers in turn, multiplying its reach far beyond what market-share statistics for Windows or Azure alone would suggest.

This switching-cost moat has a second layer that matters specifically for the AI debate. Infrastructure-as-a-Service workloads — raw virtual machines — are relatively portable between cloud providers; a VM migrates from Azure to AWS with moderate effort. Platform-as-a-Service workloads — applications built directly against proprietary managed services like Azure SQL Database, Azure Functions, or Entra ID — are not; migrating them means rewriting application code, not simply redeploying infrastructure elsewhere. Enterprise AI today is being built almost exclusively on this PaaS layer — Copilot integrations wired directly into Entra ID and Microsoft Graph, agentic workflows built on Azure AI Foundry — which means each new AI deployment deepens the same lock-in rather than creating an independent, swappable product. An organization already entrenched in Windows and Active Directory is also the organization most likely to have built its cloud workloads on Azure PaaS for integration convenience in the first place — the layers reinforce each other rather than standing as separate, independently defensible barriers. The European public-sector migrations discussed in the bear case make this point empirically: even governments with explicit political mandates to reduce dependence on Microsoft have, so far, only managed to substitute the desktop layer, leaving identity and cloud infrastructure untouched.

A demonstrated competence in structuring contracts, not just building products

The April 2026 restructuring of the OpenAI partnership is a recent, concrete illustration of this. Microsoft gave up cloud exclusivity — a real concession, made under pressure from a partner seeking to diversify its infrastructure risk — in exchange for a technology license extended to 2032, royalties capped at 20% of OpenAI’s revenue through 2030 regardless of whether OpenAI achieves AGI, a right of first refusal on capacity, and the $250 billion Azure spending commitment discussed above. The same instinct shows up at the product level: Microsoft 365 Copilot has grown to over 20 million paid seats despite penetration of the installed base remaining low and usage retention appearing weaker than GitHub Copilot’s — the company is successfully monetizing a product whose standalone value proposition remains debated, by bundling it into existing enterprise contracts rather than relying on the product winning on merit alone. This is the same mechanism, applied at different scales: Microsoft’s economic engine has historically depended less on having the best product at any given moment than on making the cost of leaving — or the cost of not adopting what’s already embedded in an existing contract — higher than the cost of staying.

The valuation gap. EPS has compounded at roughly 18-20% annually over the period shown in the financials table. The stock, over a comparable multi-year window, has compounded at a meaningfully slower rate — the PE has compressed from a ten-year average of roughly 31-33x to 22x today, the lowest level in a decade.

Catalysts

Earnings. A quarter where the capex-to-free-cash-flow ratio stabilizes or improves — even without a major beat on revenue — would likely matter more to sentiment than another quarter of headline growth, since the market’s current concern is specifically about cash conversion, not top-line demand.

Structural. Stabilization or further clarification of OpenAI’s financing path — whether through a successful IPO process or continued evidence that its Azure commitments are being honored at scale — would directly address the one bear argument that current data cannot resolve.

Macro. A shift toward lower interest rates would mechanically benefit the valuation of long-duration growth compounders as a class, Microsoft included — though the 2022 precedent, when Microsoft fell further than the broader index during the rate-hiking cycle, is a reminder that this sensitivity cuts in both directions.

What would invalidate the bull thesis

Four signals worth monitoring every quarter:

• The capex-to-operating-cash-flow ratio continuing to deteriorate without stabilization beyond 2026

• Azure growth excluding OpenAI’s contractual commitments (currently estimated around 26%) beginning to decelerate meaningfully

• Continued, unresolved deterioration in OpenAI’s equity-method losses without a new restructuring in Microsoft’s favor

• Commercial RPO converting to recognized revenue at a materially lower rate than the roughly 30% management has signaled for the next twelve months

None of these have appeared as of the most recent quarter reported. When one does, the thesis deserves reassessment.

Blind spots

The exact breakdown of the $37 billion AI revenue run rate by product and by customer is not published by Microsoft. Independent analysis of the most recent 10-Q estimates that OpenAI-linked Azure consumption represents the largest single component, but this remains a reasoned inference rather than a confirmed figure — Microsoft has not isolated it, and this should be revisited once the company provides more granular disclosure, if it ever does.

The precise terms governing newly signed datacenter lease commitments — early termination clauses, penalty structures — are not public. What is known is that roughly 200 MW of pre-commencement capacity has been cancelled with at least two operators, while market-wide lease terms have hardened in landlords’ favor on new agreements, meaning the flexibility demonstrated on cancelled commitments may not extend to leases signed going forward.

The degree to which line-of-business software lock-in protects Microsoft’s enterprise base cannot be precisely quantified from public data — no reliable figure exists for the share of enterprise applications built on the Windows/.NET/SQL Server stack versus portable alternatives. The argument rests on structural logic and specific, verifiable examples rather than an aggregate statistic, and should be read accordingly.

Valuation

This section is the output of everything above — not a standalone recommendation. The numbers only make sense if you’ve read the two thesis section. A valuation without a thesis is just a spreadsheet.

The metric

PE TTM, based on GAAP net income as published — no normalization. This is a deliberate departure from how this kind of section is sometimes built. The volatility inside Microsoft’s reported earnings tied to OpenAI (a $4.1 billion loss one quarter, a $7.6 billion gain the next, a near-neutral $14 million the quarter after that) is recurring and structural rather than a one-time, isolable charge — stripping it out trimester by trimester would introduce more judgment and arbitrariness into the number than it would remove. The published GAAP figure is taken as-is; its composition is discussed in the financials section above rather than adjusted away here.

At a current price of roughly $373, the PE TTM stands at approximately 22x — against a ten-year average of roughly 31-33x, and the lowest level the stock has traded at in a decade.

The scorecard

The table below uses EPS TTM of $16.80, a 3.5-year horizon to January 1, 2030, and three growth scenarios. Bear case assumes 10% annual EPS growth — roughly half the rate Microsoft has delivered over the past three years. Central case assumes 20%, in line with recent history. Bull case assumes 30%, reflecting continued AI-driven acceleration. Combinations that are internally contradictory — a bear earnings trajectory paired with a bull-level multiple, or vice versa — are marked irrelevant.

One important caveat: all figures in the scorecard are pre-tax and pre-fees. The actual return in your hands will depend on your tax situation, the investment vehicle you use, and any transaction costs. A gain of +113% in a taxable account is not the same as +113% in a tax-sheltered envelope. Run the numbers for your own situation before drawing conclusions.

One scenario this scorecard does not attempt to price: a broad market selloff unrelated to Microsoft’s own fundamentals — a recession, a credit event, a systemic AI-sector repricing. Any of these could push the stock below the bear case shown here, temporarily, independent of the company’s underlying performance. The scorecard maps where the stock could trade if the thesis plays out roughly as described; it says nothing about what the market does in between.

How to read this

The only scenario that produces a loss is a PE of 12x combined with EPS growth slowing to 10% a year — a multiple below the median of the broader software sector and a growth rate roughly half of what Microsoft has delivered over the past three years, sustained through 2030. That is not a base case. It requires the AI capex cycle to fail to generate meaningful returns and the multiple to compress well past anything seen even during the past decade’s lowest points.

The central case at PE 25x — $795, +113%, 24.1% CAGR — requires no heroic assumptions. It prices the business at a multiple still below its own ten-year average, with earnings growing at a rate close to what the company has already delivered. That is what a re-rating looks like when a sentiment-driven discount unwinds without requiring the bull case to be right.

The asymmetry

The realistic downside is contained to scenarios that combine both a growth slowdown and a multiple well below anything the stock has historically traded at, sustained over multiple years. The realistic upside does not require the AI investment cycle to be a triumph — it requires it not to be a failure. That gap, not any single price target, is the investment case.

Portfolio considerations

Sizing

This is structured as an initial position — sized to put real capital behind the conviction expressed in this article, not as a maximum allocation. The reasoning follows directly from the bear thesis section above: three of the four risks identified there don’t hold up under scrutiny with current data, but the fourth — OpenAI’s financing trajectory — remains genuinely unresolved. A position sized for full conviction would be premature when one material part of the thesis depends on visibility that doesn’t yet exist.

The stop is not a price. It is a thesis: if the capex-to-operating-cash-flow ratio continues deteriorating without stabilization beyond 2026, if Azure growth excluding OpenAI’s contractual commitments begins decelerating meaningfully, or if OpenAI’s equity-method losses resume worsening without a new restructuring in Microsoft’s favor, the investment case deserves reassessment — regardless of where the stock is trading at the time. As long as the thesis holds, further weakness is an opportunity to add, not a signal to reconsider.

On the exit side, the central-case scorecard above — a PE around 30x on continued 20% EPS growth — is the closest thing to a defined target this analysis produces, without being a fixed price commitment. The honest answer is that the precise exit discipline (a specific multiple, a return threshold, or a combination of both) will depend on how the thesis evolves over the coming quarters, and particularly on how the OpenAI financing question resolves. What’s fixed is the criterion for reassessment described above; what remains open is the criterion for taking profits once the re-rating, if it happens, is underway.

Correlation

This position adds limited diversification at the factor level. Alphabet, already held in the portfolio, shares the same underlying exposure — hyperscaler capital expenditure, AI monetization timing, and sensitivity to the same sector-wide sentiment swings discussed throughout this article. Both stocks fell and would likely recover together on the same catalysts. The case for Microsoft here is not that it diversifies away from that exposure, but that it offers a better entry price on it: Alphabet trades close to its own historical average multiple, while Microsoft trades at the bottom of its ten-year range. This is a reallocation within a factor, not a rotation across factors.

Currency

Microsoft is dollar-denominated, with no natural currency hedge embedded in the business structure comparable to a foreign-currency debt offset. Currency exposure here is real and unmitigated at the position level.

Defensive / offensive

The position sits between the two. The downside case rests on a defensive foundation — Windows, Office, and Azure outside its OpenAI exposure remain fully verifiable and intact even in the bear scenario, with a balance sheet carrying more cash than debt. The upside case is more offensive in nature, requiring continued execution on an AI capital expenditure cycle whose full return is not yet visible in the numbers. The position is being sized accordingly: large enough to matter if the offensive case plays out, small enough that the defensive floor is what determines the outcome if it doesn’t.

Conclusion

Microsoft is not a broken business. It is a business where the market’s confidence in one specific, bounded relationship has not kept pace with everything else the company has demonstrated.

The core — Windows, Office, Azure outside its OpenAI exposure, a balance sheet with more cash than debt, operating margins that have expanded in every year shown in this analysis — is fully intact and independently verifiable. The part of the thesis that isn’t independently verifiable is narrow and identifiable: the financing trajectory of a single partner whose audited financial statements don’t yet exist.

EPS has compounded at roughly 18-20% a year. The stock has compounded more slowly. That gap closed the multiple to its lowest level in a decade, alongside Alphabet and Amazon — both of which corroborate, with their own numbers, that AI capital expenditure across the sector is being met by demand rather than outrunning it.

I don’t know when the OpenAI financing question resolves, or in which direction. What I know is that the price being asked today does not require it to resolve favorably — only for it not to be a catastrophe. That distinction is the entire trade.

Subscribe now

Image credits

Financial charts sourced from Fiscal.ai.

Important Disclosure & Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

We have three bank cards in our European household.

We’ll keep one.

Not because of budget constraints. Because of analytical conviction.

In April 2024, I initiated positions in both Visa and Mastercard. One year later, I exited both — rotating into Nvidia and Alphabet. They were winning positions and voluntary exits.

Not because the thesis was broken at the time — the numbers were still good. Because I could see what was coming for them in Europe, and the risk I was underwriting no longer matched the multiple I was paying.

This article explains why I haven’t gone back. Why the same reasoning partially invalidates the PayPal recovery thesis. And why I believe the next decade will prove that the flywheel these businesses built their dominance on — in Europe at least — is not slowing down.

It’s broken.

Subscribe now

II. What The Market Is Pricing — The Classic Moat

Before attacking it, you have to understand it.

The Visa/Mastercard flywheel works like this: more issuers attract more merchants, more merchants attract more cardholders, more cardholders generate more transactions, more transactions produce more data, more data enables better value-added services, better services attract more issuers. Round and round.

The five pillars of the moat:

Network effects — 150 million acceptance points across 200+ countries. Switching costs — decades of embedded infrastructure in every bank’s core systems. Proprietary tokenisation — 16 billion tokens provisioned as of FY2025. Transactional data — 901 million transactions processed daily. Network-agnostic VAS — $10.9B in FY2025, growing at +24% year-over-year.

The numbers that comfort the market:

Visa FY2025: $40B net revenue, +11%. Data processing +13%. International transaction revenue +12%. VAS +24%. Client incentives: $15.8B, up 14%. The bull case looks airtight.

And if you only look at the United States, it probably is.

III. The Vectors of the Broken Flywheel

3.1 No rewards, no loyalty — just fees

The European card market has a structural weakness that rarely appears in analyst models: the European consumer derives no perceived value from their card.

In the US, Visa and Mastercard defend their moat through rewards — miles, cashbacks, airport lounges. Switching has a real psychological cost. You leave something behind.

In Europe, the Interchange Fee Regulation has capped interchange at 0.20% for debit and 0.30% for credit since 2015. Rewards are essentially nonexistent. The annual card fee pays for a commodity service the consumer already resents. Revolut, Wise and their peers have accelerated this erosion — disaggregating the last perceived advantages of the premium card one use case at a time. Free currency exchange. On-demand travel insurance. Instant payments.

When a free alternative arrives in this context, there is no friction in switching. No miles to lose. No lounges to give up. Just fees you stop paying.

The German market deserves a separate mention — not as an exception, but as the most acute exposure. PayPal commands approximately 30% of German e-commerce transactions, the dominant payment method in Europe’s largest online market. That position was built on a single use case: I want to pay online without giving my card number, with buyer protection. PayPal owned that use case in Germany for two decades.

Wero just took it. Launched in 2024 by the European Payments Initiative — backed by the major German, French and Belgian banks — Wero delivers the identical use case: no card number, instant settlement, buyer protection. Except it is European, public, and carried by the banks Germans already trust with their savings. PayPal’s strongest market in Europe is about to become its graveyard.

3.2 A2A — the disruption already underway

This is not a theory. The empirical proof exists. Two of the world’s most populated countries have already lived through it.

PIX — Brazil, launched November 2020

Mandated by the Banco Central do Brasil. Free for individuals. 0.33% for merchants versus 2.3% for cards. Participation mandatory for any institution with more than 500,000 accounts.

Five years later: 64 billion transactions in 2024, surpassing the combined volume of Visa and Mastercard. Cash usage collapsed from 43% to 6% of payments. 93% of Brazilian adults use PIX. Estimated losses for Visa and Mastercard between 2021 and 2024: R$12 billion combined.

The political signal: in September 2025, the US Trade Representative launched a formal investigation into PIX, calling it an “unfair competitive disadvantage” for US card networks. A White House report in April 2026 reiterated the concern. President Lula responded: “No one will make us change PIX.”

When Washington launches trade investigations against a payment system, it confirms the threat is real and structural — not marginal.

UPI — India, launched 2016

Nine years in, UPI processed 644 million transactions in a single day in June 2025 — surpassing Visa’s global daily average of 639 million. In May 2025, UPI transaction value was 12 times greater than the combined total of all card transactions in India. The market share of credit cards in India’s digital payments fell from 43% in 2018 to 21% in 2024. UPI is growing at roughly 40% annually. Visa at 10%.

The lesson from PIX and UPI:

Cash is the first casualty. Cards are the second. The broken flywheel doesn’t replace Visa directly — it captures the migration from cash before cards ever get there, then starts eating into card volume from below.

3.3 The digital euro — sovereign disruption

What is the digital euro?

The digital euro is a central bank digital currency (CBDC) — a form of public money issued directly by the European Central Bank, with the same legal status as cash. Not a stablecoin. Not a private payment instrument. Sovereign money, guaranteed by the ECB, accessible to every citizen and business in the eurozone.

The distinction matters. When you pay today with a card, you are using commercial bank money — private money, processed through private infrastructure owned by American corporations. The digital euro would be the first form of public digital money directly accessible to European citizens. The equivalent of a banknote, but digital.

In practical terms: you hold digital euros in a wallet — provided by your bank, a post office, or any authorised payment service provider. You pay in-store, online, or peer-to-peer, online or offline. No internet connection required for offline transactions. No transaction fees for users. No interchange fees for merchants.

The ECB has been explicit about what it is designed to replace: dependence on foreign payment infrastructure. As the Banque de France noted in its 2024 report, international card networks — Visa, Mastercard, American Express — now represent 69% of card payments in the eurozone, up from 61% in 2022. That number is moving in the wrong direction, from Brussels’ perspective.

Key design features confirmed by the ECB:

• Mandatory acceptance — every merchant in the eurozone will be required to accept the digital euro. No opt-out. Universal from day one.

• Free for users — no fees for individuals, comparable to cash withdrawals today.

• Privacy by design — the ECB will not have access to personal transaction data. Offline transactions will offer cash-equivalent confidentiality.

• Holding limit — to prevent destabilisation of commercial bank deposits, individual holdings will be capped, likely around €3,000. This is not a savings instrument. It is a payment instrument.

• Complementary — the ECB has been careful to frame the digital euro as complementary to cash and existing payment methods, not a replacement. Christine Lagarde and Ursula von der Leyen co-authored an op-ed in January 2025 positioning it explicitly as Europe’s response to the technological transformation of payments.

The timeline:

Study phase launched in 2021. Preparatory phase closed in October 2025. On February 11, 2026, the European Parliament adopted two supporting amendments by 443 votes to 71. Target legislative framework: June 2026. If adopted, real-condition pilot: mid-2027. First issuance: 2029.

The decision to issue remains conditional on the legislative framework being adopted in 2026. But the political momentum — accelerated sharply by events described below — makes that adoption increasingly likely.

The personal and professional angle

We have three bank cards in our household — at approximately €9 each per month. We will keep one — for international travel, for insurance coverage, for the handful of use cases where no alternative exists yet.

The other two will go.

Not because we are making a political statement. Because they will have become redundant for 80% of our daily transactions. Groceries, utilities, online purchases, P2P transfers — all covered by the digital euro at zero cost, with mandatory acceptance everywhere in the eurozone.

€18 saved per month in our household — €216 per year. Trivial in isolation. Multiply it across 150 million eurozone households making the same calculation, and it becomes a structural revenue erosion for the card networks. Silent. Gradual. Irreversible.

The household case is visible. The professional case is less discussed — and analytically more significant.

As an independent analyst, I may end up with no professional card at all. If the digital euro covers daily payments and domestic B2B transactions, a corporate card becomes a recurring monthly cost with no value-add on the vast majority of transactions. The one remaining use case — international business travel — does not justify a permanent card relationship for most small operators.

Multiply this across the millions of self-employed professionals, freelancers, and small businesses across the eurozone. This is not a niche. It is a structural dismantling of the commercial card base — and no one will ring a bell when it happens.

The Guillou case — when the infrastructure showed its true owner

On August 20, 2025, the US Treasury placed Nicolas Guillou — a French judge at the International Criminal Court — under sanctions, alongside narcotraffickers and Al-Qaeda members, for having authorised arrest warrants against Prime Minister Netanyahu and former Defence Minister Gallant.

The consequence was immediate: Visa and Mastercard were legally required to comply with US OFAC sanctions — they had no choice under American law. That is precisely the point. PayPal closed his account for the same reasons. On French soil, in euros, a French judge could no longer pay for groceries.

His own words, delivered at the Union Syndicale des Magistrats congress in October 2025, are the most important sentence in this article:

“I realised that we have no sovereignty left in Europe over payment systems, since we depend almost exclusively on American payment cards — Visa, Mastercard and American Express. Even if your bank doesn’t close your account, you no longer have any means of payment.”

As Le Monde reported on November 19, 2025 (in french): the executive power of the United States can exclude any European citizen from the banking system and digital space of their own country — on their own soil, in their own currency.

This is not an edge case. This is a live demonstration that European payment infrastructure is foreign infrastructure under foreign jurisdiction.

Every bureaucrat at the ECB and in Brussels saw this. They will see this project through.

Why the digital euro is categorically different from private A2A:

Private A2A wins through economic competition — slowly, use case by use case. PIX took four years. UPI took nine.

The digital euro wins by sovereign decree, on day one:

• Mandatory acceptance across the entire eurozone from launch

• Free for users and merchants — zero migration cost

• Infrastructure financed by the ECB — no switching cost for banks

The network effect is not built. It is mandated.

What Visa says itself — and what Mastercard and PayPal don’t:

Visa’s FY2025 10-K explicitly documents this risk:

“The European Central Bank has embarked on a multi-year effort to explore a digital euro, an alternative to foreign digital currency and payment service providers. If successfully deployed, these national payment platforms and digital currencies could have significant implications for Visa’s domestic and cross-border payments, including potential disintermediation.”

Mastercard’s 10-K does not formulate this risk with equivalent precision. PayPal does not address it at all. This is not reassuring for Visa. It is alarming for the other two.

The international bastion — and its limits

Version 1.0 (2029): the bastion holds

The digital euro in its initial form will be restricted to eurozone residents and non-residents holding an account at a eurozone payment service provider. An American tourist in Paris, a Japanese businessman in Frankfurt — they still pay with Visa. The cross-border revenue line holds short-term.

This is the one card we keep. Travel. Currency conversion. International insurance coverage.

The extension beyond the eurozone:

The eurozone is the starting point — not the endpoint. Once the ECB infrastructure is operational and demonstrably sovereign, the dynamics shift for neighbouring countries.

Switzerland, Poland, the Nordics — none are in the eurozone today. But they observe. They trade extensively with eurozone partners. They have watched the Guillou case. As the digital euro normalises cross-border eurozone transactions, the pressure on these countries to align — or build equivalent sovereign infrastructure — intensifies. The commercial logic is simple: if your largest trading partners transact on a free, instant, sovereign rail, the cost of staying on card networks becomes increasingly visible.

This is not a 2029 story. It is a 2032-2035 dynamic. But it is directionally certain.

Version 2.0 (2032+): the bastion falls

The ECB’s own progress reports outline potential cross-currency payment functionalities with other central bank digital currencies. India, Brazil, China — all have active CBDC programs. If the digital euro interconnects with a digital dollar, a digital rupee, a digital real — a Japanese tourist pays in euros without a card network in the chain.

The last bastion of Visa’s European revenue thesis does not survive this scenario.

IV. Effects on Visa, Mastercard and PayPal

4.1 Eurozone revenue decline

Visa does not disclose a precise eurozone revenue split. What the FY2025 10-K confirms: the US represents approximately 39% of net revenue. The remaining 61% is international — and Europe represents a significant component.

Apply a conservative scenario: 50% decline in domestic eurozone transactional volume by 2032, consistent with PIX’s trajectory in Brazil over five years.

The impact cascade is direct:

Data processing revenue ($20.0B in FY2025, +13% from 2024) — charged per transaction processed on VisaNet. If eurozone domestic transactions migrate to the digital euro rail, this line takes the first and largest hit. No transaction on VisaNet means no data processing fee. Zero.

Service revenue ($17.5B in FY2025, +9% from 2024) — tied to payments volume. Declines proportionally as eurozone card spending shifts to the digital euro.

International transaction revenue ($14.2B in FY2025, +12% from 2024) — the most resilient line. Cross-border tourist spend and currency conversion are not threatened in version 1.0. This is what survives. This is the one card.

Other/VAS ($4.1B, +27% from 2024) — partially resilient. Network-agnostic services (fraud scoring, dispute resolution) can be sold on any rail. But their input — transactional data volume — weakens as eurozone card volume falls.

The net revenue impact of a 50% domestic eurozone volume decline is not 50% of total revenue. But it is not marginal either. It targets the two largest revenue lines simultaneously.

4.2 The margin bull trap

The margin bull trap works like this. Visa’s $15.8B in client incentives are locked into multi-year contracts. When eurozone volume starts migrating to the digital euro, those obligations don’t disappear overnight — they wind down as contracts expire. For several quarters, Visa pays out less in incentives as volume falls, while gross revenue hasn’t yet fully reflected the volume loss. The two lines move at different speeds.

On the P&L, it looks like margin expansion. Analysts call it operational efficiency. Management calls it discipline. It isn’t. The declining incentive line is not a strategic achievement — it is the first visible symptom that the volume those incentives were defending has already left the network.

By the time gross revenue collapses and the structural shift becomes undeniable in reported earnings, the contraction will be irreversible. The market will have spent two or three quarters misreading the early warning signal as good news.

4.3 ROIC collapse — the operating leverage trap

Visa’s FY2025 ROIC is approximately 50% — one of the highest in the S&P 500. Operating income of $24.0B on net revenue of $40.0B. Operating margin above 59%.

This looks like an asset-light business. It isn’t.

VisaNet’s core infrastructure costs — personnel, network and processing, depreciation — are essentially fixed regardless of transaction volume. They do not scale down when European volume migrates. What scales is the top line.

This is the operating leverage that built the ROIC. And it is precisely the mechanism that will destroy it.

When revenue falls on a fixed cost base, the drop in operating income is amplified. A 20% decline in net revenue does not produce a 20% decline in operating income — it produces a 35-40% decline. ROIC compresses from 50% toward a level that no longer justifies the current multiple.

The high ROIC is not a sign of resilience. In this context, it is a sign of how far the fall will be.

4.4 PE compression — from 30x to something else

Visa and Mastercard currently trade at approximately 29x earnings — below their respective 10-year historical averages of 33x and 37x. This multiple prices flywheel continuity — a business compounding at double digits indefinitely, with no structural threat to its core revenue model.

It does not price:

• Sequential destruction of data processing and service revenue in the eurozone

• The margin bull trap masking early-stage revenue erosion

• ROIC compression amplified by fixed cost structure

• The 2027-2029 digital euro pilot and issuance timeline

• Progressive extension to non-eurozone European countries post-2032

• Inter-CBDC linkage scenarios eliminating the last cross-border bastion

At what multiple does this risk get integrated? Likely 18-20x — implying 35-40% compression from current levels before any fundamental deterioration materialises in reported earnings.

This is not a short thesis. It is a conscious exclusion at current valuation. The risk premium required to own Visa or Mastercard today is not reflected in the price.

PayPal compounds the problem: it carries the substrate risk of Visa and Mastercard in Europe, without the international transaction revenue line that provides the last defensible bastion. There is no equivalent of the “one card we keep” in the PayPal model.

V. Conclusion

This is not a disruption. It is a convergence.

Fintech unbundling. Account-to-account rails. Sovereign digital currency.

Each alone is manageable. All three simultaneously, across the eurozone, between now and 2032 — that is the flywheel dismantling piece by piece.

PIX surpassed Visa and Mastercard combined in Brazil in four years. UPI surpassed Visa in daily global transaction volume in nine years. The digital euro arrives with ECB infrastructure, mandatory acceptance from day one, and a political will that the Guillou case made irreversible.

The regulatory compression started in 2015. The fintechs are already here. The A2A rails are live. The digital euro pilot starts in 2027.

We will keep one card. For travel. For the insurance.

In two years, people will have a name for what is happening to Visa, Mastercard, and PayPal in Europe.

They’ll call it the Finpocalypse.

Subscribe now

Important Disclosure & Disclaimer:

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author hold NO position - long or short - in the companies analyzed in this article. This article reflects a conscious exclusion, not a directional trade. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

1.1 Reinforced on fundamentals. One new variable to monitor.

The three pillars of the bull case hold without exception. The fortresses — PDF, professional imaging — continue compounding at +16% and +13% respectively. The Stock Cannibal is running: 8.5 million shares repurchased in the quarter, diluted count down from 429M to 402M in twelve months, a 6.3% reduction. Total ARR growing at +12.5%. Revenue hit a record. None of the three invalidation triggers defined in the deep dive has been pulled.

What is new — and was not anticipated in the deep dive — is the freemium pivot. Adobe has made an explicit strategic decision to stop routing Acrobat and Firefly traffic toward direct-to-paid journeys and instead accelerate MAU (Monthly Active Users) acquisition through friction-free freemium funnels. Management acknowledged this will compress individual subscriber ARR growth in the second half deliberately. The early signals are strong — Acrobat MAU grew from 700M to 850M year over year, Creative freemium MAU from 50M to 90M, Firefly ARR up 50% quarter over quarter — but the conversion velocity from MAU to paid at scale remains unproven over a full cycle.

This is a timing nuance, not a thesis change. The Reader trojan horse logic — hundreds of millions of free users converted progressively into paid tiers — was always the foundation of the Acrobat bull case. Adobe is now applying the same playbook to Firefly and Express at scale. The logic is coherent. The proof will arrive in Q3 and Q4.

One other note: CFO Dan Durn departs June 15. He came from Marvell Technology, stayed less than five years, and is returning to the semiconductor sector. The profile is that of a transitional CFO recruited for a specific phase — post-Figma M&A discipline, margin communication during the multiple compression period. Nothing in the numbers suggests a forced exit: RPO clean, cash flow intact, no accounting adjustments. The more likely read is that Durn anticipates the incoming CEO will install his own CFO and departs on his own terms. Steve Day, 20 years at Adobe, takes over as interim. Operationally, continuity is not at risk.

At the time of writing and publication, Adobe is trading premarket at $206.88, down $11.92 (-5.45%). The decline is a sentiment reaction, not a fundamental one.

Verdict: thesis intact with one new variable. The freemium conversion velocity is the single open question. Q3 results in September 2026 are the next decision point.

1.2 My reaction with a 10% Adobe portfolio

I’ll be transparent: I’m pissed off.

I initiated my position on March 19, 2025, and reinforced throughout the decline — every dip, every bad headline, every “Adobe is dying” narrative. My average cost is €295.5. With the premarket at $206.88, I’m sitting on a loss of approximately 36% — probably closer to 40% by the time the session opens. Adobe still represents approximately 10% of my portfolio. That’s not inertia — that’s a deliberate choice to maintain full weight on a thesis I believe in.

And yet the numbers are good. Revenue record. Fortresses intact. AI-first ARR tripling. Stock Cannibal running. None of the three invalidation criteria touched.

That gap — between what the business is doing and what the price is doing — is exactly what the deep dive was built around. The market priced a dying business. It got a fortress. I wrote that on June 10. The Q2 results confirmed it on June 11. The price went down anyway.

It’s frustrating. It’s also, if I’m being analytically honest, a feature rather than a bug. Markets that overreact on the downside create entry points that rational pricing never would. The same mechanism that is hurting my P&L today is the one that will produce the asymmetric return when sentiment normalizes. I’ve seen it with Novo Nordisk. The pattern is not new.

I’m holding. Not because I’m anchored to my cost basis — that would be the wrong reason. But because the thesis is intact, the business is compounding, and the buyback is running at prices management itself considers deeply depressed. Those are the right reasons.

If you’re reading this with Adobe in your portfolio, sitting on a similar loss, asking yourself whether to exit — that question is worth taking seriously. The emotional pull to stop the bleeding is real. But the answer has to come from the invalidation criteria, not from the price action. None of the three has moved. That’s the only compass that matters here.

The market’s overreaction is both annoying and a blessing. Annoying for those already in. A blessing for those who aren’t yet.

It reminds me of a Charlie Munger’s thought on this:

2. The Numbers

2.1 Q2 FY2026 at a glance

This table summarizes the key metrics from Adobe’s Q2 FY2026 earnings release : https://www.adobe.com/cc-shared/assets/investor-relations/pdfs/11606202/bu45teegrf.pdf

2.2 Commentary

Top line. $6.62B is a record. The +13% YoY marks a slight acceleration on the prior two quarters (+12% Q1, +10.5% Q2 2025). There is no revenue deceleration story here — and that matters, because the bear thesis requires the fortresses to be visibly eroding. They are not.

ARR. The +12.5% headline includes approximately $480M from Semrush, which closed in April. Organic ARR growth is therefore closer to +10.5% — consistent with prior quarters, no organic acceleration. This is the number the market focused on, and the deliberate H2 freemium pivot implies it will soften further before the conversion effect shows up. Management’s FY26 total ARR growth target of 10.2% — Semrush included — signals this explicitly. The market read “deceleration.” The correct read is “deliberate short-term trade-off for long-term MAU foundation.”

AI-first ARR. The standout signal of the quarter. AI-first ARR tripled year over year and crossed $500M. Firefly ARR is approaching $300M, up 50% quarter over quarter. Acrobat AI Assistant ARR grew 3× year over year. These are not rounding errors — they are the early empirical validation of the double-lock thesis: the compliance moat and the workflow integration moat are deepening simultaneously. The self-cannibalization signal identified in the deep dive — Adobe replacing its own Adobe Stock revenue with Firefly generative credit subscriptions — is confirmed and accelerating.

Operating margin. GAAP at 33.8% versus 37.8% in Q1. The Q1 figure was seasonally elevated by annual renewal concentrations. The full-year FY26 GAAP operating margin target is 35% — above the 30% assumed in the base case of the deep dive scorecard, and directionally consistent with the bull case trajectory toward 35%.

Operating cash flow. $2.17B versus $2.96B in Q1. Seasonal, not structural. The trailing twelve-month figure remains above $10B. The $70M goodwill impairment on the Publishing & Advertising unit is non-cash and immaterial at $0.17 per share — a quiet acknowledgment that this segment is not a priority, consistent with the fortress concentration strategy.

RPO. $22.27B, +13% year over year. One full year of revenue already contractually committed before a single new contract is signed. This is the most underappreciated line in the earnings release. A business with eroding competitive position does not sustain RPO growth at this rate.

Stock Cannibal. Diluted count at 402M versus 429M twelve months ago: -6.3% after SBC issuance. The $25B buyback authorization announced in April is running. At the current pace, EPS grows mechanically at 16-17% annually from share count reduction alone, independent of revenue growth, independent of the freemium narrative.

Quality check. No accounting flags worth raising. The $30M loss contingency (litigation settlement) is consistent with Q1’s $62M and reflects normal legal exposure for a company of this scale. Revenue recognition is clean. No restatements. The CFO departure reads as orderly, not forced — nothing in the numbers contradicts that reading.

3. Thesis Update

3.1 Invalidation criteria — status

The three triggers defined in the deep dive as requiring reassessment to validate the bear thesis :

• Digital Media ARR decelerating structurally below 5% growth → not triggered

• Gross margin declining durably below 87% → not triggered

• Creative Cloud retention rates visibly declining → not triggered

3.2 Bull case prerequisites — status

• Fortresses holding (PDF, professional imaging) → confirmed

• Stock Cannibal running → confirmed, -6.3% share count in twelve months

• Firefly beginning to register in aggregate ARR → in progress, ~$300M ARR approaching, ×3 AI-first YoY

• Credible new CEO named → pending, search described as “progressing well,” target before FY27 planning

3.3 New this quarter

The freemium pivot is the only variable the deep dive did not model explicitly. Adobe is institutionalizing what the Reader trojan horse always was: a massive free installed base converted progressively into paid tiers. The difference is scale and speed — 850M Acrobat MAU, 90M Creative freemium MAU, both growing fast. The short-term ARR cost is real and assumed. The long-term logic is consistent with the thesis. The proof is in the conversion velocity over the next two to three quarters.

Semrush integration closed as expected — bolt-on, cash-funded, no dilution, no antitrust risk. The exact profile of post-Figma M&A discipline described in the deep dive as a positive signal.

4. Valuation — Updated Entry Point

The deep dive scorecard was built at ~$258 (June 5, 2026). After the consecutive post-earnings declines, the entry point is now more favorable — same EPS trajectory, lower price, wider upside on every scenario.

At the current price, the base case (PE 25×, EPS ~$27.50 in 2028) and bull case (PE 25×, operating margin 35%, EPS ~$32.08) both represent a more attractive risk/reward than at the time of writing. The thesis did not weaken. The price did. That gap is the opportunity.

One honest note on positioning: the contradiction between the price signal and the fundamental confirmation makes this objectively an interesting reinforcement point. I have no more cash to reinforce the position, and I am concentrated enough, so I don’t want to sell my other positions.

A note on the decline

Adobe is trading down 5.45% in premarket at $206.88 as this article is published. The decline is a sentiment reaction, not a fundamental one. Management language that explicitly assumes short-term ARR compression — however strategically coherent — activates momentum sellers who read the headline without modeling the logic behind it.

An additional technical factor may extend the pressure in the coming sessions: SpaceX’s inclusion in the Nasdaq indices will trigger forced ETF buying of SpaceX, partially funded by mechanical sales of other constituents. If Adobe is among them, the selling pressure will have no relationship whatsoever to the quality of the business or the validity of the thesis.

The title can continue to fall for reasons entirely disconnected from what this document describes. The three invalidation criteria remain the only relevant compass. None of them has moved.

The fundamentals confirmed. The price fell. For an investor with available cash and conviction on the thesis, this week is more interesting than last week — not less.

Important Disclosure & Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

The pattern is familiar. A new technology emerges. The market extrapolates the worst-case scenario immediately, prices it as present reality, and sells first. The underlying business keeps compounding. Twelve to eighteen months later, the sentiment reverses — and the investors who read the narrative instead of the numbers have already missed the move.

It happened with Alphabet. In early 2025, the question on every desk was whether Google Search was structurally broken by AI. The stock traded at 17× earnings — a decade low. The business posted records. The stock is up over 100% since.

It happened with Booking Holdings. The AI agents were going to disintermediate online travel. ChatGPT would plan your holidays, Booking would become invisible, the OTA model would collapse. The stock fell 33% from its peak. Room nights hit 1.235 billion — an all-time record. The business wasn’t broken. The sentiment was.

Now it’s Adobe’s turn. The narrative has a name: the SaaSpocalypse. AI is making creative professionals obsolete. Canva has taken the consumer market. Figma took UI/UX. Midjourney generates images in two seconds. The creative software stack is being commoditized, and Adobe — the company that built it — will be its biggest victim.

The stock is trading near its lowest PE in a decade. A franchise generating 89% gross margins, 97% recurring revenues, and $2.96 billion in operating cash flow in a single quarter.

The SaaSpocalypse is a story. The numbers tell a different one.

This article starts with the business — what Adobe does, how it makes money, and why this model is structurally difficult to displace. The competitive advantage section examines each segment individually: the moat, the competition, and the real exposure — with a summary table at the end of the section. Financials and management follow. The article then presents the two competing theses, a valuation scorecard, and portfolio considerations.

A note on length. This article is long by design. Adobe is a business that requires its products and competitive position to be understood before the investment thesis makes sense. The moat analysis is not decoration — it is the foundation of everything that follows. If you’re here for the thesis directly, the Two Thesis section is the heart of the article, and the Valuation section translates those arguments into concrete scenarios.

I know you’re busy, so I always start with a summary called The short version. If that’s all you have time for, that’s fine. The rest of this article explains why.

The Short Version

Adobe is the infrastructure of the global content economy. Photoshop. Illustrator. Acrobat. The tools that creative professionals use daily, the PDF standard that runs through every corporate document workflow in the world, the platform that manages and activates enterprise marketing at scale. $23.77 billion in revenue. 97% recurring. 89% gross margins. $10 billion in annual operating cash flow.

The stock has lost 35% from its peak. The market has a name for what is happening: the SaaSpocalypse. AI is making creative professionals obsolete. Canva has taken the consumer market. Figma took UI/UX. Midjourney generates images in two seconds. Adobe is the next victim.

My view: the market is pricing a possible future disruption as a present reality. The business is posting records. Digital Media ARR grew 11.5%. Gross margin hit 89.6% — a record. The field signals that precede structural deterioration — design schools abandoning Photoshop, enterprise procurement shifting away from Acrobat, Creative Cloud retention declining — are absent.

The confirmed casualties are Express, which lost to Canva, and UI/UX, which was surrendered to Figma. Together they represent less than 5% of revenues. The bear thesis requires the destruction of the fortresses. There is no evidence of that.

The bears are right about the edges. They are wrong about the conclusion.

At 15× trailing earnings — the lowest multiple in a decade — you are not paying for the AI optionality, the Firefly ARR trajectory, or the operating leverage. You are paying for the rents that already exist. And while the market debates the SaaSpocalypse, Adobe retires 6% of its own shares every year, growing EPS mechanically at 16-17% annually independent of everything else.

The position is 10% of the portfolio. The central valuation case puts the stock at approximately $420 over two years — +62%, approximately 28% CAGR — at a PE of 18×, simply normalizing toward the lower bound of the historical range. No heroic assumptions required. No visionary CEO required. No AI moonshot required.

My personal conviction sits on the bull case — a PE of 25× combined with operating margins expanding from the current 30% toward 35% as the AI infrastructure cost cycle stabilizes and the operating leverage embedded in the 89% gross margin structure expresses itself fully. That is not the 2021 euphoria multiple. It is simply what a quality SaaS franchise is worth when the market stops pricing it as a dying business. Adobe ran above 35% operating margins before the AI infrastructure investment cycle began. The conditions for a return to that level are already embedded in the business model.

Superior products and superior environments drive superior returns. With Adobe you got world-class products with fortress environments on most of the products — with the valuation on a dying business.

Subscribe now

Understanding Adobe’s business, supply chain and environment

History

Adobe didn’t start as a creative company. It started with a problem about printers.

In 1982, John Warnock and Chuck Geschke left Xerox PARC with a single idea: a device-independent language that would tell any printer exactly how to render a page. PostScript solved a problem that had frustrated every computer user who had ever watched a beautifully designed document turn into garbled output on paper. Apple licensed it for the LaserWriter in 1985. The desktop publishing revolution followed. Adobe had, without fully intending to, invented an industry.

The PDF came eleven years later, in 1993. The logic was the same: a format that would look identical on every screen and every printer, regardless of the software that created it. Adobe invented the format, standardized it, and eventually released it as an open standard in 2008. They gave away the container. They kept the tooling. Thirty years later, that decision is still generating billions in recurring revenue.

The real transformation came in 2012. Adobe ended the perpetual license model for Creative Suite and moved entirely to Creative Cloud — a monthly subscription. The backlash was immediate and furious. Designers signed petitions. Forums declared Adobe dead. The stock fell on the announcement. Within eighteen months, it became clear that the transition was one of the most successful pivots in software history. Revenue became predictable. Churn became measurable. The flywheel of subscription ARR began to compound.

What followed was a decade of acquisitions that built the second half of the business. Omniture in 2009 brought web analytics. Marketo in 2018 brought marketing automation. Magento the same year brought e-commerce. Workfront in 2021 brought project management for creative teams. Frame.io brought video collaboration. Each acquisition extended Adobe’s reach from creation into the enterprise marketing stack — from the tool that makes the content to the platform that manages, deploys, and measures it.

The Figma chapter deserves its own paragraph. In 2022, Adobe announced a $20 billion acquisition of Figma — the collaborative design tool that had quietly taken 80-90% of the UI/UX market while Adobe’s own product, XD, stagnated. The deal valued Figma at roughly 50× ARR. Antitrust regulators in Europe and the UK blocked it in late 2023. Adobe paid a $1 billion breakup fee and abandoned XD. The market read this as a strategic failure. The correct reading is more nuanced — developed in the Two Thesis section.

Today, Adobe is a SaaS company with $23.77 billion in revenue, 97% of it recurring, operating across the full lifecycle of content: from the first sketch in Photoshop to the activated campaign measured in Adobe Analytics. At its April 2026 Summit, management presented what this lifecycle looks like in the era of AI agents — a vision that is coherent on paper and still early in its financial translation.

What Adobe sells, and who buys it

Adobe has decided to merge its three historical reporting segments into a single operational unit from FY2026 onward. The stated rationale is a unified platform vision. The practical consequence for anyone trying to understand the business is that granularity disappears precisely when the AI transition makes it most valuable to track. This article keeps the two meaningful customer groups as the organizing framework — it is the structure that best reflects how the business actually creates and captures value.

Creative and Marketing Professionals — $16.30 billion in subscription revenue.

This is the segment that built Adobe. Designers, photographers, videographers, illustrators, motion artists, creative directors, agency teams, and marketing professionals at enterprises. These are the people for whom Photoshop is a verb, an After Effects project file is a professional deliverable, and the Adobe suite is the assumed baseline of any creative career.

The product lines that serve this group:

• Imaging and illustration — Photoshop, Illustrator, Lightroom. The historical core. Industry-standard formats (.psd, .ai), industry-standard workflows, industry-standard careers built around them.

• Video and motion — Premiere Pro, After Effects, Frame.io. The post-production stack. Native integration between After Effects and Premiere locks workflows that take years to build.

• 3D — Substance 3D Painter, Sampler, Stager, Modeler. A technical niche in gaming, architecture, and industrial design. Solidly positioned in texturing and materials, largely insulated from the AI disruption hitting 2D imaging.

• AI generation — Firefly, Firefly Foundry, Firefly Custom Models, Brand Intelligence. Adobe’s generative AI family, trained exclusively on licensed content and public domain material. The commercial safety guarantee is the product, not the generation quality. Discussed in detail in the competitive advantage section.

• Collaboration and workflow — Frame.io for video review, Workfront for creative project management. Enterprise connective tissue between creative production and delivery.

• Grand public and prosumer — Adobe Express. The lightweight design tool aimed at non-designers, small businesses, and marketing teams that need fast content without professional software. The segment where Canva won and Adobe is a distant challenger.

Business Professionals and Consumers — $6.50 billion in subscription revenue, +15% in FY2025.

This is the fastest-growing segment and the least discussed. It is built almost entirely around one product family and one decision made in 1993.

• PDF and Document Cloud — Acrobat Standard, Acrobat Pro, Reader, Sign, AI Assistant, PDF Spaces, Acrobat Studio. Adobe invented the PDF, open-sourced the format in 2008, and has spent thirty years building the premium tooling layer above a free reader that sits on virtually every corporate machine on the planet. The monetization engine is the conversion of that installed base — hundreds of millions of Reader users — into paid Acrobat tiers. The +15% growth in FY2025 is that conversion accelerating.

• Customer Experience Orchestration — Adobe Experience Platform, Real-Time CDP, Analytics, Customer Journey Analytics, AEM, Commerce, Marketo, GenStudio, Journey Optimizer, LLM Optimizer, and Semrush (closing Q2 2026, $1.9 billion, cash-funded). Management now uses the label Customer Experience Orchestration rather than Digital Experience — a deliberate reframe toward the agentic and AI-native workflows presented at Summit 2026. This bloc manages the enterprise content supply chain from creation through activation to measurement. Subscription revenue growth in FY2025: +11%. Three products within this segment have crossed $1 billion in ARR individually and are growing above 20% year-over-year — a detail buried in the aggregate figure.

Suppliers

Three dependencies worth naming precisely.

Cloud hosting and data centers. The largest material commitment: $6.82 billion in non-cancelable purchase obligations, primarily for third-party hosting and data center services. Adobe is publicly known as a large Microsoft Azure customer and uses AWS and Google Cloud Platform — the 10-K does not name the hyperscalers directly. At 89% gross margins, this cost structure is manageable. The 10-K explicitly acknowledges that rising AI inferencing costs could compress margins if monetization does not keep pace. This is the most material supplier risk in the business.

Third-party AI model providers. Adobe integrates 30+ external models — Google, OpenAI, Anthropic, Runway, Flux, Luma, Ideogram, and others — alongside its own Firefly models. The strategy is orchestration, not exclusivity. Adobe does not bet on a single model. Every new model that enters the market is a potential addition to the platform rather than a competitive threat. This dependency is simultaneously a strategic choice and a structural hedge against model obsolescence.

Talent. With 50% of employees outside the US and engineering concentrated in Bay Area, Salt Lake City, and Bangalore, Adobe’s exposure to visa and immigration policy is real and acknowledged in the 10-K. An eNPS of 76 and an attrition rate of 9.9% — low for Silicon Valley — suggest the dependency is currently well-managed.

Segments and Competitive Advantage

The standard approach to Adobe’s competitive position is to describe the moat as a single entity. That framing misses the most important analytical point: the moat is not uniform. It is deep in some segments, absent in others, and actively contested in several. Treating it as monolithic leads to the analytical error that drives both the bear overreaction and the bull complacency.

What follows is a segment-by-segment analysis — description, moat, and competition — with a summary table at the end.

1. PDF and Document Cloud — The Unassailable Fortress

Description. The PDF is the universal language of the professional document. Contracts, invoices, financial reports, legal filings, client presentations — virtually every formal document exchanged between businesses travels as a PDF. Adobe invented the format in 1993, standardized it, and released it as an open standard in 2008. Anyone can create a PDF reader. Anyone can build a PDF export function. The format itself is free. What Adobe built — and what nobody has successfully replicated at enterprise scale — is the professional tooling layer above it: the ability to edit, sign, compare, redact, automate, and collaborate on PDFs in a corporate environment. That tooling is what generates $6.50 billion in annual subscription revenue.

The mechanics are straightforward. Adobe gives Reader away for free. Reader is installed on virtually every corporate machine in the world. Every user who opens a PDF in Reader is inside the Adobe ecosystem. The conversion to paid tiers happens the moment that user needs to do something Reader will not let them do — edit a contract, sign a document, compare two versions, redact sensitive data. The free format is the trojan horse. The Acrobat subscription is the monetization. It is the oldest and most effective freemium model in enterprise software.

Acrobat Standard and Pro are the working tools for the PDF itself. Create a PDF from any source — Word, Excel, a physical scan. Edit its content, reorganize its pages, compare two versions of a contract side by side, redact sensitive information, build interactive forms, manage accessibility compliance. Pro adds the enterprise layer: Microsoft 365 integration, advanced legal tools, document workflow automation. This is the product that legal, HR, finance, and compliance teams use daily across virtually every large organization in the world.

Acrobat Sign is electronic signature: send a contract, collect a legally valid signature in over 180 countries, manage multi-party approval workflows. DocuSign leads this segment as a standalone product — Acrobat Sign exists primarily because it is bundled with Acrobat rather than on its own competitive merits. That is a weakness in isolation and a distribution strength in the context of the suite.

AI Assistant is the conversational interface layered on top of documents. A lawyer interrogating a 300-page contract rather than reading it sequentially. An analyst querying ten annual reports simultaneously. Ask a question, get a sourced answer. This is the AI monetization layer of Document Cloud — and a meaningful contributor to the +15% growth this segment delivered in FY2025.

PDF Spaces is the collaborative workspace built around documents: real-time review, annotation, and co-editing of shared PDFs across distributed teams. The answer to document collaboration in organizations where five people need to work on the same file without emailing attachments back and forth.

Competition. Foxit is a PDF tooling competitor with a real product and lower pricing — the kind of alternative that gets evaluated during budget reviews and rarely gets selected, because the migration cost exceeds the subscription savings. The 10-K acknowledges competitive pressure without specifying where Foxit wins. Chrome and Edge now read PDFs natively — this competes on the free layer, not on the professional tooling. Smallpdf and iLovePDF serve lightweight web use cases without enterprise depth. DocuSign leads standalone e-signature but does not threaten the core Acrobat business.

Moat. Adobe no longer owns the PDF format. What it owns is thirty years of tooling built around a format that became the backbone of global business communication. The switching cost on the premium tooling is the lock.

A legal firm whose entire document workflow runs through Acrobat, whose paralegals have years of Acrobat Sign muscle memory, whose IT department has provisioned Acrobat Pro across thousands of machines — that firm is not switching to Foxit because Foxit is cheaper.

Competitive exposure: low.

2. Professional Imaging and Illustration — The Cultural Fortress

Description. Photoshop, Illustrator, Lightroom. The historical core of Creative Cloud Pro. Included in Creative and Marketing Professionals ($16.30 billion, +11% in FY2025).

Photoshop is the industry standard for image editing and compositing. Retouching a photograph, building a multi-layer advertising visual, removing a background, correcting color — these are Photoshop workflows. The software has been the baseline of professional image work for thirty years. Its name entered the dictionary as a verb.

Illustrator is the industry standard for vector graphics — logos, icons, typography, illustrations, packaging design. Where Photoshop works with pixels, Illustrator works with mathematical shapes that scale to any size without quality loss. A brand’s logo exists as an Illustrator file. A magazine’s infographics are built in Illustrator. The .ai format is the currency of the graphic design profession.

Lightroom is the standard for photo management and color grading at scale. A photographer who shoots 2,000 images at a wedding does not edit them one by one in Photoshop. Lightroom organizes the catalog, applies batch corrections, and manages the entire post-processing workflow. It is the operating system of professional photography.

Competition. Affinity (owned by Canva) is the most credible alternative — serious quality, aggressive pricing, a one-time purchase model that directly targets subscription fatigue. It has gained real traction among freelancers and small studios. Procreate dominates illustration on iPad but does not compete with the desktop suite. GIMP and Inkscape serve zero-budget users, not agencies. AI generation tools — Midjourney, DALL-E, Flux — attack creation from below but do not replace the professional imaging workflow. They are relevant to the Firefly segment discussion, not to this one.

Moat. Photoshop became a verb. That is not a marketing achievement — it is the most durable form of competitive advantage in consumer-facing software: behavioral absorption.

The switching cost is cognitive and cumulative. A senior designer who has spent a decade building muscle memory around Photoshop’s shortcuts, layer logic, and blending modes does not migrate to Affinity in a weekend. They migrate never, unless forced. The cost is not the price of a new subscription — it is the temporary regression in professional output quality, the retraining of ingrained reflexes, the risk of missing a client deadline during the transition.

The moat is self-replicating through the labor market. Design schools teach Photoshop. Job postings require proficiency in the Adobe suite. Graduate designers arrive at their first agency already captive. The muscle memory is transmitted through education and hiring before Adobe charges a single dollar.

The ecosystem reinforces the lock-in further. Files flow between Photoshop, Illustrator, InDesign, and Premiere without friction. A studio that has built its production pipeline around native Adobe interoperability is not evaluating Affinity on its technical merits — it is evaluating the cost of rebuilding its entire infrastructure.

Competitive exposure: low on the professional segment. The attack vector exists at the entry level, not at the core.

3. Video and Motion — Solid but Under Dual Pressure

Description. Premiere Pro, After Effects, Frame.io. The post-production stack for film, television, advertising, and digital content. Included in Creative and Marketing Professionals.

Premiere Pro is the industry standard non-linear video editor. Cut a film, assemble a commercial, edit a documentary — these are Premiere workflows. The timeline, the multicam editing, the audio mixing, the color correction pipeline. Used by Hollywood studios, broadcast networks, and independent filmmakers worldwide.

After Effects is the industry standard for motion graphics and visual effects. Animated titles, lower thirds, composited visual effects, explainer video animations — After Effects is where video gets its visual complexity added after the raw edit. Every broadcast package, every animated logo, every motion graphics reel is built here.

Frame.io is the cloud-based video review and collaboration platform. A director in Los Angeles sends a cut to a client in Tokyo. The client annotates directly on the frame — “tighten this cut, change this line.” The editor receives the feedback linked to the exact timecode. Frame.io removes the back-and-forth of emailed PDF notes and replaced it with frame-accurate collaboration.

Competition. DaVinci Resolve (Blackmagic Design) is the most structurally threatening competitor. Blackmagic monetizes hardware — cameras, control surfaces, capture cards — and offers the software at near-zero cost. The color grading capability in DaVinci is widely considered superior to Premiere for high-end cinema work. The business model asymmetry is dangerous: Blackmagic can sustain the software at cost because hardware margins fund it. Adobe cannot compete on price without destroying its margin structure.

Final Cut Pro (Apple) is strong but confined to the Mac ecosystem — a platform constraint that limits its competitive reach.

CapCut (ByteDance) attacks from below on short-form mobile content — a different workflow, a different user, but a real encroachment on the next generation of video creators who may never develop Premiere habits.

Runway, Sora (OpenAI), and Veo (Google) represent the paradigm shift risk: AI-native video generation that does not replace Premiere today but potentially bypasses traditional post-production on certain content types. Adobe is integrating these models rather than fighting them — coherent strategy, unproven execution at scale.

Moat. The native integration between After Effects and Premiere Pro is the primary lock. A production house that has built its template library, its motion graphics toolkit, and its color pipeline around the Adobe stack does not migrate to DaVinci without rebuilding its infrastructure. The project files, the presets, the team’s shared workflows — all of it is Adobe-native.

The switching cost is real but lower than on the imaging side. Formats are less proprietary — video files are more portable than .psd or .ai files. The muscle memory is deep but more transferable between NLE platforms than between image editing suites. A colorist who switches from Premiere to DaVinci does not start from zero the way a Photoshop designer switching to Affinity does.

Frame.io adds a collaboration layer that raises the switching cost further at the enterprise level — a production studio whose review workflow runs through Frame.io has built client habits and approval processes around it that are not trivial to migrate.

Competitive exposure: medium-high. The dual pressure from DaVinci on the high end and AI-native generation on the paradigm level is real. The fortress holds for now. It requires monitoring.

4. Adobe Express and the Consumer Market — The Open Flank

Description. Adobe Express is the lightweight design tool for non-designers. A marketing manager who needs a social media post. A small business owner who wants a flyer. A HR team that needs a presentation. No professional training required — drag and drop, pre-built templates, brand colors applied automatically. Freemium, with a paid tier for advanced features and team collaboration.

Competition. Canva owns this market. 185 million monthly active users, templates for every use case, team collaboration built in from day one, free tier generous enough that millions never pay. Canva arrived first, grew faster, and built the network effect before Adobe took the segment seriously. CapCut dominates short-form video creation on mobile. Microsoft Designer is embedded in the Microsoft 365 ecosystem that most enterprises already use. Adobe Express is a distant challenger in a market it should have owned.

Moat. Effectively none on the consumer segment. The switching cost for a Canva user is zero — the platform is free, the templates live in a browser, there is nothing to migrate. The network effect belongs to Canva.

Where Express has a more defensible position is inside the enterprise GenStudio workflow — as the last-mile editing tool for AI-generated content produced at scale. A marketing team that generates 10,000 campaign variations through GenStudio needs a simple interface to review, adjust, and approve the final assets before activation. Express fills that role. That use case is not competing with Canva — it is a different function entirely, embedded in a workflow Canva cannot replicate.

The analytical error the bears make is treating Express as representative of the whole. It represents less than 5% of revenues. A complete Express failure changes nothing material about the investment case.

Competitive exposure: maximum on consumer. Immaterial to the financial model.

5. Firefly and AI Generation — The Compliance Moat

Description. Firefly is Adobe’s family of generative AI models — image, video, audio, vector — trained exclusively on licensed content and public domain material. It is not a standalone application in the traditional sense. It is a capability layer embedded across the entire Adobe product suite and exposed as a separate product family for enterprise use.

Firefly (app and web) is the consumer-facing generation interface. Type a prompt, generate an image, edit it, iterate. The entry point for individuals exploring AI generation within the Adobe ecosystem.

Generative Fill and Generative Expand are Firefly capabilities embedded directly in Photoshop. Select an area of an image, describe what should replace it, and the model fills it in — without leaving Photoshop, without switching tools, without importing and exporting files. This is the practical expression of Adobe’s integration strategy: AI generation as a native feature of the professional workflow, not a separate step in a fragmented process.

Firefly Foundry is the enterprise model training platform. A brand uploads its own visual assets — campaign imagery, product photography, brand guidelines — and trains a custom model on that proprietary material. The output is a generation model that produces content consistent with that brand’s visual identity by construction.

Firefly Custom Models are the trained brand models themselves. Once a brand has trained its model in Foundry, it can generate unlimited on-brand content without manual brand compliance review on every asset.

Brand Intelligence is the layer that codifies a brand’s visual rules — color palettes, typography, tone, compositional preferences — and enforces them automatically across all generated content. The brand’s identity becomes a parameter in the generation process rather than a post-production checklist.

Generative credits are the consumption-based monetization unit. Every AI generation action consumes credits. Credits are included in subscription tiers and sold separately as add-on packs. Credit pack ARR grew 75% quarter-over-quarter in Q1 FY2026.

Competition. Midjourney produces more striking images. OpenAI’s DALL-E and Google’s Imagen are technically competitive on raw generation quality. Flux, Runway, Luma, and Ideogram each have specific strengths. Adobe knows this and does not claim otherwise. The competition on raw model quality is real and Adobe is not winning it.

What Adobe does not compete on is generation quality. It competes on a different axis entirely.

Moat. Adobe sells commercial safety, not generation beauty. Every Firefly output is indemnified — Adobe guarantees that the generated content does not infringe on third-party intellectual property because the training data is entirely licensed or in the public domain. For a Fortune 500 company running a global advertising campaign, the question is not which model produces the most beautiful image. It is which model does not expose the company to a Getty Images lawsuit. Adobe is currently the only scaled answer to that question at enterprise level.

This is a compliance moat, not a product moat. It is narrow but structurally defensible in a specific and lucrative segment — large enterprises with legal departments that have already said no to Midjourney.

6. 3D — Substance Suite — The Technical Niche

Description. Substance 3D is Adobe’s toolset for three-dimensional asset creation, focused specifically on materials, textures, and staging. It sits inside the Creative and Marketing Professionals segment but serves a distinct technical audience: 3D artists in gaming studios, product designers, architects, and visual effects teams.

Substance 3D Painter is the industry standard for 3D texture painting. Take a three-dimensional model — a character, a product, a vehicle — and paint its surface materials directly onto it. The rust on a metal pipe. The fabric weave on a jacket. The scuff marks on a shoe sole. Painter is where 3D objects get their physical appearance.

Substance 3D Designer is the node-based material creation tool. Rather than painting surfaces manually, Designer builds materials procedurally — mathematical recipes that generate infinitely variable, photorealistic surface appearances. A concrete material built in Designer can be adjusted endlessly: wetter, older, more cracked, differently lit. The output feeds into game engines, rendering software, and visualization pipelines.

Substance 3D Sampler converts real-world photographs into usable 3D materials. Photograph a brick wall, a wooden floor, a piece of fabric — Sampler extracts the material properties and turns them into a reusable 3D asset. It closes the loop between physical reality and digital production.

Substance 3D Stager is the product visualization tool. Place 3D models in a scene, apply materials, set lighting, render a photorealistic image — without a photographer, without a physical studio, without a product sample. An e-commerce company launching a new product can generate 500 photorealistic packshots in a day. This is the commercial application that connects Substance to the broader content supply chain.

Competition. Autodesk dominates 3D generalist workflows — Maya and 3ds Max are the industry standards for character animation and visual effects in film and television. But Autodesk does not compete directly with Substance on texturing and materials. The two toolsets are complementary in most professional pipelines — artists use Maya to build the model and Substance to surface it.

Blender is the open-source alternative that covers the full 3D workflow including texturing. It is free, powerful, and growing rapidly in adoption among independent artists and smaller studios. Blender sets an effective price ceiling on the market — it is difficult to charge premium pricing for capabilities that a well-maintained open-source project offers at zero cost. Adobe’s answer is depth, integration, and the asset library.

Maxon (Cinema 4D) dominates motion graphics — a adjacent segment where After Effects integration matters more than texturing depth.

Moat. Substance Painter is the industry standard for game asset texturing. That status was earned over a decade before Adobe acquired the Substance suite in 2019, and it has not eroded since. The switching cost is technical: production pipelines in gaming studios are built around Substance workflows, and the material libraries accumulated over years of production are Substance-native assets.

The integration with the broader Adobe ecosystem adds a layer that independent competitors cannot replicate — Substance materials flow into Photoshop, into Stager for visualization, and eventually into the content supply chain that connects to GenStudio and activation. For enterprises that use Adobe end-to-end, Substance becomes part of the same workflow rather than a separate tool.

The market is small relative to the core Creative Cloud segments, but structurally insulated from the AI disruption hitting 2D imaging. AI generation for 3D materials and photorealistic surfaces is less mature than 2D image generation, and the technical complexity of production pipelines creates barriers that consumer-facing AI tools have not yet addressed. The tailwind from gaming, AR, and e-commerce product visualization is real and long-duration.

Blender’s zero-cost model is the primary constraint on pricing power. Adobe competes on depth, workflow integration, and the professional asset library — not on price.

Competitive exposure: low. Market size is the constraint, not the competitive position.

7. Customer Experience Orchestration — Enterprise Sticky, No Dominant Pricing Power

Description. This is the segment that manages what happens to content after it is created. Adobe Experience Platform, Real-Time CDP, Analytics, Customer Journey Analytics, AEM, Commerce, Marketo, GenStudio, Journey Optimizer, Workfront, LLM Optimizer, and Semrush (closing Q2 2026). Management now uses the label Customer Experience Orchestration — a deliberate reframe from the older Digital Experience nomenclature toward the agentic and AI-native workflows presented at Summit 2026. Revenue: $5.86 billion, subscription growth +11% in FY2025.

Adobe Experience Platform (AEP) is the customer data foundation. It ingests behavioral, transactional, and demographic data from every touchpoint — website visits, app interactions, purchase history, email opens — and assembles it into unified customer profiles. Over 70 billion profiles managed. Over one trillion experiences delivered annually. The enterprise that knows who its customers are and how they behave across every channel runs that knowledge through AEP.

Real-Time CDP sits on top of AEP and activates those profiles in real time. A customer abandons a cart on a website — Real-Time CDP identifies them, segments them, and triggers a personalized re-engagement across email, paid social, and push notification simultaneously. The intelligence is in the platform. The activation is instantaneous.

Adobe Analytics and Customer Journey Analytics measure what is working. Traffic sources, conversion rates, revenue attribution, customer journey mapping across every touchpoint. The data layer that tells the enterprise whether its campaigns are generating returns.

AEM (Adobe Experience Manager) is the content management system for enterprise websites and digital properties. Virtually every major corporate website runs on AEM. It is the infrastructure layer that ensures content is published correctly, governed appropriately, and optimized for every channel — including, increasingly, the LLM channels where brand visibility now depends on how AI systems index and present corporate content.

Marketo is the marketing automation platform. Email campaigns, lead nurturing, demand generation, account-based marketing for B2B enterprises. The system that manages the relationship between a company and its prospects across months-long sales cycles.

GenStudio is the content supply chain platform. It connects creative production — the assets built in Creative Cloud — to marketing activation — the campaigns deployed through AEM, Marketo, and paid channels. A campaign brief enters GenStudio, creative assets are produced and approved within it, and the final content is activated directly to Google Campaign Manager 360, Meta Ads, LinkedIn, and Amazon Ads through native integrations. The last-mile activation layer that connects creation to distribution without manual export and re-import across disconnected tools.

Journey Optimizer orchestrates customer communications across every channel in real time — email, SMS, push, in-app, web. The system that ensures the right message reaches the right customer at the right moment across every touchpoint simultaneously.

LLM Optimizer is Adobe’s answer to generative engine optimization — the emerging discipline of ensuring that a brand’s content appears correctly and prominently when AI systems like ChatGPT, Perplexity, and Claude generate responses to consumer queries. As search behavior shifts from keyword queries to conversational AI responses, brands that do not manage their LLM presence risk becoming invisible. LLM Optimizer, combined with the pending Semrush acquisition, positions Adobe to own this new distribution channel.

Semrush (closing Q2 2026, $1.9 billion, cash-funded) brings SEO intelligence, competitive analysis, and content performance data into the Adobe stack. The combination of traditional search optimization and LLM optimization creates a unified visibility platform — manage how a brand appears in Google and how it appears in AI-generated responses from the same interface.

Competition. Salesforce Marketing Cloud and Data Cloud is the most direct competitor — comparable platform depth, comparable enterprise scale, comparable pricing. Microsoft Dynamics and Copilot benefit from Office 365 distribution that gives Microsoft a structural advantage in enterprises already standardized on the Microsoft stack. Oracle has deep roots in large enterprise accounts through its historical database and ERP relationships. Braze and Klaviyo are more agile on specific use cases — mobile engagement and e-commerce respectively — and growing faster on the mid-market. HubSpot dominates the SMB and mid-market. Shopify owns commerce for a large segment of e-commerce operators.

Adobe is not the pricing power leader in this segment. The competitive landscape is dense with well-funded, well-entrenched players. The Semrush acquisition illustrates the dynamic honestly: Adobe needs to buy capabilities to fill gaps rather than building them organically from a position of dominance.

Moat. The moat here is enterprise stickiness rather than structural dominance. Customer data embedded in AEP — 70 billion profiles, behavioral history, segment definitions, attribution models — does not migrate easily. An enterprise that has spent two years building its customer data infrastructure on AEP is not rebuilding it on Salesforce Data Cloud because the renewal negotiation was uncomfortable. The switching cost is operational and temporal: the data can theoretically be exported, but the institutional knowledge built around the platform — the workflows, the integrations, the trained teams — cannot.

Multi-year ETLA contracts add the contractual layer. The largest Adobe enterprise relationships are governed by agreements that lock in capacity commitments across the full product suite. The unified pricing model — internally called Pangea — allows enterprises to swap between Adobe products within their contract without additional paperwork, which increases adoption breadth and makes partial defection more difficult.

The cross-sell between Creative Cloud and Customer Experience Orchestration is the distinctive structural advantage Adobe holds over pure-play marketing technology vendors. A brand that creates its content in Creative Cloud and activates it through GenStudio and AEP has a workflow that Salesforce cannot replicate — Salesforce does not make the content. That integration is the argument for Adobe’s platform over best-of-breed point solutions.

Three products within this segment have individually crossed $1 billion in ARR and are growing above 20% year-over-year — a signal that the segment contains fast-growing businesses that the aggregate 9-11% growth rate does not fully represent.

Competitive exposure: medium. Enterprise sticky but no pricing power dominance. Growth in line with the market, not above it.

8. UI/UX — Total Capitulation

Description. Adobe XD was Adobe’s UI and UX design tool — the product used to design the interfaces of websites, mobile applications, and digital products. Wireframes, prototypes, interactive mockups, design handoff to developers. Adobe XD is no longer available. Adobe discontinued it following the collapse of the Figma acquisition. Revenue: zero.

Competition. Figma owns this market. Approximately 80-90% market share. $1.056 billion in revenue in 2025, growing at 41% year-over-year. Net dollar retention of 136% in Q4 2025 — meaning existing customers spend 36% more each year without Figma acquiring a single new account. 1,405 customers spending above $100,000 annually. Figma is not a challenger. It is a monopoly.

The mechanism of Figma’s victory is analytically important because it is the clearest available case study of how Adobe loses a market. Figma did not build a better version of Adobe XD. It built a different product with a different architecture — browser-based, multiplayer, collaborative by default. Designers and developers work in the same file simultaneously. Comments are attached to specific elements. Design handoff happens through a shared link rather than an exported file. The network effect is direct: every new team member who opens a Figma file is immediately productive without installation, training, or file format conversion.

Adobe XD was a locally-installed, single-player application in a world that had decided design was a team sport. By the time Adobe understood what had happened, Figma had the market. The $20 billion acquisition attempt was the acknowledgment. The antitrust veto was the consequence. The discontinuation of XD was the exit.

Moat. None. Adobe has no presence in this segment.

This is the case study the bears cite most frequently — and they are right to cite it. A cloud-native entrant with a direct network effect entered on a flanking route Adobe had neglected, won the segment entirely, and Adobe’s only strategic response was an acquisition that regulators blocked. The lesson is not that Adobe is generically fragile. It is that Adobe is specifically vulnerable when a cloud-native product with a direct collaborative network effect enters a segment Adobe is serving with a legacy single-player architecture.

The question the bear thesis must answer — and cannot yet answer empirically — is whether this pattern is replicating itself in Photoshop, Acrobat, or Premiere. The current data does not support that conclusion. But the UI/UX loss is the right reference point for what the warning signs would look like if it were.

Competitive exposure: not applicable. Adobe is absent.

Summary table

A practical demonstration of everything described above. To generate the summary table below, I asked Firefly: “Use the reference image to create a summary table, clear with colors, to illustrate an article.” The best result came from Gemini 3.1 via the Nano Banana 2 model — available directly inside Firefly without leaving the Adobe ecosystem. Fast, effective, gets the job done. The output is functional, not premium — the rendering feels a little cheap.

That is precisely the point. Adobe did not produce the best image. It produced the most integrated workflow. One prompt, one interface, multiple models orchestrated behind the scenes. The result is not a demonstration of Firefly’s generation quality. It is a demonstration of Adobe’s orchestration strategy — and an honest illustration of where the moat actually sits.

Financials

Key financial metrics

*FY2024 operating margin and net income depressed by the $1 billion Figma breakup fee.

Four comments on the numbers above.

On FY2024 and FY2025 net income. FY2024 was penalized by the $1 billion Figma breakup fee recorded as an operating expense. FY2025 shows +28% net income growth — real, but amplified by the depressed FY2024 base. The underlying organic growth trend is in the 10-12% corridor. Do not read the FY2025 jump as an acceleration in operational performance. It is a normalization.

On gross and operating margins. Gross margin runs at 89% — structurally above peers. Microsoft runs at approximately 70%, Salesforce at approximately 75%. The operating leverage is real: R&D and marketing are largely fixed costs. Every incremental dollar of subscription revenue falls through to operating income at a high rate. The emerging pressure is on the cost of goods sold line — AI inferencing costs (GPU compute, cloud hosting for generative workloads) are rising faster than the generative credit revenue they support. The 10-K acknowledges this explicitly. It is not yet a margin problem. It is a trend to monitor.

On operating cash flow. Q1 2026 operating cash flow of $2.96 billion grew 19% versus Q1 2025 — significantly outpacing the 4% growth in net income. The divergence reflects strong receivables collection, not a structural change. Do not annualize the quarterly figure. The relevant number is the trailing twelve-month operating cash flow, which runs above $10 billion for FY2025 per the Summit disclosure.

On ROIC, buybacks, and the ROE distortion. NOPAT for FY2025 approximates $7.14 billion (operating income of $8.71 billion multiplied by one minus the 18% effective tax rate). Invested capital approximates $11.24 billion (debt of $6.21 billion plus equity of $11.62 billion minus cash of $6.60 billion). ROIC approximates 63% — six to seven times the weighted average cost of capital of approximately 9-11%. This is a business that finances its growth with its customers’ money: deferred revenue of $7.03 billion is a free float, and capital expenditure of $179 million represents less than 1% of revenues.

(The y-axis does not start at zero. This exaggerates movements and misleads the reader. A chart that does not respect this basic principle should not be trusted. )

The buyback program translates this directly into per-share value. Diluted shares fell from 438 million in Q1 2025 to 411 million in Q1 2026 — a reduction of 6.16% in twelve months. At $2.48 billion deployed in Q1 alone, the mechanical EPS growth from share count reduction runs at 16-17% annually independent of revenue growth. A $25 billion buyback authorization announced at Summit 2026 signals management’s explicit view on the undervaluation.

A note on ROE: the accumulated treasury stock of $48.8 billion makes the reported book equity figure ($11.43 billion) economically misleading and the resulting ROE astronomically high. Ignore the ROE. The relevant metric is ROIC and its direction — structurally stable to rising, with the FY2024 to FY2025 improvement partially explained by the Figma base effect and the mechanical reduction in invested capital from buybacks rather than purely operational improvement.

The recent quarterly filings show no accounting flags worth flagging — clean revenue recognition, no unusual adjustments, no restatements. The balance sheet is straightforward: $6.89 billion in cash and short-term investments, $6.23 billion in total debt, revolving credit facility of $1.5 billion undrawn, commercial paper program of $3 billion undrawn. The Semrush acquisition at $1.9 billion closes in Q2 2026 and is fully cash-funded without debt issuance or equity dilution.

Management

Shantanu Narayen — CEO since 2007, departure announced

Narayen did not found Adobe. He inherited a dominant business at an inflection point and made the most consequential decision in the company’s history since the invention of PostScript.

In 2012, he ended the perpetual license model for Creative Suite and moved the entire product portfolio to a monthly subscription. The backlash was immediate — designer communities organized boycotts, petitions circulated, the stock fell on the announcement day. Narayen held the line. Within eighteen months the model was clearly working. Within five years it had transformed Adobe from a cyclical software vendor into one of the most predictable recurring revenue machines in enterprise software. That is the track record that matters.

The Figma chapter is the more complicated entry on his ledger. The $20 billion acquisition attempt valued Figma at approximately 50 times ARR — a price that reflected strategic panic as much as strategic vision. Regulators blocked it. Adobe paid $1 billion to walk away. The market read it as a failure of judgment. The correct reading is more nuanced, developed in the Two Thesis section.

His departure is the central uncertainty of this investment in June 2026. The market prices it as a risk. It is also a potential catalyst — the new CEO’s first act will almost certainly be a conservative reset of expectations, a purge of near-term cost visibility, and a re-anchoring of guidance to beatable levels. That Kitchen Sinking dynamic — depressed expectations followed by modest outperformance — is a well-documented pattern in CEO transitions at large software companies. It tends to be the starting point of a rerating, not the continuation of a decline.

Dan Durn — CFO

The CFO is the more analytically useful signal in this management team. Durn has been transparent about the infrastructure cost increases associated with AI workloads in every recent earnings call — no varnish on the GPU spend, no inflation of the timeline for cost normalization. ARR, RPO, and buyback volumes are presented as raw figures without embellishment. The $25 billion buyback authorization announced at Summit 2026 came with explicit language: a direct expression of confidence in the long-term cash flows and intrinsic value of the business.

Capital allocation

R&D investment. $4.29 billion in FY2025, 18% of revenues, concentrated on the segments with the highest ROIC. XD was discontinued and the engineering resources were redeployed toward Photoshop, Acrobat, and Firefly. No budget spreading across dying products for organizational comfort. The allocation follows the returns.

Buybacks. No dividend — correct for a business trading at 11 times forward earnings. The first available dollar goes to repurchasing shares at a price management considers depressed. $2.48 billion deployed in Q1 2026 alone. 6.16% of shares retired in twelve months. $25 billion authorized through April 2030.

Skin in the game

Executive compensation is structured around performance RSUs tied to recurring revenue growth, operating margin, and relative total shareholder return over multi-year periods. Management has meaningful equity exposure to the outcomes they are describing.

On the SBC cost: stock-based compensation runs at approximately $800 million annually — roughly 9-10% of operating cash flow. This is in line with industry standards for a software company of this scale and complexity, and is acceptable given the talent retention imperative in AI and engineering. The FCF minus SBC figure is the honest measure of cash generation available to shareholders after the dilution cost of retaining talent is accounted for. At the current buyback pace, Adobe is repurchasing shares materially faster than it is issuing them — the net share count reduction of 6.16% in twelve months is after SBC issuance, not before.

The Two Thesis

Bear

Why the stock has fallen

The decline is not explained by a deterioration in fundamentals. Revenue grew +10.5% in FY2025, operating cash flow grew +19% in Q1 2026, Digital Media ARR grew +11.5%. The stock fell because the market repriced the risk of a future that has not yet arrived.

Five factors combined:

• The UI/UX capitulation — a visible, quantified loss, revenue = zero, that gave the bear thesis a concrete data point.

• The weakness of Express against Canva — a segment Adobe should have owned and didn’t.

• The uncertainty around AI monetization — inferencing costs rising faster than generative credit revenues, a genuine near-term margin question.

• The announced departure of Narayen — a management risk premium layered on top of everything else.

• The antitrust veto on Figma — the removal of the historical defense mechanism that had protected Adobe’s competitive position for two decades. Adobe’s playbook for handling threatening entrants was to acquire them before they became existential: Macromedia, Omniture, Marketo, Magento, Workfront, Frame.io. Figma was the first time that playbook failed. The market concluded — reasonably — that Adobe can no longer defend its borders through acquisition. That constraint is permanent.

The bear arguments

AI horizontal disruption. The value in the content creation stack is migrating toward the model layer — and Adobe does not own the best models. Midjourney, OpenAI, and Google produce superior generation quality. If the model becomes the product and the interface becomes a commodity, Adobe’s decades of tooling investment become a legacy liability rather than a competitive asset. The installed base protects nothing if users stop needing the installed base.

The generalist weakness. Adobe defends many fronts simultaneously — imaging, video, design, PDF, customer experience, consumer — with finite R&D of $4.29 billion. Each attacker concentrates everything on a single front: Canva on consumer design, DaVinci on high-end video color grading, Runway on AI video generation, Midjourney on image generation. A specialist with all its resources focused on one battlefield consistently outperforms a generalist spreading its attention across many. The UI/UX loss is the empirical proof of this dynamic. Figma concentrated everything on collaborative browser-based design. Adobe had XD as one of many priorities. Figma won completely. The question is not whether this pattern exists — it does. The question is which front is next.

Vertical to horizontal. Adobe is a vertically integrated stack — ideation to creation to production to activation, all proprietary, all Adobe. The disruption dynamic pushes toward modular horizontal architecture: best-of-breed point tools connected by open APIs, with AI models as a pluggable horizontal layer. If enterprise buyers shift from suite purchasing to best-of-breed assembly, the integrated stack advantage erodes into a coordination cost.

The trust narrative is not a moat. Narayen frames Adobe as the trusted partner enterprises turn to when they are anxious about AI proliferation. That is CEO positioning — the kind of thing you say on stage at your own conference. Enterprises do not pay 89% gross margin software because a brand reduces their anxiety. If the operational and legal lock-in erodes — if compliance standards around AI training data become commoditized, if activation integrations become open APIs that any tool can plug into — the trust narrative evaporates with it. A moat built on emotional preference is not a moat.

What if the bear thesis is really true?

If AI disruption is genuinely underway on the core segments, the warning signs would appear in the field before the financials. Competitive share losses become visible twelve to eighteen months before they show up in revenue — Figma had won the UI/UX market in the design community before Adobe’s revenue line showed anything. The field signals worth watching:

• Design schools dropping Photoshop from their curriculum in favor of AI-native tools.

• Enterprise procurement shifting Creative Cloud standardization to best-of-breed alternatives.

• Job postings no longer requiring Adobe proficiency as a baseline.

• Creative agencies publicly migrating workflows away from the Adobe stack.

None of these signals are present today. When they appear, the financial deterioration will follow within twelve to eighteen months. Positioning on the field signal — before the financial confirmation — is the entire point. Waiting for Digital Media ARR to decelerate below 5%, for gross margin to fall durably below 87%, for retention rates to visibly decline — by then the entry point at 11 times earnings is gone. The market will have moved twelve months earlier.

Bull

The business the market is ignoring

The bear thesis is being priced as present reality. It remains a future risk. Digital Media ARR grew 11.5% in Q1 2026. Gross margin came in at 89.6% — a record. Operating cash flow grew 19%. RPO stands at $22.22 billion — one full year of revenue already contractually committed before a single new contract is signed. 97% recurring. The field signals that would precede a structural deterioration are absent. This is not the financial profile of a business in structural decline.

The mathematical invalidation

The bears focus on the attacked segments. The numbers tell a different story. Acrobat growing at +15% and professional imaging growing at +10-11% represent approximately 81% of total revenues. The segments under attack — Express and the abandoned UI/UX — represent less than 5% of revenues combined. A complete collapse of both changes nothing material about the financial model. The bear thesis requires the destruction of the fortresses, not the periphery. There is no evidence of that.

The moat remains globally intact

The bear narrative conflates two very different realities: Adobe is losing on the edges, and Adobe is losing everywhere. The revenue map does not support that conclusion.

(Generated with Firefly / Nano Banana)

81% of revenues sit in segments with high moats and stable growth — Photoshop, Illustrator, Acrobat PDF. These are not segments under competitive pressure. They are segments where switching costs are prohibitive, where the labor market replicates the lock-in through every new hire, and where no competitor has made structural inroads in a decade. 14% sits in Customer Experience Orchestration — enterprise multi-year contracts, data embedded in AEP, high switching costs of a different nature. 5% is the exposed flank: Express and the abandoned UI/UX.

The bears have built a thesis on the 5% and extrapolated it to the 100%. That is the analytical error. A franchise where 81% of revenues are in intact fortresses, growing at 10-15% annually, with 89% gross margins, does not trade at 11× earnings because the business is broken. It trades at 11× earnings because the narrative is broken.

The fortresses have not moved. The sentiment has.

Two captive populations, two different locks

The investment case rests on understanding that Adobe’s customer base contains two structurally distinct captive populations — and that each is captive through a different mechanism that a single attacker cannot simultaneously break.

The first population is the creative professional. The lock is cognitive and cumulative. A senior designer who has spent ten years building muscle memory around Photoshop’s shortcuts, a photographer whose entire catalog lives in Lightroom, a motion artist whose After Effects template library represents years of production — none of these people are switching platforms because Affinity is cheaper or Midjourney is more impressive. The cost of switching is not the subscription fee. It is the temporary destruction of professional productivity, the retraining of ingrained reflexes, and the risk of failing a client during the transition. The lock is also self-replicating: design schools teach Photoshop, job postings require Adobe proficiency, and the muscle memory is transmitted through the labor market before Adobe charges a single dollar.

The second population is the large enterprise. The lock operates at two levels simultaneously.

The legal level first. Enterprise legal departments have already said no to Midjourney. Not because Midjourney produces inferior images — it often produces superior ones. Because the training data provenance is legally uncertain, the IP indemnification is absent, and a multinational running a global advertising campaign cannot accept the litigation risk. Adobe Firefly, trained on licensed content with full IP indemnification, is the only scaled answer to that legal constraint. Adobe is not selling generation quality to this customer. It is selling an insurance policy against a Getty Images lawsuit.

The operational level second. Adobe does not claim to have the best generative model. It claims to be the place where all the best models work together. Firefly integrates 30+ third-party models — Google, OpenAI, Anthropic, Runway, Flux, Ideogram — directly into the creative workflow. A designer who wants Midjourney’s aesthetic, OpenAI’s precision, and Runway’s video generation does not need to open 50 tabs, download from one platform, upload to another, reformat, re-import, and start over. They stay in Photoshop. They stay in Premiere. The models come to them.

The alternative is what happens without Adobe. Generate in Midjourney, download the file, open Photoshop, import, edit, export, upload to the campaign management platform, reformat for each channel, re-upload to each ad platform separately. Then do it 10,000 times. Then ensure every asset is brand-compliant. Then ensure no asset contains training data that exposes the company to an IP lawsuit. Then govern which employees are sharing which proprietary assets into which public models. And before any of that — get each best-of-breed tool individually approved, budgeted, contracted, and security-reviewed by IT and procurement. Every new tool is a separate vendor relationship, a separate budget line, a separate compliance review, a separate renewal negotiation.

“It’s an operational and a legal nightmare. That’s the kind of thing you wish to your enemy.”

Adobe controls the last-mile activation points through GenStudio’s native integrations with every major advertising platform — Google Campaign Manager 360, Meta Ads, LinkedIn, Amazon Ads. Even an enterprise that generates content with an open-source model upstream must transit through Adobe to activate, measure, and optimize at scale. The pipes are Adobe’s.

The self-cannibalization signal

Adobe Stock — the licensed image marketplace — is seeing accelerating revenue decline as AI generation replaces stock photo purchases. Management acknowledged approximately 30 basis points of drag on total ARR in Q1 2026. The bears read this as evidence that AI is destroying Adobe from within.

The correct reading is the opposite. Adobe is deliberately cannibalizing its own stock photo business with Firefly rather than letting Midjourney do it instead. Apple made the same decision when it killed the iPod with the iPhone. The $30 iTunes download was replaced by the $1,000 iPhone. Adobe is replacing a stock photo purchase — a one-time transaction — with a generative credit subscription embedded in a recurring ARR relationship. The transition costs 30 basis points today. The question is what it builds tomorrow.

The Stock Cannibal at a distressed price

Since the market decided Adobe was worth 11 times its earnings, Adobe has been buying its own shares at a historically low price. 6.16% of shares retired in twelve months. At this pace, EPS grows at 16-17% annually through pure share count reduction — independent of revenue growth, independent of AI monetization, independent of the SaaSpocalypse narrative. Even in a scenario where revenues stagnate, the investor’s share of the earnings base grows every quarter. The Stock Cannibal does not require a bull market to work. It requires a depressed price and a cash-generative business. Both conditions are currently met.

The Ballmer scenario — why no visionary is required

The market is punishing the Narayen departure as if Adobe requires a visionary CEO to survive the AI transition. That is the wrong frame.

Microsoft under Steve Ballmer missed every major technology shift of the 2000s — smartphones, tablets, social networks. The market berated him for fourteen years. During that time, profits tripled. The infrastructure survived the strategic errors. Satya Nadella then monetized that infrastructure in ways nobody had anticipated.

A Ballmer-equivalent at Adobe — a disciplined operator who protects the fortresses, maintains the buyback program, and does not destroy capital on ill-conceived acquisitions — produces a satisfactory return from the current valuation without requiring any heroic assumptions about AI monetization. The PDF tooling franchise and the professional imaging suite do not need a visionary to keep compounding. They need competent stewardship of structural advantages that have taken thirty years to build. The bar is lower than the market is pricing.

If the successor turns out to be more than a Ballmer — a Satya Nadella profile who finds the next monetization layer in the AI transition — the upside is considerably larger. But the base case does not require it.

The cool of today is the cheap of tomorrow

The AI generation tools that feel disruptive today are following a pattern that has repeated itself in every technology cycle. The CGI effects of Jurassic Park required supercomputers and months of specialist work — today a TikTok filter replicates them in three clicks. The professional graphic design of the 2000s required years of Adobe training — Canva made that aesthetic available to anyone. The hyperrealistic AI images that impressed everyone two years ago now saturate every feed and are beginning to feel generic.

When technical execution becomes free and ubiquitous, the eye adjusts. The value migrates toward what the machine cannot replicate: judgment, narrative, cultural relevance, brand authenticity. Producing 10,000 images in a day is now trivial. Producing 10,000 images that are meaningfully different, strategically coherent, and brand-perfect is still hard. That is the problem Adobe’s professional tooling and enterprise orchestration platform are built to solve. The demand for creation does not shrink when creation gets cheaper — it explodes. That is Jevons’ paradox applied to content. Adobe is the infrastructure of that explosion.

Catalysts

Operational. Q2 2026 results on June 11th. The analyst consensus has been cut to $5.01 non-GAAP EPS against Adobe’s own guidance of $5.80-$5.85. The bar is historically low. A delivery in line with guidance produces a violent surprise effect — not because the business improved, but because the expectations had been driven below reality. The stabilization of inferencing costs relative to credit revenue growth is the second operational catalyst: when the margin pressure from AI compute visibly plateaus, the operating leverage embedded in the 89% gross margin structure will express itself fully.

Market. The bear thesis has become consensus. A significant portion of institutional holders are underweight or short Adobe on the SaaSpocalypse narrative. A reassuring publication forces those managers to cover — the buying pressure is mechanical and independent of any new fundamental development. The $25 billion buyback authorization running simultaneously creates a permanent bid below the market price.

Strategic. The CEO succession announcement is the single largest discrete catalyst available. A recognized, AI-credible successor profile eliminates the management uncertainty premium instantaneously. The Semrush closing in Q2 2026 validates the post-Figma M&A discipline — bolt-on, cash-funded, no dilution, no antitrust risk.

Macro. A Federal Reserve rate cut reduces the discount rate applied to long-duration recurring cash flows — mechanically expanding the PE multiple on a business with $22 billion in committed future revenues. A regulatory tightening on AI training datasets in the EU or US widens the Firefly compliance moat automatically: if legally clean training data becomes mandatory, Adobe’s competitive position strengthens through its competitors’ legal exposure rather than through any action Adobe takes.

Reverse-DCF — what the market implies

At approximately $260 per share and a market capitalization of approximately $102 billion, the market implies that the present value of Adobe’s growth opportunities — the PVGO — represents only 20-35% of the total price, depending on the WACC assumption. The remaining 65-80% is paid for by the earnings the business generates today, with zero incremental growth assumed.

The market is pricing Adobe as a no-growth cash machine. At 11 times forward earnings, you are not paying for the AI monetization optionality, the Firefly ARR trajectory, the Customer Experience Orchestration expansion, or the operating leverage embedded in the margin structure. You are paying for the rents that already exist — and getting everything else for free.

What would invalidate the bull thesis

Three signals to monitor every quarter:

• Digital Media ARR decelerating structurally below 5% growth.

• Gross margin declining durably below 87% under inferencing cost pressure.

• Creative Cloud retention rates falling visibly in any disclosed metric.

None of these signals are present. When one appears, the thesis requires reassessment. Until then, the bear case is a future risk priced as a present reality.

Blind spots

The monetization velocity of generative credits into ARR is difficult to isolate from public disclosures — the aggregate figures support the narrative but do not yet prove the thesis at scale. The inferencing cost trajectory remains uncertain: nobody outside Adobe knows how fast GPU costs will rise relative to credit revenue growth over the next four quarters. The segment merger from FY2026 reduces the granularity available to track Digital Media versus Customer Experience Orchestration separately. The CEO succession timeline and profile are unknown. The transition toward consumption and outcome-based pricing introduces partial variabilization of ARR that could create quarterly volatility in reported metrics without reflecting underlying business deterioration.

Valuation

The PE story

Adobe traded between 40× and 60× trailing earnings during the 2021 SaaS euphoria. The normalization began in 2022 with rising rates. The Figma blocking in late 2023 accelerated the compression. The SaaSpocalypse narrative and the Narayen departure announcement finished the job.

Today Adobe trades at approximately 14×-16× trailing earnings — its lowest level since the pre-pandemic era. The software sector trades at a forward PE median of 13×-15×. Adobe, with 89% gross margins and 97% recurring revenues, trades at or below the sector median. A franchise of this quality has never sustainably traded at these multiples outside of crisis conditions.

Two readings are possible. Either the market is right and Adobe is in structural decline — in which case the financial data should already be showing early deterioration. Or the market is wrong and is pricing a future risk as a present reality — in which case the current multiple is an anomaly that will correct when the narrative shifts.

The financial data supports the second reading. The PE Gap is the entry point.

The capitulation signal

The technical picture confirms what the fundamentals suggest. In late May 2026, Adobe touched a low of $241.44 on volume of approximately 8.8 million shares — roughly double the daily average. A volume spike of that magnitude on a multi-year low is the signature of capitulation: forced sellers and momentum traders exiting at any price, absorbed by institutional buyers with a longer time horizon.

Since that low, the stock has recovered to the $256-$263 range. The short-term moving averages — 8, 20, and 50-day — have been reclaimed. The RSI has returned to a constructive 57-58, confirming that selling pressure has exhausted itself without the business having deteriorated.

The stock is still well below its 200-day moving average of approximately $303 — the long-term trend remains technically impaired. But the combination of a capitulation low, a volume-confirmed floor, and a $25 billion buyback program running at depressed prices creates an asymmetric setup: the downside is bounded by the buyback bid, the upside is bounded only by the pace of sentiment normalization.

Capitulation is not a prediction of immediate recovery. It is a signal that the most motivated sellers have sold. What remains is a cleaner shareholder base — and a management team deploying $2.48 billion per quarter into the same stock at the same depressed prices.

Valuation scorecard

Assumptions

Entry price: $258.00 (June 5, 2026). Time horizon: 2.57 years, targeting end of 2028. Base GAAP EPS run-rate: approximately $17.35 (FY2025 net income of $7.13 billion divided by approximately 411 million diluted shares).

The EPS growth in each scenario is built from the revenue trajectory of the individual segments, combined with the buyback program. Bear case assumes a defensive freeze — share count stays flat at 410.1 million, no contribution from capital return. Central and bull cases assume 6% annual share count reduction.

Base case — segment revenue assumptions:

• PDF / Acrobat: +15% — verified FY2025 trajectory, AI Assistant adoption adds a layer to the structural monetization of the Reader installed base.

• Professional imaging (Photoshop, Illustrator, Lightroom): +10-11% — the cultural fortress compounds steadily.

• Video and motion (Premiere, After Effects): +10% — DaVinci pressure is real but contained; the workflow lock holds.

• Firefly / AI generation: strong growth on a small base — generative credit consumption accelerating, enterprise compliance contracts building; not yet material to the aggregate.

• 3D — Substance: moderate growth — niche market, insulated from AI disruption short term.

• Digital Experience / Customer Experience Orchestration: +9% revenue, +11% subscription — in line with market, no pricing power expansion assumed.

• Adobe Express: +2% — no recovery assumed against Canva.

• UI/UX — ex-XD: zero.

On the EPS side, the buyback program retires approximately 6% of shares annually independently of revenue growth — 6 percentage points of EPS growth with no operational improvement required. Combined with the segment trajectory above, base case EPS growth is approximately +16% annually.

Bear case (+6% EPS/year) — this scenario implies disruption contaminating the fortresses themselves. PDF and Document Cloud decelerates to +8%, professional imaging to +5%, Digital Experience to +5%. Express stays at +2%. Firefly monetization stalls. Buybacks continue but cannot compensate for fortress erosion. This is not a scenario where Canva wins the consumer market — that has already happened and is already priced. This is a scenario where the field signals described in the bear thesis begin to materialize: design schools dropping Photoshop, enterprise procurement shifting away from Acrobat, Creative Cloud retention visibly declining. The +6% EPS is the mechanical floor when revenue growth collapses to near-zero and only buybacks remain.

Base case (+16% EPS/year) — the Ballmer scenario. No visionary CEO required. No AI monetization acceleration required. No rerating beyond historical norms required. The fortresses hold, the buyback runs, and the multiple normalizes toward the lower bound of the historical range. This is the minimum reasonable outcome if the bear thesis does not materialize on the segments that matter.

Bull case (+26% EPS/year) — the fortresses hold AND Firefly begins to print materially in the aggregate ARR AND the new CEO is credible AND Customer Experience Orchestration reaccelerates on agentic adoption. The multiple returns toward a normal SaaS quality valuation. This is not the 2021 euphoria. This is simply what Adobe is worth when the market stops pricing it as a dying business.

The scorecard

Two-year horizon. Current price ~$260. Pre-tax, pre-fees.

One important caveat: all figures are pre-tax and pre-fees. The actual return in your hands will depend on your tax situation, the investment vehicle you use, and any transaction costs. A gain of +62% in a taxable account is not the same as +62% in a tax-sheltered envelope. Run the numbers for your own situation before drawing conclusions.

How to read this

The bear case assumes no buyback contribution — a defensive freeze with share count flat at 410.1 million — and an operating margin of 20%, reflecting fortress erosion. EPS 2028: $15.22.

At PE 15× — $228, -11.5%, CAGR -4.6% — this is the scenario where the SaaSpocalypse narrative persists and disruption has genuinely begun to erode the core segments. A real loss, but a modest one. The earnings power of a business generating $10 billion annually in operating cash flow does not evaporate overnight. At PE 20× — $304, +18%, CAGR +6.7% — growth disappoints but the multiple partially normalizes. A positive return even in the pessimistic scenario.

The central case assumes 6% annual buyback and an operating margin of 30%. EPS 2028: $27.50. At PE 20× — $550, +113%, CAGR +34.3% — the Ballmer scenario. No visionary CEO required. No AI moonshot required. The fortresses hold, the buyback runs, the multiple normalizes toward the lower bound of its historical range. At PE 25× — $687, +166%, CAGR +46.4% — the same scenario with a multiple that reflects the quality of the business rather than the fear surrounding it.

The bull case assumes 6% annual buyback and an operating margin of 35% — returning to pre-AI-infrastructure-investment levels as inferencing costs stabilize and operating leverage expresses itself. EPS 2028: $32.08. At PE 25× — $802, +211%, CAGR +55.5% — this is my personal conviction scenario. Not the prediction. The consequence if Adobe stops being priced as a dying business. At PE 30× — $962, +273%, CAGR +66.9% — a full rerating toward historical norms. Not necessary for the thesis to work.

The S&P 500 benchmark over the same 2.57-year horizon: +27.4% total return at +10% CAGR. The central case at PE 20× already doubles the benchmark. The bear case at PE 20× still beats it.

The asymmetry

The realistic downside is contained. The realistic upside is significant. That gap — not the absolute price target — is the investment case.

You don’t need the bull scenario to make money here. You need the fortresses not to be broken.

Portfolio considerations

Sizing

The position sizing follows one principle: conviction should be proportional to the clarity of the thesis and the measurability of the downside.

On the thesis: the bear case requires the destruction of fortresses representing 81% of revenues. That destruction is not visible in the current data — not in ARR, not in gross margin, not in retention metrics, not in the field signals that precede financial deterioration. The thesis is clear.

On the downside: the bear case at PE 13× produces a -6% loss over two years. The floor is the earnings power of a business generating $10 billion in operating cash flow annually with 97% recurring revenues. That floor is measurable and concrete.

Both conditions — thesis clarity and measurable downside — justify a position above the portfolio neutral weight.

The position is currently 10% of the portfolio. The concentration is temporary by design. The target exit is a multiple normalization toward 18×-22×. When that normalization occurs — driven by a catalyst or simply by the passage of time — the position will be trimmed and the capital redeployed toward the next anomaly.

Style and correlation

Adobe is currently a Quality business priced as Deep Value. The fundamentals — 89% gross margins, 63% ROIC, 97% recurring revenues — are those of a premium software franchise. The price — 15× trailing earnings — is that of a mature industrial cyclical in a down cycle. That mismatch is the opportunity.

In a portfolio already concentrated in US large-cap technology, Adobe adds a style diversification rather than a sector diversification. The return driver here is not momentum or growth multiple expansion — it is sentiment normalization on a business whose fundamentals have not moved. That dynamic is largely decorrelated from the AI momentum trade that drives names like Nvidia or Microsoft at current valuations.

The defensive characteristic is real: Acrobat and Photoshop are operational expenses for the businesses and professionals that use them. They are not discretionary spend. In a recession, a law firm does not cancel its Acrobat Pro licenses. A design agency does not stop using Photoshop. The subscription base is structurally resilient to economic cycles in a way that advertising-dependent or transaction-dependent businesses are not.

A note on the cycle

Howard Marks’ framework on market cycles applies directly here. The SaaSpocalypse has moved sentiment from optimism to pessimism — from 50× earnings in 2021 to 15× earnings in 2026. That move has been driven by narrative, not by a proportional deterioration in fundamentals. The business that generated $7.13 billion in net income in FY2025 is not priced like a business generating $7.13 billion in net income. It is priced like a business expected to generate significantly less.

Cycles turn not when the news gets good, but when the news stops getting worse. The Q2 2026 results on June 11th are the first test. A delivery in line with guidance — against a consensus that has been cut to levels below Adobe’s own guidance — is sufficient to begin the turn. No acceleration required. No new narrative required. Just the absence of the deterioration the market has priced in.

Subscribe now

Conclusion

Adobe is not a broken business. It is a misread one.

The market has applied a distressed multiple to a franchise generating 89% gross margins, 97% recurring revenues, and $10 billion in annual operating cash flow. The fear driving that discount — the SaaSpocalypse — is a legitimate long-term risk and an absent present reality. The ARR is growing. The gross margin is at a record. The field signals that would precede a structural deterioration are not there.

The bears are right about the edges. Express lost to Canva. UI/UX was surrendered to Figma. These are real losses. They represent less than 5% of revenues. The bears are wrong about the conclusion: that peripheral losses signal systemic collapse. The fortresses — PDF, professional imaging — represent 81% of the business and are intact.

At 15× trailing earnings, you are not paying for the AI optionality, the Firefly ARR trajectory, the Customer Experience Orchestration expansion, or the operating leverage embedded in the margin structure. You are paying for the rents that already exist. Everything else is free.

And while the market debates the SaaSpocalypse, Adobe retires 6% of its own shares every year.

Superior products and superior environments drive superior returns. With Adobe you got world-class products with fortress environments on most of the products — with the valuation on a dying business.

The SaaSpocalypse is a story. The numbers tell a different one.

Share

Image credits

Product and marketing visuals sourced from Adobe Inc. (adobe.com). Financial charts sourced from Fiscal.ai.

Important Disclosure & Disclaimer

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

After weeks of research, I found it. Booking Holdings.

The stock is trading at a PE of 21.6x today, its lowest valuation since 2023. Looking back further, this valuation level has only appeared twice in the last ten years: March 2020, when borders were closed and planes were grounded, and March 2016. Two aberrations in a decade. This feels like a third one in the making.

The business is posting operational records. Revenue up 13%, margins expanding, free cash flow north of $9 billion, buybacks running at full speed. And yet the market is pricing it as if the model is about to be destroyed. The fear: AI will disintermediate online travel agencies. Users will plan their holidays through ChatGPT, Claude or Gemini, and Booking will become invisible.

In May 2025, I bought Alphabet at a PE of 17x, its lowest in ten years. The question everyone was asking: “Is Google Search broken by AI?” Since then, the stock is up +100%.

Today I’m asking the same question about Booking, as it holds the same mechanics: operational records, an AI disruption fear not yet showing up in the numbers, and a PE at a multi-year floor. The question is whether Booking will be its victim or its infrastructure.

This article starts with the business itself: what Booking Holdings actually does, how it makes money, who its customers and suppliers are, and what makes it structurally difficult to displace. From there, it examines the two competing theses: why the market is afraid, and why that fear may be overstated. The valuation section translates those arguments into a scorecard with concrete scenarios. The article closes with portfolio considerations: how this position fits into a concentrated ten-stock portfolio and a conclusion.

I know you’re busy, so I always start with a summary called The short version. If that’s all you have time for, that’s fine. The rest of this article explains why.

The short version

Booking Holdings is the world’s dominant travel marketplace. 4.4 million properties. 1.2 billion room nights per year. 60% of bookings arriving directly, without touching Google.

The stock has lost 33% from its peak. The market is punishing a narrative: AI will disintermediate online travel agencies. ChatGPT, Claude and Gemini will plan your holidays, and Booking will become invisible.

My view: the market is pricing a future disruption as a present reality. The business is posting records. Room nights are growing. Direct traffic is rising. The only confirmed casualty is KAYAK, a metasearch brand representing 4% of revenues. The core is intact.

At a normalized PE of 18x (stripping out $1.3B in non-cash FX losses and a one-time impairment) you are paying below the COVID floor for a franchise that generates $8.5B in free cash flow minus stock-based compensation and has $21.8B in buyback authorization left to deploy at depressed prices.

I bought on May 12th at €149.03, a normalized PE of 18x. The position is 6% of my portfolio. I am prepared to increase to 20% if the stock continues to fall and the thesis holds.

The valuation scorecard puts the central case at $297(+82% from current prices, 35% CAGR over two years) at a PE of 25x, simply normalizing toward the lower end of the historical range.

Understanding Booking’s business, supply chain and environment

History

Booking Holdings didn’t start as a travel company. It started as an experiment in consumer psychology.

Priceline was founded in 1997 with a single idea: let consumers name their own price for airline tickets, hotels and rental cars. The model was radical for its time, and famously promoted by William Shatner in ads that became part of American pop culture. The concept worked well enough to survive the dot-com crash, but the real transformation came quietly, from the other side of the Atlantic.

In 2005, Priceline acquired Booking.com, a small Dutch startup that had been building something far less glamorous but far more durable: a straightforward commission-based marketplace for European hotel reservations. No auctions, no gimmicks. Just inventory, search, and a clean booking experience. The acquisition cost a fraction of what the business would become. It was one of the greatest capital allocation decisions in internet history.

Over the following decade, Booking.com became the dominant force in global online travel, while the Priceline brand receded to its North American discount niche. The parent company eventually formalized what had been obvious for years: in 2018, it renamed itself Booking Holdings. The Dutch acquisition had consumed the American parent.

The group has since added Agoda for Asia-Pacific, KAYAK for metasearch, and OpenTable for restaurant reservations. A 25-for-1 stock split took effect in April 2026, bringing the share price from over $4,000 to approximately $160, making the stock accessible to retail investors for the first time in years.

The marketplace model

What Booking Holdings sells matters less than what it actually is. Booking calls itself a travel company. What it runs is a two-sided marketplace, a platform whose entire purpose is connecting two audiences that need each other but can’t find each other efficiently without an intermediary.

On one side, 4.4 million properties looking for guests. On the other, hundreds of millions of travelers looking for somewhere to stay. Booking organizes that meeting, takes a commission on the transaction, and scales without owning a single bed.

But the marketplace model goes beyond the transaction itself. Booking also handles what happens when things go wrong: customer service, cancellations, disputes, overbookings, or fraud. That after-sales layer is a core part of the value proposition, and it’s one of the reasons the platform commands 15 to 25% commissions without facing mass defection from either side. A traveler who knows Booking will fix a problem at 2am in a foreign city pays the slight premium without thinking twice. A hotel accepts the commission for the same reason: it’s the cost of outsourcing headaches nobody on the property wants to deal with.

That structure, asset-light, transaction-based, network-driven, with service embedded, is the foundation of everything that follows.

Booking.com: the engine

Booking.com is four businesses running on a single platform, each at a different stage of maturity.

Accommodation is the core: 4.4 million properties across 220 countries in over 40 languages. Hotels, apartments, villas, hostels, boats. This segment is the foundation everything else is built on.

Flights are the growth story. Available in 55 markets, the segment grew 28.5% in Q1 2026. Booking isn’t trying to become an airline booking specialist. It’s trying to own the full travel itinerary.

Attractions (tours, experiences, activities) grew 80% in 2025, albeit from a small base. The logic is to capture more of the trip: a traveler who books a Louvre skip-the-line ticket through Booking.com has one more reason to start there next time.

Payments are the least visible and potentially the most significant. Booking is expanding its payments infrastructure across millions of bookings. The 10-K is explicit on the intent: payments remove friction and deliver additional value for both travelers and partners. It’s an extension of the Connected Trip vision.

Taken together, these four products represent what management calls the Connected Trip: the idea that Booking owns every meaningful touchpoint of a journey, from inspiration to checkout. It’s an ambitious vision, still early in execution, but the direction is clear.

The other brands

Priceline serves the North American discount market: hotels, flights and rental cars at negotiated rates, with a loyalty program layered on top. It remains profitable but isn’t the growth driver.

Agoda covers Asia-Pacific, a region where Booking.com has historically underperformed relative to its global dominance. With outbound Chinese tourism recovering and Southeast Asian middle classes expanding, Agoda is the optionality play on the fastest-growing travel market in the world.

KAYAK is the metasearch comparator, the one that aggregates prices from Booking.com, Expedia, and direct hotel sites, then sends traffic to whoever wins the auction. Nobody says “I booked it on KAYAK.” It exists in the background of travel planning, which is precisely why it’s vulnerable. When an AI agent does the comparison for you, KAYAK loses its reason to exist. Management acknowledged this in 2025 with a $457 million impairment. The problem is real, the write-down is honest, and the exposure is limited: KAYAK represents roughly 4% of group revenues.

OpenTable handles restaurant reservations, primarily in the US. It’s a useful adjacency to the Connected Trip thesis.

Suppliers

Booking’s supplier base goes beyond the properties listed on its platform. Several critical dependencies are worth naming clearly.

Google is simultaneously Booking’s largest traffic supplier and a potential competitor, probably the most structurally ambivalent relationship in the business. Performance marketing on Google Search and Google Hotel Ads drives a significant portion of inbound traffic. Booking pays billions annually for that visibility. The fact that 60-65% of bookings now arrive through direct channels is partly a deliberate effort to reduce that dependency.

Apple and Google control the distribution of Booking’s mobile app through their respective stores, a structural dependency shared with every consumer app company. The mobile channel now accounts for a mid-fifties percentage of room nights booked, up from low-fifties in 2024, and the vast majority of that mobile traffic is direct.

Cloud infrastructure providers host the technical backbone of the platform. Payment processors, Adyen and equivalents, handle the transaction layer of the merchant model. Global Distribution Systems such as Amadeus and Sabre provide aggregated flight content for the flights vertical.

None of these supplier relationships are unique to Booking. But they are real dependencies, and an investor who treats Booking as purely asset-light is missing the operational infrastructure it relies on daily.

Agency vs merchant

For most of its history, Booking operated on an agency model: traveler pays hotel at check-in, hotel pays Booking a commission afterward. Simple and low-risk, but cash comes in late and Booking holds no funds in transit.

The merchant model inverts this: Booking collects payment from the traveler at the time of booking, holds the funds, and settles with the hotel later. This generates a meaningful float, cash that technically belongs to suppliers but temporarily sits on Booking’s balance sheet.

The transition is accelerating. Merchant bookings represented 70% of gross bookings in 2025, up from 63% in 2024. The 10-K is transparent about the cost: the merchant model generates additional expenses (payment processing, fraud chargebacks, personnel). But it’s also explicit on the outcome: in 2025, incremental revenues from facilitating payments exceeded the associated incremental costs. The transition is already profitable on its marginal economics.

Geographic revenue

Booking doesn’t publish a geographic revenue breakdown. The 10-K consolidates everything into a single reportable segment with no regional split, a deliberate choice that masks the European concentration.

Using a market share proxy, Europe accounts for roughly 55 to 60% of revenues, North America for 17 to 20%, Asia-Pacific for 12 to 15%, and the rest of the world for the remainder.

The European concentration deserves a more precise reading. Europe is the world’s number one travel destination. Demand flows in from the US, Asia, the Middle East, and Latin America. The revenue is recognized where the hotel is, not where the traveler comes from. Booking isn’t just the leader in Europe. It’s the global gateway to Europe. A weak dollar, rising Asian outbound tourism, or recovering transatlantic demand all flow through Booking’s European inventory. The concentration in the accounts understates the geographic diversity of the underlying demand.

Ethics issue

No analysis of Booking Holdings is intellectually complete without naming the friction points in its model.

On the consumer side, Booking has systematically deployed nudge marketing: “Only 1 room left,” “34 people looking at this right now,” countdown timers on prices. These techniques manufacture urgency that may not reflect reality. Consumer protection authorities across Europe have taken notice, and the regulatory risk is explicitly acknowledged in the 10-K.

The relationship with hoteliers is structurally asymmetric. An independent hotel that delists from Booking.com loses roughly half its online visibility overnight. That dependency gives Booking the leverage to maintain 15 to 25% commission rates without facing meaningful defection. Hotels participate because the alternative is worse, not always because the terms feel fair.

None of this is existential. But a company that generates this much value from network effects and supplier dependency will always attract regulatory attention. That’s the price of dominance.

Competitive advantage

Porter, Mauboussin, and most frameworks for analyzing competitive moats converge on the same question: why can’t a well-funded competitor simply replicate what this business does? For Booking Holdings, there are four distinct answers.

Network effects

Booking operates a classic two-sided network effect: more properties attract more travelers, more travelers attract more properties. At 4.4 million listings, the network has reached a scale that is self-reinforcing and practically impossible to replicate from scratch, not because of the technology, but because of the trust infrastructure built around it. Verified reviews accumulated over decades, cancellation guarantees, multilingual customer service, fraud protection. These take years and billions to build. They cannot be downloaded.

The network effect also operates within the traveler base itself. Every completed booking generates a review. Every review makes the next traveler’s decision easier. Every easier decision brings another traveler. The data flywheel compounds quietly in the background.

Brand

Booking.com is one of the most recognized travel brands in the world. But brand here means something more precise than awareness. It means habit. Travelers who have used Booking.com once, resolved a problem through its customer service, or benefited from a Genius discount don’t actively choose it again. They default to it. That behavioral anchoring, the reflex of opening the app rather than running a search, is what transforms a brand into a distribution moat. Consumer habits of this kind build slowly and erode slowly. They are among the most durable competitive advantages in consumer-facing businesses.

The contrast with KAYAK is instructive. KAYAK is a useful tool, technically competent, widely used, but it has generated no behavioral habit whatsoever. Users pass through it without remembering it. Booking.com users return to it without thinking. That difference is the difference between a commodity aggregator and a franchise.

Pricing power and economies of scale

Booking maintains commission rates of 15 to 25% across its property base without facing meaningful defection. For an independent hotel, the alternative to paying Booking’s commission is losing roughly half of its online distribution. That asymmetry is pricing power in its purest form: not the ability to raise prices arbitrarily, but the ability to maintain them without justification.

At scale, Booking also buys Google traffic more efficiently than any competitor. The same search auction that costs a smaller OTA $X per click costs Booking less per converted booking, because Booking’s conversion rate, average booking value, and repeat customer rate are all higher. Scale begets efficiency begets scale.

The Transformation Program, $550 million in annual cost savings achieved by end of 2025, is the operational manifestation of this dynamic. Fixed costs have been compressed and mutualized across brands while revenue continues to grow. The operating leverage is now structurally embedded.

Competition

Airbnb is the most culturally visible competitor but the least directly comparable. Airbnb’s inventory is almost entirely alternative accommodation: private homes, apartments, unique stays. Booking.com’s inventory spans both traditional hotels and 3.9 million alternative properties. The overlap is real but partial. The brand is really strong, especially in Europe, the biggest market of Booking.

Expedia is the most structurally comparable, a global Online Travel Agency (OTA) with a similar portfolio of brands (Hotels.com, Vrbo, Trivago) and a similar marketplace model. But where Booking has built a globally recognized brand with deep behavioral habits, Expedia’s brand recognition is significantly weaker outside North America. The profitability gap reflects this: Booking’s margins run structurally higher than Expedia’s despite operating in the same market. Booking simply runs the same model better, with a stronger brand behind it.

Google Hotels aggregates hotel prices directly in search results, allowing travelers to compare and sometimes book without visiting an OTA. This is a genuine threat, but it has been a genuine threat for a decade, and Booking’s direct traffic has risen rather than fallen during that period. The 60-65% direct booking rate is the empirical answer to the Google Hotels question. Travelers who know what they want go to Booking directly. Google captures the undecided.

Trip.com is the dominant OTA in China and increasingly relevant in Asia-Pacific outbound travel. As Chinese tourism recovers and expands globally, Trip.com represents genuine competition for international bookings, particularly in Europe, where Chinese tourists are a growing segment of inbound demand. Agoda is Booking’s answer to this dynamic, but the competitive intensity in Asia is real and shouldn’t be understated.

Financials

Key financial metrics

Commentary

Operating margin: Q1 is structurally Booking’s weakest quarter every year. European summer travel, the core revenue driver, peaks in Q3. The annual operating margin of 32.8% is the right baseline. The 23% Q1 figure is seasonal. Q3 2026 will be the real test of the thesis.

FCF decline in Q1 2026 (-2%): not a concern. Q1 FCF benefited from $1.9B in working capital movements driven by the seasonal increase in deferred merchant bookings. This number shouldn’t be annualized. Trailing twelve-month FCF stands at $9.0B, up 6% year-over-year, the relevant figure.

Net income drop in FY 2025 (-8%): the business didn’t deteriorate. Net income was depressed by $1.3B in non-cash FX losses on euro-denominated debt and a $457M one-time KAYAK impairment. Strip those out and normalized earnings were approximately $6.8B, a record. This is covered in detail in the accounting risks section below.

Net income surge in Q1 2026 (+225%): don’t over-read this figure. The Q1 2025 base was artificially low for the same FX reasons. Adjusted EPS growth of +14% is the more meaningful number for underlying operational performance.

A note on ROIC and ROE: both metrics are difficult to use meaningfully for Booking Holdings. The company carries negative book equity (-$5.6B) as a result of its aggressive buyback program, a sign of capital returns discipline. This makes ROE mathematically distorted and ROIC highly sensitive to how invested capital is defined, with published figures ranging from 30% to 79% depending on the methodology. What matters is the direction: returns on capital have expanded dramatically since 2021 and are well above the company’s cost of capital. The precise figure is less important than the trend.

The natural hedge and why the FX losses don’t matter economically

Booking is a US-listed company that reports in dollars. The majority of its revenues are generated in euros, hotels in Europe, priced in euros, booked by travelers worldwide. Its long-term debt is also partially denominated in euros, issued on European capital markets at historically favorable rates.

The mechanism is straightforward. When the euro strengthens, European revenues converted into dollars increase, a direct benefit to the income statement. When the euro weakens, those same revenues decrease, but the euro-denominated debt, converted into dollars on the balance sheet, also shrinks, generating an accounting gain that partially offsets the revenue impact. A stronger euro hurts the debt side and helps the revenue side; a weaker euro does the reverse. The liability structure hedges the operating exposure naturally, without derivatives, without cost.

The $1.297B FX loss in 2025 is the accounting manifestation of a stronger euro inflating the dollar value of the debt on the balance sheet, not a business loss so much as a translation artifact. The CFO comes from institutional finance. The euro debt is not an accident.

The merchant float: a hidden asset

As Booking shifts from agency to merchant model, it collects payment from travelers at the time of booking and remits to hotels only after the stay. At any given moment, Booking holds billions in cash that technically belongs to its hotel partners.

This float is not Booking’s money — it appears as a liability on the balance sheet. But it is interest-free funding provided involuntarily by the supply side of the marketplace. As merchant bookings grow — 70% of gross bookings in 2025, up from 63% in 2024 — the float grows with them.

Two practical implications for the investor. First, the gross cash figure overstates available liquidity — the $16.8B on the balance sheet as of Q1 2026 includes deferred merchant bookings that will be remitted to hotels. It is not all Booking’s money to deploy freely. Second, quarterly FCF figures can be flattered by seasonal float movements. Q1 is peak booking season — travelers pay upfront for summer stays that haven’t happened yet. The float swells, boosting reported cash generation. Q1 2026 FCF of $3.1B included $1.9B from this seasonal effect. The relevant figure is trailing twelve-month FCF — $9.0B.

The float is such a stron asset. It is a structural feature of the merchant model — one that grows as the business grows, and that represents a form of supplier financing that most businesses would pay dearly for. Booking gets it for free.

Management

Glenn Fogel: CEO since 2017

Fogel didn’t found Booking. He inherited a dominant business and made it more dominant, and that tells you something about the culture he runs. No grand vision speeches, no moonshot announcements. Quarterly calls are sober, measured, and consistently conservative in tone.

The track record on guidance is one of the cleanest in large-cap internet. Fogel systematically under-promises and over-delivers, room nights guided conservatively, delivered above the high end of the range, quarter after quarter. The Q1 2026 beat, room nights up 6% against guidance that signaled caution on Middle East headwinds, is the latest in a long series. Markets tend to penalize conservative guidance with lower multiples.

The KAYAK impairment in 2025 is the most revealing data point on Fogel’s character as a capital allocator. Writing down $457 million on an asset representing 4% of revenues, doing so explicitly and clearly, with a direct explanation of why (rising AI-driven customer acquisition costs in metasearch) isn’t what insecure management teams do. They obscure it, or restructure around it, or blame the macro. Fogel named the problem, sized it, and moved on. That’s the behavior of someone who cares more about the accuracy of the picture than the comfort of the audience.

Skin in the game

Fogel holds approximately 643,000 shares post-split, worth around $102M, split between direct holdings and a grantor retained annuity trust. His compensation is structured around base salary, annual bonus, PSUs and RSUs tied to ROIC and relative TSR targets. The regular share sales under a pre-established 10b5-1 plan are mechanical: they reflect vesting schedules and portfolio diversification, not a discretionary view on the stock. We don’t know his total net worth, but for a CEO whose career has been built entirely at Booking Holdings, it’s reasonable to assume Booking represents a substantial portion of his personal wealth. Zero insider purchases over five years is a neutral signal for someone whose entire professional net worth is already concentrated in a single name.

The more relevant skin-in-the-game signal is the buyback program itself. Management has returned over 100% of free cash flow to shareholders since restarting the program in 2022, and reduced the share count by 22% net of dilution in that period. At current prices, which management presumably believes are depressed, the $3.6B in Q1 2026 buybacks represent an unusually large deployment of capital into their own stock.

The two thesis

Bear

Why the stock has fallen

The decline isn’t explained by a deterioration in fundamentals. Revenue grew 13% in 2025, free cash flow minus SBC reached $8.5B, and room nights hit a record 1.235 billion. The stock fell because the market repriced the risk of a future that hasn’t yet arrived.

Three factors combined: cautious Q1 2026 guidance that flagged a Middle East conflict impact on room night growth (roughly two percentage points of headwind, according to management), macro uncertainty around US consumer spending and transatlantic tourism flows under tariff pressure, and, most significantly, the AI disruption narrative. The market has decided that online travel agencies are structurally vulnerable to agents that can plan and book travel autonomously, bypassing intermediaries entirely.

The KAYAK impairment of $457M gave the bears a concrete data point. It’s the only one they have.

The bear arguments

AI disintermediation: It is the central fear. The scenario: travelers ask Claude, ChatGPT or Gemini to plan a trip, the agent searches inventory, compares prices, and completes the booking without the traveler ever visiting Booking.com. In this world, Booking becomes either invisible or a backend supplier with no pricing power. The fear is legitimate. The timeline, unknown. The evidence in the current numbers, absent.

Three sub-scenarios deserve distinction. In the light scenario, AI agents become powerful travel planners but still route transactions through Online Travel Agencies; Booking pays a new “AI tax” on top of the existing Google tax, margins compress but the business survives. In the intermediate scenario, agents bypass OTAs for search but still need Booking’s inventory and trust infrastructure to complete the transaction, so Booking’s role shifts from discovery to fulfillment. In the extreme scenario, agents connect directly to hotel APIs, Booking’s 4.4 million properties become accessible without intermediation, and the platform loses its reason to exist.

DMA and price parity: under the EU Digital Markets Act, Booking can no longer contractually require hotels to offer their lowest rates on its platform. A rational traveler who finds a property on Booking and books directly with the hotel pays less. Booking becomes a free discovery engine. The bear case: this structurally erodes conversion and take rates over time.

Mix dilution: flights and attractions are growing fast, 37% and 80% respectively in 2025. But both carry lower margins than accommodation. As they grow as a share of revenue, blended margins face structural pressure regardless of operational efficiency.

What if the bear thesis is really true?

If AI disintermediation is genuinely underway, the first measurable signals would be declining room nights in absolute terms on Booking.com’s core, rising customer acquisition costs on the accommodation segment specifically, and erosion of direct booking rates. None of these signals are present in Q4 2025 or Q1 2026 data. The bear thesis is being priced as present reality. It remains a future risk.

And even in the extreme scenario: 4.4 million verified properties, decades of reviews, cancellation guarantees, multilingual customer service and fraud protection cannot be replicated by an API connection. The inventory and trust infrastructure Booking has built isn’t downloadable. Booking in the extreme scenario becomes the infrastructure layer AI agents plug into, less glamorous, but not zero.

Bull

The business the market is ignoring

While the market prices a disruption that hasn’t arrived, the underlying business keeps compounding. FCF minus SBC grew 16% in FY 2025 to $8.5B. Operating margins expanded to 32.8%, more than 1,100 basis points above 2021 levels. The Transformation Program delivered $550M in annual savings, already in the run-rate. Every dollar of that flows directly to the bottom line in 2026.

60% direct: the empirical answer to the AI fear

Over 60% of room nights are now booked through direct channels: users who open the Booking app or type the URL without passing through Google or any other intermediary. That figure has been rising consistently year over year. It’s the single most important data point in this analysis.

When I type “Booking” into Google to navigate to Booking.com, I’m one data point in that 60%. Google is serving as my address bar. Booking pays no commission on that reservation. The same logic applies to AI agents: a traveler who opens the Booking app directly because that’s their habit bypasses every intermediary, AI or otherwise.

The DMA argument has the same answer. Hotels that offer lower prices on their own websites risk being downgraded in Booking’s search rankings, losing visibility on a platform that drives the majority of their bookings. The contractual lever is gone. The algorithmic lever remains. Most hotels play along.

Genius as a disintermediation defense

The Genius program is a structural moat against disintermediation. A traveler at Genius Level 2 or 3 (now representing a high-50% share of room nights) compares prices with a Genius discount already embedded in their mental model. A competing platform offering the same base price appears more expensive. An AI agent that recommends a cheaper alternative on a direct hotel website is fighting against a behavioral anchor Booking spent years building.

The stock cannibal at work

Since restarting buybacks in 2022, Booking has reduced its share count by 22% net of dilution. $3.6B was deployed in Q1 2026 alone, at prices management presumably considers depressed. $18.2B in buyback authorization remains. At current prices, every buyback dollar buys more earnings per share than it would at historical multiples. The mechanism compounds more powerfully precisely because the stock is cheap.

Catalysts

Four categories of catalysts could trigger a re-rating.

Earnings: Q3 2026 is the key quarter, peak European summer season, first full year of Transformation Program savings in the cost base, and the first quarter where Middle East headwinds from Q1-Q2 anniversary out. A beat and raise on that print would address the macro fear, the margin fear, and the AI fear all at once.

Structure: short interest has built on the AI narrative. A strong quarter could force covering, and a short squeeze on a stock with $18B in buyback authorization behind it is a powerful combination.

Strategic: Booking has $16.8B in cash and investments. An acquisition in AI travel technology, or an announced partnership making Booking the backend of a major LLM travel agent, would invert the narrative entirely.

Macro: dollar weakness benefits both revenue conversion and the FX line in the income statement. A Fed rate cut cycle expands multiples on profitable growth companies mechanically. Clarification of DMA obligations removes a regulatory uncertainty that’s been overhanging the stock.

What would invalidate the bull thesis

Four signals worth monitoring every quarter:

• room nights declining in absolute terms on the core Booking.com accommodation segment;

• the direct booking rate falling below 60% and trending down;

• customer acquisition cost rising on accommodation specifically;

• an AI agent demonstrably completing hotel bookings at scale without routing through an OTA.

None of these have appeared. When one does, the thesis deserves reassessment.

Test it yourself

Ask Claude, ChatGPT or Gemini to plan your next holiday. Note where you end up. Then compare the same search on Booking.com and Airbnb: pricing, cancellation terms, customer service guarantees. The bear thesis assumes AI makes Booking irrelevant. The bull thesis says AI makes Booking more necessary, because travelers need someone to trust when things go wrong, and that trust takes decades to build.

Blind spots

Four blind spots worth acknowledging honestly.

Geographic revenue isn’t published. The proxy method used in this analysis rests on market share estimates that could be wrong. If Booking’s European concentration is higher than estimated, FX sensitivity is higher than modeled.

The quality and adoption rate of the AI Trip Planner isn’t measurable from public data. Management reports positive signals on conversion, but the counterfactual (what conversion would be without it) is unknowable.

The long-term impact of DMA on take rates isn’t yet visible in the numbers. It may take several years to materialize, or it may never matter if the algorithmic lever proves as effective as the contractual one was.

Glenn Fogel’s tenure: he’s run the business well for eight years. There’s no succession plan visible in public filings. Key man risk exists, even if it isn’t the central concern today.

Price scorecard

This section is the output of everything above. The numbers only make sense if you’ve read the two thesis section. As Damodaran said, “a valuation without a thesis is just a spreadsheet”.

The metric

We use the normalized PE, instead of the forward PE, which is built on analyst estimates rather than published facts. Starting from the 10-K, we strip out the non-cash, non-recurring items that distort the GAAP net income:

Net income GAAP: $5.404B

+ Non-cash FX losses: +$1.297B

+ KAYAK impairment: +$457M

- Associated tax benefit (~20%): -$351M

Normalized earnings: ~$6.8B

At the current price of $163, market cap ~$128B, the normalized PE is approximately 18x, against a historical range of 25-30x in normal conditions, and a COVID floor of 16.8x in March 2020. The only times Booking traded below 20x in the last ten years were March 2020 and March 2016. This is the third occurrence.

You’re paying less than 22x the structural earnings power of one of the most profitable marketplaces in the world.

The scorecard map

The core thesis

My central assumption is that Booking Holdings will, over time, trade back toward its long-term average earnings and its long-term average multiple.

What happens between now and then, macro shocks, AI developments, rate cycles, geopolitical events, a crash, I have no idea. Nobody does. The scorecard below maps possible destinations and deliberately excludes crash scenarios. Price fluctuations will be driven by investor sentiment as much as by fundamentals.

A broad market selloff, an oil shock, a recession: any of these could push the stock well below the bear case temporarily, independent of Booking’s fundamentals. That risk is real and is addressed in the portfolio section.

What I believe is that paying 21.5x normalized earnings for a business of this quality, at a valuation that’s appeared only twice in ten years, offers a margin of safety that makes the uncertainty manageable.

The scorecard

The table uses EPS TTM of $7.61, a central growth assumption of +25% per year over two years, and three scenarios for growth and multiple expansion. Bear case assumes growth 20% below base. Bull case assumes growth 20% above base. Combinations that are internally contradictory, a bear earnings trajectory with a bull multiple, or vice versa, are marked irrelevant.

One important caveat: all figures in the scorecard are pre-tax and pre-fees. The actual return in your hands will depend on your tax situation, the investment vehicle you use, and any transaction costs. A gain of +82% in a taxable account is not the same as +82% in a tax-sheltered envelope. Run the numbers for your own situation before drawing conclusions.

How to read this

The bear case at PE 20x ($198, +21% from current price) is the realistic downside if the AI disruption narrative persists and growth slows. Even here, the return is positive over two years. The only scenario that produces a loss is PE 15x in the bear case, a multiple last seen at the absolute trough of COVID, applied to a business posting records. That’s not a base case. That’s a panic scenario.

The central case at PE 25x ($297, +82%, 35% CAGR) requires no heroic assumptions. It simply prices the business at the lower end of its historical multiple range, with earnings growing at the central rate. That’s what a re-rating looks like when a sentiment-driven discount unwinds.

The bull case at PE 30x ($428, +162%) requires both strong earnings growth and multiple expansion back to peak levels. It isn’t necessary for the thesis to work.

The asymmetry

The realistic downside is contained. The realistic upside is significant. That gap is the investment case.

You don’t need the bull scenario to make money here. You need the business not to be broken. Everything in this article suggests it isn’t.

Portfolio considerations

Sizing

I initiated a position on May 12th at €149.03 per share, a normalized PE of approximately 18x at the time of purchase. The position currently represents approximately 6% of the portfolio.

I’m prepared to increase that allocation to up to 20% if the stock continues to fall, not because I expect it to, but because the quality of the business at depressed valuations justifies a larger conviction bet. It’s a thesis: if room nights decline in absolute terms on the core Booking.com accommodation segment, or if the direct booking rate falls consistently below 60%, the investment case deserves reassessment. As long as the thesis holds, lower prices are an opportunity.

Cyclicality

Booking carries meaningful exposure to travel demand, consumer confidence, and oil prices. A cheaper barrel makes flying cheaper, drives volume, and lifts the whole travel ecosystem. Conversely, an oil shock or a consumer spending contraction hits travel before most other discretionary categories.

That cyclicality is precisely what creates the entry point. The market prices in the downturn before it arrives, compresses the multiple, and offers the business at a discount to intrinsic value. The exit comes when optimism returns and the multiple normalizes. Buy the sentiment trough, hold through the recovery, sell the enthusiasm. The cycle does the work.

This is also deliberate tactical allocation. I sold OKEA, a Norwegian oil producer, a direct play on the oil cycle, to partially fund this position. Rotating from a commodity cyclical at peak geopolitical risk premium into a quality consumer cyclical at a sentiment trough isn’t a coincidence. It’s the same logic applied twice, on opposite sides of the oil price.

Currency

Booking is listed in dollars. I hold it in euros. The currency exposure is real but partially self-correcting: as covered in the accounting section, Booking’s euro revenue base and euro-denominated debt create a natural hedge within the business itself. A weaker dollar benefits both the converted revenue line and the FX accounting line simultaneously. I don’t hedge the currency exposure at the portfolio level. The business structure already does part of that work.

Conclusion

Booking Holdings is a misread business.

The market has applied a COVID-level valuation to a company posting record revenue, record free cash flow, and expanding margins. The fear driving that discount, AI disintermediation, is legitimate as a long-term risk and absent as a present reality. Room nights are growing. Direct traffic is rising. The Transformation Program has delivered. The stock cannibal is buying back shares at the cheapest multiple in a decade.

I bought on May 12th at a normalized PE of 18x. That’s the third time in ten years this valuation has appeared. The previous two were March 2016 and March 2020. Both were followed by significant re-ratings.

I don’t know when the re-rating happens this time. I don’t know what the path looks like. What I know is that I’m paying a fair price for an exceptional business, and that the cycle, eventually, always completes.

The bear thesis is true as a risk. It isn’t true as a present reality. The market is confusing the two.

That gap is the trade.

In August 2025, I bought OKEA ASA at 19 NOK, a Norwegian oil company.

The thesis was contrarian by nature. OKEA was in a temporary production trough — new wells under development, high capex, dividend suspended for several quarters. The market priced it as a broken story. It was a sequencing problem, not a structural one — and the stock was trading at a significant discount to intrinsic value as a result. The underlying asset, Brent crude, was sitting quietly around $70 a barrel. Inelastic by nature : supply takes years to adjust, demand moves faster, and when the two fall out of sync, prices don’t drift. They snap.

Then a president pressed a button.

In late February 2026, the US-Israel war against Iran broke out. Brent jumped from $72 to nearly $120 at its peak — one of the largest one-month oil price surges on record. OKEA, as a leveraged proxy on oil, amplified every point of that move mechanically.

I exited in two tranches at approximately 37-38 NOK. My signal was simple : ceasefire talks had begun, the geopolitical risk premium that had driven the move was tied to a condition that would eventually reverse. By early April, as de-escalation signals emerged, Brent had already dropped back below $100 — the war premium deflating as fast as it had built.

I made +110% in less than 9 months.

Not because I predicted a war. Because I understood the mechanism — a fundamentally undervalued proxy on an inelastic asset, where any external shock doesn’t produce a linear price move. It produces an explosion.

I am now applying the exact same logic. But to an asset whose supply is not constrained by drilling schedules, OPEC decisions, or geopolitical risk premiums.

It is constrained by design.

And no one — no president, no central bank, no government — can press a button to change that.

This article is structured in four parts : the supply mechanics of Bitcoin, the structure of Strategy Inc. as a leveraged proxy, the risks, and the exit discipline. Each part builds on the previous one. The thesis only makes sense if all four hold simultaneously.

The Short Version

Bitcoin has pulled back from its highs as sentiment swung from enthusiasm to fear — the pendulum Howard Marks describes, completing its arc. Meanwhile, the supply side has not moved. If anything, it has tightened : fewer coins on exchanges, more absorbed by ETFs, sovereigns, and corporate treasuries with no intention of selling. The available float shrinks with time, not with price. When risk appetite returns — and it always does — the same inelastic market that produced the last rally will produce the next one, amplified by a smaller float than before.

Strategy Inc. is the leveraged proxy on that dynamic. Its mNAV is at historic lows. Its Bitcoin per share is growing. The pendulum is at the fear end of its arc.

This is a fixed supply, variable sentiment trade. The supply side is decided. The sentiment side always comes back.

Part 1 — Bitcoin : The Most Inelastic Asset in the World

1.1 Supply : A Mathematical Constraint, Not a Physical One

Every commodity has a supply ceiling. For oil, it is defined by geology, capital expenditure cycles, and political decisions — all of which can be adjusted, accelerated, or reversed over a 2-3 year horizon. New fields can be opened. OPEC can increase quotas.

Bitcoin’s supply ceiling is different in nature. It is written in code.

The numbers are simple and final :

• 21 million BTC maximum. Not a target. A hard cap encoded at the protocol level, immutable by design.

• ~20 million already mined. The remaining issuance is minimal and decreasing with each halving cycle.

• 3-4 million BTC estimated permanently lost — locked in wallets whose private keys no longer exist, sent to unspendable addresses, forgotten on hard drives from the early years of the network.

This leaves fewer than 17 million BTC realistically accessible in the entire world.

Of those, approximately 3 million BTC sit on exchanges — the real float available for trading at any given moment. The rest — more than 75% of circulating supply — is held by Long Term Holders (LTH) : entities and individuals who have not moved their coins in over 155 days and have demonstrated, cycle after cycle, that they do not sell.

In both cases — oil and Bitcoin — supply is fixed or near-fixed in the short term. The difference is that Bitcoin has a hard ceiling of 21 million units. Oil supply can eventually respond to price signals, given enough time and capital. Bitcoin’s ceiling is permanent, non-negotiable, and visible to everyone in the market simultaneously.

1.2 — But Will Bitcoin Even Survive ?

It is a fair question. And it deserves a direct answer before we go any further into mechanics.

Bitcoin has existed since 2009. In that time, it has survived an 80% crash — multiple times. It survived the collapse of Mt. Gox, the largest exchange of its era. It survived the FTX implosion, which wiped out tens of billions in a matter of days and triggered the kind of contagion that would have destroyed any asset without genuine underlying demand. It survived coordinated regulatory attacks from some of the world’s largest economies. It survived being declared dead by mainstream financial media more times than anyone has bothered to count.

It is still here.

But survival alone is not the argument. The argument is that Bitcoin has crossed a threshold beyond which the question of disappearance is no longer the relevant one.

In January 2024, the SEC approved the first US spot Bitcoin ETFs. BlackRock — the largest asset manager in the world, with $10 trillion under management — launched IBIT. When BlackRock decides to build a product around an asset, it is not making a speculative bet. It is responding to client demand that has already been validated at scale. The United States government has established a strategic Bitcoin reserve. Sovereign wealth funds have begun allocating. Pension funds are following.

This is not enthusiasm. This is infrastructure.

The practical reality is simple : enough people want Bitcoin as an asset class that an entire institutional ecosystem has been built around it. That ecosystem — custodians, ETFs, derivatives markets, regulatory frameworks — does not get dismantled. It compounds.

And underneath the institutional narrative sits something more fundamental. We live in a world where central banks have demonstrated, beyond any reasonable doubt, that they will print money when the system requires it. The 2020-2022 episode was not an anomaly. It was a confirmation. Fiat currencies are, by design, inflationary. Bitcoin, by design, is not.

You do not need to believe in Bitcoin’s philosophy to understand its appeal. You only need to observe that in a world of expanding money supply and shrinking purchasing power, a finite asset with a hard ceiling of 21 million units solves a real problem for a growing number of people.

“I don’t need to believe in Bitcoin. I need to observe that enough people do — and that the number keeps growing.”

The question is no longer whether Bitcoin will be part of our financial world. It already is. The question is what happens to its price when institutional demand keeps growing against a supply that cannot.

That is the question the rest of this article answers.

1.3 Demand : A New Structural Buyer Has Entered the Room

For most of Bitcoin’s history, demand was driven by retail speculation — volatile, emotional, and cyclical. That structure has fundamentally changed.

Three new categories of structural buyers have entered the market since 2024, and none of them behave like retail traders.

The ETF issuers. US spot Bitcoin ETFs — led by BlackRock’s IBIT — have become the dominant price-setting force in the market. The scale is striking : at peak inflow periods, these ETFs have absorbed up to 9 times the daily mining output of new Bitcoin.

But the mechanism matters as much as the scale. ETF issuers do not negotiate prices. When a new dollar flows into IBIT, BlackRock must go into the open market and buy whatever Bitcoin is available — at whatever price sellers are willing to accept. They work through the order book from the bottom up, lifting offers until the required amount is filled. With only 3 million BTC on exchanges and 75% of supply structurally illiquid, that order book is thin. When a large ETF buy hits a thin book, it does not move the price gradually. It tears through available supply, pushing the price up in discrete steps until enough sellers are found.

This is not discretionary buying. It is a market obligation with no price sensitivity.

The sovereign buyer. The United States has established a strategic Bitcoin reserve. A sovereign buyer operates on a different logic entirely — it does not buy to generate returns, it buys to hold. Coins acquired at the state level do not return to the market. They permanently reduce the float.

The corporate accumulators. Strategy Inc. and its growing list of corporate imitators systematically remove Bitcoin from exchanges into cold storage. Each purchase is permanent by design.

The table below shows the monthly ETF flow trajectory from October 2025 through March 2026 :

• October 2025 : -$3.50B | ATH at $126,000 — mass profit-taking

• November 2025 : -$3.48B | Continued de-risking

• December 2025 : -$1.09B | Slowdown in outflows

• January 2026 : -$1.60B | Macro risk-off

• February 2026 : -$3.56B | Peak institutional capitulation

• March 2026 : +$2.80B | Major reversal — net accumulation

• April 2026 : +$2.44B | Institutional re-entry & rally toward $80,000

Five months of sustained outflows. Then a clean reversal. The structural buyers did not disappear during the correction — they accumulated. The float tightened further. And when sentiment turned, there were fewer coins available to absorb the demand than before the correction began.

1.4 The Supply Shock Mechanism — Why Small Flows Move Big Prices

The intuitive assumption is that a $3 billion inflow into a market with $250 billion in tradeable float should move the price by roughly 1.2%. Simple division.

That assumption is wrong, and there is rigorous academic work explaining why.

In 2021, Xavier Gabaix (Harvard) and Ralph Koijen (University of Chicago) published “In Search of the Origins of Financial Fluctuations : The Inelastic Markets Hypothesis” — one of the most consequential papers in modern finance. Their central finding : financial markets are far less elastic than classical theory assumes. In equity markets, $1 of net inflow moves total market capitalisation by approximately $5. The multiplier exists because most investors — index funds, pension funds, ETFs — have rigid mandates. They must buy regardless of price, and there are too few discretionary sellers to absorb the flow without significant price movement.

On Bitcoin, the multiplier is almost certainly higher. The reasons are structural :

• The float is extraordinarily thin — 3 million BTC tradeable out of 17 million accessible

• Long term holders have demonstrated near-zero price sensitivity — they do not sell into strength

• ETF buying is non-discretionary, as described above

• No short-selling mechanism exists at the scale needed to absorb large inflows

The practical implication : a $3 billion monthly inflow does not move Bitcoin 1.2%. Observed market behaviour suggests the real move is closer to 4% to 10%, and potentially more during periods of peak illiquidity.

This is not speculation. This is mechanics.

1.5 The 200-Week Moving Average — Sentiment Made Visible

Blue dots : accumulation zones. Red/orange dots : cycle peaks. Purple line : 200W MA. Source : Bitcoin Magazine Pro.

Howard Marks describes market sentiment as a pendulum. It swings between fear and enthusiasm, rarely resting at the midpoint, always overshooting in both directions. The investor’s job is not to predict when it swings — it is to recognise where it currently is.

This chart is that pendulum, made visible.

Blue dots mark the fear phase : Bitcoin trading near its 200-week moving average, sentiment at its worst, long-term holders absorbing supply that short-term sellers are desperate to offload. Red and orange dots mark the enthusiasm phase : Bitcoin trading far above the 200W MA, narratives euphoric, cycle peaks forming.

The pattern has repeated without exception since 2012. Fear compresses the price toward the average. Enthusiasm explodes it away. The moves from blue to red are not incremental — they are multiples. 5x, 8x, 10x from trough to peak.

Today, Bitcoin is in blue territory. The pendulum is now at the fear end of its arc.

It always swings back.

Part 2 — Strategy Inc. : The Leveraged Proxy

2.1 What Strategy Inc. Actually Is

Strategy Inc. (NASDAQ : MSTR) is no longer meaningfully a software company. It is a Bitcoin accumulation vehicle, using convertible debt and equity issuance to acquire and hold Bitcoin permanently.

The key structural facts :

• 843,738 BTC on the balance sheet — the largest corporate Bitcoin holding in the world

• ~$8.2 billion in convertible debt — fixed obligations, not linked to Bitcoin’s price

• Debt is unsecured — there is no covenant, no collateral, no mechanism that forces a Bitcoin sale at any specific price level

• The legacy software business generates ~$460 million annually — negligible relative to the Bitcoin treasury, but sufficient to cover a portion of interest obligations

The company holds $2.25 billion in cash reserves, covering over 2.5 years of debt and dividend obligations without selling a single Bitcoin.

Understanding what Strategy Inc. is not is as important as understanding what it is. It is not an ETF. It is not a fund. It is a company that has made a permanent, structural bet on Bitcoin appreciation — and engineered its entire capital structure around that bet. The software business is a legacy artifact. The Bitcoin treasury is the company.

2.2 The Natural Leverage

The leverage in Strategy Inc. is structural, not speculative. It arises from a simple balance sheet dynamic : the debt is fixed, the assets (Bitcoin) are variable.

When Bitcoin rises, the value of the asset side of the balance sheet increases. The liability side does not move. The equity — the value accruing to shareholders — grows disproportionately faster than the underlying asset.

Historically, this has produced a beta of 1.5x to 3x relative to Bitcoin during bull phases. In concrete terms :

• Bitcoin +10% → MSTR +15% to +40%

• Bitcoin +50% → MSTR +150% to +300%

• Options gamma squeeze : if Bitcoin crosses certain thresholds, forced short covering on MSTR options can produce moves of +70% for a +14% Bitcoin move

This is the same mechanism that made OKEA interesting as a proxy on oil. The underlying asset moves. The proxy amplifies. The fixed cost structure — whether it is drilling costs for an oil producer or convertible debt for a Bitcoin accumulator — creates the leverage naturally, without requiring any speculative instrument.

The leverage works in both directions. A 10% Bitcoin decline has historically produced a 20-25% MSTR decline. This is the price of the amplification, and it is precisely why entry point and exit discipline matter more for MSTR than for direct Bitcoin exposure.

2.3 The mNAV Premium — The Real Driver

The multiple-to-net-asset-value (mNAV) is the single most important metric for understanding where MSTR is in its cycle.

mNAV measures how much the market is paying for MSTR shares relative to the underlying Bitcoin value per share. At mNAV = 1.0x, you are paying exactly the Bitcoin value. At mNAV = 2.0x, you are paying double. The premium reflects three things : the built-in leverage that no ETF replicates, the rarity of a listed instrument offering 1.5x to 3x Bitcoin exposure without margin or expiry — accessible from any standard brokerage account, IRA, or tax-advantaged wrapper that cannot hold Bitcoin directly — and the sentiment of the market at any given moment.

“MSTR mNAV Multiplier (2021-2026) : From 3x Euphoria to 0.94x Discount”

Howard Marks’ pendulum applies here too. The mNAV has its own fear and enthusiasm cycle, layered on top of Bitcoin’s :

1. Fear : mNAV compresses toward 1.0x — the market prices Strategy as if the flywheel is broken, the leverage is a liability, and Bitcoin will never recover

2. Accumulation : sophisticated investors buy at or near NAV — leveraged Bitcoin exposure at no premium

3. Bitcoin reversal : structural buyers absorb available supply, price inflects

4. Enthusiasm : mNAV expands as investors pay an increasing premium for leveraged exposure and optionality

5. Peak : mNAV reaches 3x-4x, the flywheel runs at full speed, the cycle peaks

In November 2024, mNAV reached 3.4x — investors were paying $3.40 for every $1 of Bitcoin held by the company. Enthusiasm at its peak.

Today, mNAV sits between 0.94x and 1.19x depending on methodology — the lowest range since the strategy was launched. Two ways to read the same signal : Saylor Tracker’s 0.94x measures equity market cap only against Bitcoin held, meaning you are currently buying MSTR’s Bitcoin at a 6% discount to spot price. Strategy’s own 1.19x includes the full capital structure — convertible debt and preferred shares — and is the figure management uses to define its 1.22x operational pivot. Both are near historic lows.

Two pendulums are currently compressed simultaneously : Bitcoin’s sentiment, visible on the 200W MA heatmap, and Strategy’s mNAV premium. When both swing back — and historically they always have — the amplification is not additive. It is multiplicative.

The management has itself defined the key threshold : at 1.22x mNAV, the economics of the flywheel shift. Above this level, issuing equity to buy Bitcoin is accretive — each share sold at a premium to NAV buys more Bitcoin than it represents, increasing BTC per share for existing holders. Below it, selling Bitcoin to buy back shares becomes more accretive than issuing new equity.

Both sides of this pivot are constructive for the shareholder. The market is currently pricing Strategy as if the flywheel is permanently broken.

2.4 Decorrelation from AI — An Important Distinction

Strategy Inc. is a risk-on asset. It rises when risk appetite rises, and it falls when it falls — similar in surface behaviour to high-growth technology stocks.

But the thesis is structurally decorrelated from the AI cycle.

AI valuations depend on capex cycles, model release cadence, enterprise adoption curves, and quarterly earnings revisions. A disappointment from a hyperscaler, a regulatory move on data centres, or a shift in the competitive landscape can reprice the entire sector overnight. The driver is execution — and execution can disappoint.

Strategy’s value depends on one variable : the price of Bitcoin. And Bitcoin’s price depends on supply constraints that are fixed by design, demand flows that are institutional and structural, and a monetary narrative that has nothing to do with GPU clusters or foundation models.

In practice, MSTR may move in the same direction as AI stocks on a given day — risk-on is risk-on. A broad market sell-off hits everything simultaneously, and a risk-on rally lifts everything together. But the drivers of performance are independent. Bitcoin does not care about Nvidia’s earnings. It does not care about OpenAI’s latest model. It does not care about hyperscaler capex guidance.

It cares about one thing : how many coins are available for sale versus how many buyers need to own them.

For an investor with significant technology exposure — and most sophisticated portfolios in 2026 have significant technology exposure — Strategy Inc. represents a genuine thematic diversification. Not a correlated bet dressed up differently. A structurally different engine, in a different asset class, responding to different signals.

The surface correlation is noise. The underlying drivers are independent.

Part 3 — The Risks

3.1 Dilution — The Real Risk

The risk that deserves the most attention is not bankruptcy. It is dilution.

Strategy funds its Bitcoin purchases through two mechanisms : convertible debt and equity issuance via an at-the-money (ATM) programme. When mNAV is high, each share issued at a premium to Bitcoin NAV is accretive — the proceeds buy more Bitcoin than the shares represent, increasing BTC per share for existing holders.

When mNAV is compressed — as it is today — the accretion is minimal. At 0.94x-1.19x mNAV, issuing shares buys only marginally more Bitcoin than the shares represent. If management continues issuing aggressively at these levels, existing shareholders are diluted without meaningful compensation in BTC per share terms.

This is the tension to monitor : the pace of ATM issuance relative to mNAV. The 1.22x management pivot is the reference point.

Dilution is why I don’t want to buy and hold Strategy out of this thesis. This is a trade with a defined entry, a defined target, and a defined exit. The thesis is not “own Strategy forever.” The thesis is “own Strategy while the pendulum swings from fear to enthusiasm — and exit before dilution quietly erodes what the trade has built.”

3.2 ETF Competition — The Structural Pressure

BlackRock’s IBIT and its peers offer direct Bitcoin exposure — simpler, cheaper, no dilution risk, no management execution risk. As institutional awareness of these products grows, the marginal dollar that might have gone into MSTR goes into an ETF instead.

This is not a temporary headwind. It is a structural shift in how institutions access Bitcoin — and it has a direct consequence on the mNAV premium that Strategy can sustainably command.

In 2024, before ETFs reached critical mass, investors accepted a 3x mNAV premium because MSTR was one of the only liquid, regulated instruments offering leveraged Bitcoin exposure at scale. That scarcity premium has been partially arbitraged away. It will not fully return.

My base case is that mNAV above 2.5x is unlikely to be sustained going forward. The ETF ecosystem has permanently raised the bar for what premium investors will pay for indirect Bitcoin exposure. Why pay 3x NAV for MSTR when you can buy Bitcoin directly through IBIT at 1x, with no dilution risk and no management execution risk?

The answer — leverage, tax wrapper access, brokerage account accessibility — justifies a premium. But a structurally lower one than the cycle peaks of 2024.

This is why my exit target of $500-600 is calibrated on a mNAV of 2x to 2.5x, not 3x. It is not pessimism. It is an honest adjustment for a market structure that has permanently changed.

The counter-argument — that MSTR retains irreplaceable value for investors in accounts that cannot hold Bitcoin directly — is real but insufficient to rebuild the 3x premium of 2024. The marginal institutional buyer now has a better alternative. The premium compresses accordingly.

3.3 Bankruptcy — The Wrong Conversation

This question dominates retail discussion of MSTR and it is largely a distraction.

The debt is unsecured. There is no liquidation trigger. The cash reserve covers 2.5 years of obligations. Strategy’s preferred shares (STRC) carry an 11.5% dividend — but management retains the ability to suspend that dividend to protect the principal, adding another buffer before any Bitcoin sale becomes necessary.

In a notable shift from its original stance, CEO Phong Le confirmed in May 2026 that selling Bitcoin to service debt or reduce obligations is now a viable operational strategy — no longer a last resort. The company is not a one-way bet with no exit valves. It has a layered defence.

And for the balance sheet to go underwater, Bitcoin would need to fall below $10,000-13,000 — an 85%+ decline from current levels.

That scenario deserves an honest treatment. But let’s keep a sense of proportion.

For Bitcoin to fall to $10,000 in 2026, the following would need to unwind simultaneously : the US strategic Bitcoin reserve, BlackRock’s IBIT and the entire ETF infrastructure, every corporate treasury that has adopted a Bitcoin standard, and the institutional custody ecosystem that has been built over the past three years. This is not impossible. It is, however, extraordinarily unlikely — and it would signal a systemic financial crisis of a magnitude that would make MSTR the least of anyone’s concerns.

The theoretical scenario comes in two versions.

Version one : Bitcoin falls to $10,000 and does not recover. The thesis is wrong, Bitcoin as an asset class is over, and MSTR is worthless. Every risk asset is in freefall. This conversation is irrelevant.

Version two : Bitcoin falls to $10,000 and recovers. Bitcoin fell 80%+ in 2018, 70%+ in 2022. It recovered both times, reaching new all-time highs. In the current cycle, the deepest correction from the October 2025 all-time high of $126,000 was approximately 36% — nowhere near the historical drawdown levels that would threaten Strategy’s balance sheet. The $10,000 scenario would require a drawdown four times deeper than anything this cycle has produced. In this scenario, Strategy Inc. — sitting on hundreds of thousands of Bitcoin accumulated over years — becomes the most leveraged instrument on the recovery trade ever constructed. The company that survives the trough owns the mountain.

And one final point : the graph in section 1.5 shows that Bitcoin’s volatility has a structural tendency to compress over time. Each successive cycle produces shallower drawdowns and less extreme peaks — the mechanical signature of growing adoption. The $10,000 scenario belongs to an earlier era of Bitcoin, before sovereign reserves, before institutional ETFs, before the asset became a standard allocation. The infrastructure that now surrounds Bitcoin has permanently raised the structural floor.

“The bankruptcy scenario and the generational opportunity scenario are the same moment, viewed from two different time horizons.”

The risk to size your position around is not bankruptcy. It is the slower, quieter, far more probable risk of dilution eroding BTC per share while Bitcoin consolidates for two years. That is the bear case worth modelling — and the reason entry point and exit discipline matter more than catastrophe scenarios that would require the dismantling of an entire sovereign and institutional ecosystem to materialise.

Part 4 — The Discipline : Entry, Exit, Execution

4.1 Valuation Dashboard — BTC Price vs mNAV

The table maps implied MSTR share prices across Bitcoin price and mNAV scenarios, with CAGR calculated on the assumption that the target price is reached within 2 years from the current price of $159.89 (May 22, 2026). If the target is reached sooner, returns are higher. If it takes longer, they are lower.

These calculations assume a BTC yield of zero — meaning no change in BTC per share over the holding period. This is a conservative simplification : as long as Strategy’s BTC yield remains positive (currently 9.4% year-to-date), every new share issued is accretive to BTC per share, which increases the implied share price above the figures shown. Any positive BTC yield makes these numbers a floor, not a ceiling.

Methodology : BTC per share (basic) × BTC target price × mNAV target = MSTR implied share price. Current BTC per share : 0.002403 (source : Saylor Tracker / Bitcoin Treasuries, May 22, 2026). Current BTC price : $76,610. Current MSTR price : $159.89. Current mNAV : 0.86x.

CAGR calculated from $159.89 (MSTR closing price, May 22, 2026). Formula : (exit price / $159.89)^(1/2) — 1. mNAV 3.0x excluded from base case — see section 3.2.

The conservative exit target of $500-600 maps to BTC at ~$100,000 with mNAV between 2.0x and 2.5x. That is not an optimistic scenario — it is BTC recovering to a level it has already reached, combined with a mNAV normalising from its current historic low. At $150,000 BTC with mNAV 2.0x, the implied price is already $721.

Two variables drive the outcome. Bitcoin’s price is the engine. The mNAV is the multiplier. Both are currently compressed. Both have expanded before. The table shows what happens when they expand simultaneously.

4.2 The OKEA Playbook — Same Framework, Different Asset

The OKEA trade was not a lucky call. It was the application of a repeatable framework, executed in four steps.

Step 1 — Fundamentals justify the entry.

OKEA was in a temporary production trough — new wells under development, high capex, dividend suspended for several quarters. The market priced it as a broken story. It was a sequencing problem, not a structural one. Two catalysts in view : production recovery as new wells came online, and the oil price itself. Either was sufficient. Both together created the asymmetry.

Step 2 — The underlying asset is inelastic. Oil supply cannot respond quickly to demand shocks. Any disruption — geopolitical, weather, infrastructure — hits price before supply can adjust.

Step 3 — An exogenous catalyst amplifies the mechanism. The Iran conflict was not predicted. But when it arrived, the framework identified exactly what would happen : an inelastic asset under supply shock moves disproportionately, and the leveraged proxy amplifies every point of that move.

Step 4 — The exit is defined before the catalyst arrives. I entered OKEA on the hypothesis that a conflict would drive the oil price higher. When that scenario materialised and reached a plateau — Brent near $120, geopolitical risk premium fully priced in — the thesis was complete. The position closed.

But the exit framework had a second layer. In the event of further escalation — a broader market crash driven by an intensification of the conflict — a contingency plan was already in place before entry. The scenario was mapped. The decision was not made under pressure.

This is the discipline that matters most : not the entry, not the target, but the fact that every foreseeable outcome had a pre-defined response before the first share was purchased.

The same discipline applies to Strategy Inc.

Strategy Inc. follows the same four steps :

• Fundamentals : mNAV at historic lows, debt structure intact, cash covering 2.5 years of obligations, BTC per share growing at 18% year-over-year

• Inelastic asset : Bitcoin supply mathematically capped, ETF demand non-discretionary, float shrinking structurally

• Exogenous catalyst : geopolitical de-escalation, macro risk-on rotation, continued institutional adoption

• Exit defined : initial target $500-600, with clear reversal signals monitored in real time

4.3 The Exit — Directional, Not Mechanical

The exit strategy is directional, not mechanical. The initial target is $500-600 per share — consistent with BTC at $100,000 and mNAV between 2.0x and 2.5x. Beyond that threshold, several approaches are possible depending on market conditions at the time :

• A full exit if mNAV signals are clearly in euphoria territory (>2.5x) and ETF flows turn sustainably negative

• A laddered reduction : for every 10% increase in the share price above the initial target, 10% of the remaining position is sold. At $550, sell 10%. At $605, sell 10% of what remains. At $665, another 10%. In practice, this caps the total exposure as the trade moves into euphoria territory — the position size shrinks as the risk increases.

• A partial hold if the thesis remains intact and BTC shows no signs of structural reversal

The honest answer is that the exact exit will be determined by conditions that don’t yet exist. What is defined in advance is not the precise exit point, but the signals that will trigger it : mNAV expansion toward 2.0x-2.5x, ETF flows turning sustainably negative, and the Bitcoin 200W MA heatmap moving from blue to orange territory.

The pendulum tells you when to leave the room. You don’t need to decide exactly how fast to walk out the door before it starts swinging.

Subscribe now

Conclusion — The Same Trade, A Scarcer Asset

The OKEA trade worked because three things were true simultaneously : the fundamentals were solid, the underlying asset was inelastic, and an external shock hit a thin market.

The Strategy Inc. trade is the same structure. The fundamentals are intact — the debt is manageable, the cash is there, the BTC per share growing at 18% year-over-year is the right metric to watch. The underlying asset is more inelastic than oil has ever been, constrained not by geology or politics but by protocol. And the external conditions — geopolitical de-escalation, institutional adoption, sovereign accumulation — are already visible in the flow data.

The difference is permanence. Oil can be replaced. OPEC can open the taps. A president can press a button.

Bitcoin cannot be recoded.

This is not a bet on crypto technology. It is not a bet on Michael Saylor’s vision or on the next cycle of retail euphoria. It is a bet on the mechanics of inelastic markets — a framework tested on oil, validated by a hundred and ten percent return in less than nine months, and now applied to the scarcest asset that has ever existed.

Share

Important Disclosure & Disclaimer:

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.

Most investors spend their entire lives searching for the stocks that actually matter. Here’s what the data tells us: only 4% of all listed stocks account for 100% of the net wealth created in equity markets since 1926.

That single statistic is the foundation of my approach. I don’t try to own everything. I try to identify the few companies that have the potential to be part of that 4% — and hold them until my thesis is done.

A quick word on track record

I started stock picking in October 2023. Since then, my portfolio has compounded at a 24% CAGR, versus approximately 18% for the S&P 500 in euros over the same period (I’m an European investor, so it doesn’t make sense for me to compare in dollars, as the USD/EUR is a major component of performance).

My approach splits roughly 50/50 between quality compounders and higher-conviction opportunities/multibaggers — small caps, turnarounds, and growth stories. A few positions that shaped that return : Nebius Group (+197%), OKEA ASA (+110%), Medpace (+55%), Wise (+50%), Alphabet (+118%).

I’ll publish a monthly portfolio review to track performance transparently. But for now, let’s get into what matters.

Which brings me to Novo Nordisk

I already own it. And I’m currently sitting on a -20% loss on that position.

I’m writing this deep dive anyway — not to justify a bad trade, but because I believe the market is making a mistake. That’s the only reason to hold a losing position: not hope, not denial, but a clearly articulated thesis that the current price doesn’t reflect the underlying reality.

That’s what this article is about.

The healthcare sector is notoriously difficult to analyze and even harder to predict. I rarely touch it. But what is happening with Novo Nordisk is, in my view, a historically rare setup — the kind that only emerges a handful of times per decade.

The Short Version

Novo Nordisk makes Wegovy and Ozempic — the drugs reshaping how the world treats obesity and diabetes. The stock has lost 60% from its peak. The market is punishing a difficult 2026 guidance and Eli Lilly’s market share gains.

My view: the market is pricing permanent decline in a temporary situation. Prices fell before volumes followed. The factories are being built. The oral pill just launched in the US. Wegovy HD just matched — and slightly exceeded — Zepbound on efficacy.

At PE 10x, the downside is ~9% CAGR from current prices. The central scenario gives ~33% CAGR to December 2028. I have high conviction on the bull scenario at ~36% CAGR: the duopoly holds, the production moat is real, and the volume response to lower prices hasn’t shown up in the numbers yet and it will.

I own 9% of my portfolio in Novo Nordisk at an average cost of €48.39 — currently down 20%. I haven’t sold. At this price, I think it’s still a deal.

The rest of this article explains why.

Subscribe now

The Market — Three Segments, One That Matters

Diabetes & Rare Disease — Steady and Predictable

Diabetes care is a mature, commoditized market — predictable, but increasingly competitive. 42 million patients treated in 2025, growing at +4% in constant currency. For modeling purposes, we assume growth stays on its current trajectory — low single digits, nothing more.

The market runs on two distinct tiers:

• The oligopoly — Novo Nordisk, Eli Lilly, and Sanofi collectively control around 90% of global insulin value, with Novo leading at over 45% market share. These three capture the economics.

• The volume players — biosimilar manufacturers like Biocon and Wockhardt compete on price in emerging markets, with razor-thin margins. High volume, low value.

Rare diseases add a modest +9% growth cushion — hemophilia, growth disorders — useful as a margin stabilizer, nothing more.

This is a segment for dividend investors — predictable, low-growth, and frankly not why I’m here.

Obesity — A Billion-Person Market, 98% Untouched

Almost 1 billion people worldwide live with obesity. More than 100 million in the US alone, roughly 30% of UK adults, and around 15% of EU adults. Only 2% of the global obesity population is currently receiving treatment.

Let me flip that: 98% of the market is untouched. We are not talking about a product cycle. We are talking about a demographic wave that has barely started.

The alternatives? Bariatric surgery is invasive by definition — you’re cutting into someone. From conversations with physicians, a daily pill or injection is not only more practical, it’s fully reversible. The other option — doing nothing — means letting a public health crisis compound silently, with severe consequences at both the individual and systemic level. Obesity drives diabetes, cardiovascular disease, cancer. Ignoring it isn’t a neutral choice.

This market belongs to whoever wins the GLP-1 race.

The Business — The Duel That Defines The Following Years

Presentation and History

Novo Nordisk is the result of a historic merger in 1989 between two bitter Danish rivals: Nordisk, founded in 1923 by Nobel Laureate August Krogh and physician Hans Christian Hagedorn, which operated initially in the extraction and purification of bovine insulin after securing the manufacturing rights from Canada. Novo, founded in 1925 by the Pedersen brothers (a chemist and an engineer previously employed by Krogh), which operated initially in the production of its own competing insulin and later diversified into industrial enzymes.

For 64 years, this intense rivalry forced both laboratories to constantly innovate, pushing Denmark to the forefront of global diabetes care. Today, shielded from hostile takeovers by the unique governance of the Novo Nordisk Foundation, the unified group has transitioned its century-long mastery of peptide chemistry into the current GLP-1 revolution.

How We Got Here

Novo Nordisk and Eli Lilly are running the most consequential race in modern pharma. To understand where we are today, we need to understand how we got here — and what the current state of the duel looks like across every dimension that matters: molecules, production, and pricing.

Novo Nordisk had a head start. Years before obesity became the hottest market in pharma, the company was already sitting on semaglutide — a molecule originally developed for diabetes that turned out to do something remarkable: it made people lose weight. A lot of weight. Ozempic became a cultural phenomenon before Wegovy, its obesity-approved sibling, even launched. Novo Nordisk was, for a brief moment, the most valuable company in Europe.

Then Eli Lilly showed up.

Tirzepatide — Mounjaro for diabetes, Zepbound for obesity — hit two receptors instead of one. In head-to-head trials it produced slightly superior weight loss. Physicians noticed. Patients noticed. Prescriptions shifted. By mid-2025, Lilly held 57% of the GLP-1 market, having overtaken Novo in the segment Novo had pioneered. The gap has continued to widen on revenue trajectory. Lilly is projected to reach $113 billion in prescription drug sales by 2030, versus $84 billion for Novo. Both are growing fast — but Lilly is growing faster, from a higher base.

Novo Nordisk returns ~50% of earnings as dividends versus ~22% for Eli Lilly. Less cash retained means less fuel for buybacks and reinvestment — which mechanically dampens share price appreciation. The total return picture is closer than the chart suggests.

That’s the past dynamic. Let’s see where we are today.

Molecules

Semaglutide remains the most clinically documented GLP-1 molecule in existence. The SELECT trial demonstrated a 20% reduction in major cardiovascular events. Early data shows signals across sleep apnea, kidney disease, and addiction. Novo now has three approved obesity products: Wegovy (2.4mg, 13.7% weight loss), Wegovy HD (7.2mg, 20.7% weight loss — approved March 2026), and the world’s first oral GLP-1 pill (25mg, 16.6% weight loss).

Tirzepatide hits two receptors simultaneously — GLP-1 and GIP. In SURMOUNT-5, the first published head-to-head trial, Zepbound patients lost 20.2% of body weight versus 13.7% for Wegovy at standard doses over 72 weeks. That gap is real on current approved doses, and it explains the prescribing shift toward Lilly. Note: the trial was open-label and funded by Eli Lilly — results are robust but the methodology deserves mention.

The arrival of Wegovy HD changes the equation. At 20.7% weight loss, it exceeds Zepbound’s 20.2% in SURMOUNT-5 — though no direct head-to-head exists yet at these doses.

The next generation could widen Novo’s lead further. CagriSema — semaglutide combined with cagrilintide — shows up to 22% weight loss in Phase 2, with Phase 3 ongoing. Lilly’s retatrutide shows up to 24% in Phase 2. Both companies are converging on the same destination: more efficacy, oral delivery, broader indications.

Production

This is where the story gets interesting — and where the moat lives. Both companies are spending at a scale that is almost impossible to overstate. Novo committed $4.1 billion to a new facility in North Carolina. Lilly is spending $9 billion on its Indiana complex. These are not capacity additions. These are decade-long bets on a market that has barely started.

Building a biologics manufacturing facility takes 5 to 7 years from groundbreaking to full production. No molecule in a Phase 2 trial today will be manufactured at scale before 2030. That timeline protects both incumbents from any challenger — regardless of how good their science is.

Pricing

Pricing is the most contested battleground — and it just changed dramatically.

Before November 2025, Wegovy’s US list price sat around $1,300 per month. Real-world net prices after rebates were significantly lower, but coverage remained inconsistent and access was largely limited to patients with private insurance willing to fight for reimbursement.

Then Trump signed the Most Favored Nation executive order.

The MFN agreement caps Wegovy and Ozempic at $350/month for TrumpRx self-pay patients and $245/month for Medicare and Medicaid beneficiaries — effective 2026. For context, that’s a 73-82% cut from list price on the government channel. The market reacted badly to the announcement, pricing in margin destruction.

But here’s the counterintuitive read: lower prices mean more patients. Novo has been explicit about this — volume at $245 beats no volume at $1,300. The company that accepts price compression today to lock in 50 million patients builds a franchise that no competitor can dislodge tomorrow.

Eli Lilly is navigating the same environment. Both companies face the same pricing pressure, the same Medicare dynamics, the same employer plan inertia. This is not a Novo-specific risk — it’s a sector-wide reset that actually benefits the incumbents with manufacturing scale over any challenger trying to enter at premium pricing.

The pricing war is real. But it’s a war both duopoly players can survive — and smaller challengers cannot.

Pipeline

The current products are only the beginning. Both companies are racing to build the next generation of GLP-1 therapies — and the pipeline tells you who is investing in the future versus managing the present.

Novo’s most advanced candidate is CagriSema — semaglutide combined with cagrilintide, a long-acting amylin analogue — showing up to 22% weight loss in Phase 3 trials. Behind it, zenagamtide, a triple receptor agonist licensed from The United Laboratories, is entering Phase 3 in 2026. The oral Wegovy pill, already FDA-approved, opens an entirely new patient population. And CagriSema’s potential approval for MASH — metabolic liver disease — broadens the indication beyond obesity into a multi-billion dollar adjacent market.

Lilly is developing retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon simultaneously, showing up to 24% weight loss in Phase 2. If Phase 3 data holds, it would be the most efficacious GLP-1 molecule on the market.

The pattern is clear: both companies are converging toward triple agonists, oral formulations, and broader indications. The molecule war is accelerating. What neither can shortcut is the time it takes to manufacture at scale — which is the real moat.

Financials - A Quality Compounder

Novo Nordisk has built one of the most profitable franchises in global pharma — and is now absorbing the cost of its next chapter.

Net sales reached DKK 309 billion in 2025, up 6.4% year on year, with a compound annual growth rate of 17% since 2021. Operating profit stands at DKK 128 billion. Gross margin at 81%. These are not the numbers of a company in distress.

The balance sheet is a fortress. Net cash position of DKK 95.4 billion. No leverage risk. Free cash flow recovered to DKK 28.3 billion in 2025 after a distorted 2024 impacted by the Catalent acquisition. CAPEX guidance of approximately DKK 55 billion for 2026 — the company is spending aggressively on production capacity, from a position of financial strength.

Novo Nordisk’s ROIC has declined from 51.6% in 2017 to 22.3% today — a steady compression over eight years, accelerated by the manufacturing buildout of 2024-2025.

A ROIC of 22.3% remains exceptional by any industry standard. For context, Eli Lilly’s ROIC on the same definition currently stands at 12.2% — nearly half of Novo’s, despite Lilly’s current market leadership. Both companies are in heavy investment mode. On this metric, Novo’s financial machine remains structurally superior.

The direction is down — and the market is punishing that direction. But a declining ROIC in the context of record CAPEX deployment is not a broken business. It’s a company trading current returns for future capacity. The question is whether that capacity pays off. That’s exactly what the next section Bear vs Bull is about. Before that, a last checkup on management.

Management — Aligned with Shareholders

The governance structure starts at the top. The Novo Nordisk Foundation controls 28.1% of the share capital and 77.3% of the voting rights. This is not a management team that can be pressured by activist shareholders into short-term thinking. That alignment with long-term value creation is structural, not optional.

On executive compensation, the Long-Term Incentive Programme ties executive pay to share performance over a three-year vesting period, with metrics covering financials, innovation, commercial execution, and sustainability. Short-term bonuses exist but are capped. For the detailed breakdown, Novo Nordisk publishes a separate Remuneration Report available in the annual report.

Two elements are worth flagging as potential warnings — not deal-breakers, but worth monitoring. First, Lars Fruergaard Jørgensen, who had led Novo Nordisk since 2017, was shown the door in May 2025. The announcement on the same day as a profit warning tells you everything about the real reason. Second, Doustdar is new to the CEO role. Thirty-three years inside the company is reassuring on culture and institutional knowledge, but he has never run an organization of this scale as its chief executive. Execution risk is real.

Which brings us to the central question: what happens next and what’s actually in the price today ?

Bull vs Bear : A World-Changing Drug At A Distressed Price

I own Novo Nordisk. I’m down 20% on the position. And I haven’t sold — because at this price, I think it’s still a deal. This section is my attempt to show you why.

The Bear Case — What The Market Is Seeing

At PE 10x, the market is implying a perpetual growth rate of roughly 6% per year. A company in the middle of the GLP-1 revolution, with 98% of its addressable market untouched, priced like a mature utility. That’s the bet the bears are making.

Here is what drives that pessimism:

No guidance beyond 2026. Novo guides for a mid-single digit sales decline and a low-to-mid single digit operating profit decline in 2026 — the first revenue contraction in years. Beyond that? Nothing. The market hates uncertainty more than bad news. Right now it has both.

The CEO was shown the door. Lars Fruergaard Jørgensen didn’t resign — he was replaced on the same day as the profit warning, with the quiet dignity that senior executive departures always command. That’s not a neutral signal.

Lilly is winning the market. Eli Lilly holds 57% of the GLP-1 market and is growing faster. The efficacy gap in the only published head-to-head trial was real — Zepbound 20.2% vs Wegovy 13.7%. Prescriptions followed the data.

Margin compression is structural. The MFN agreement capped Wegovy at $245-350/month — a 73-82% cut from list price on the government channel. ROIC has declined from 51.6% in 2017 to 22.3% today. The direction is down.

The patent cliff is coming. Semaglutide’s core patent expires in the US and EU in 2031. From that date, licensed Western generics manufacturers can legally copy and commercialize. Not today — but a reason not to hold forever.

And above all — the framework the market applies: The winner-takes-all logic. Zepbound delivered 20.2% weight loss vs Wegovy’s 13.7% in the only published head-to-head trial — a 47% relative difference. Google crushed Yahoo. Facebook crushed MySpace. Lilly is at 57% — so Novo becomes irrelevant. At PE 10x, the market has already written the ending.

The Bull Case — My Conviction

Here is what I believe the market is missing:

The winner-takes-all framework is wrong. And even if it were right — it no longer applies. Wegovy HD, approved March 2026, delivers 20.7% weight loss. Zepbound delivers 20.2%. The efficacy gap that justified the bear narrative has reversed. The molecule war is over.

Think Visa and Mastercard — two players, one massive structural market, both winning simultaneously. The market has had its fears about their future too and they’re still here. That’s the right mental model for Novo and Lilly through 2028.

The valuation gap makes no sense for a duopoly. Eli Lilly trades at PE 36x. Novo Nordisk trades at PE 10x. In a winner-takes-all market, that gap is justified — one player survives, the other dies. But in a duopoly where both players have manufacturing scale, approved products, and access to the same 98% untouched market, a 3.6x valuation gap is an anomaly, not an equilibrium.

The rational duopoly pricing looks more like: market leader at PE 30x, solid second at PE 22x. That’s our central and bull scenario. The current 10x is the market applying the wrong mental model to the wrong type of business.

And there’s an upside scenario the model doesn’t fully capture: if Wegovy HD takes real-world market share from Zepbound, if the oral pill unlocks a new patient population at scale, and if CagriSema delivers in Phase 3 — Novo doesn’t stay second. It challenges for pole position. At that point, the PE gap between the two companies doesn’t just close. It reverses.

Prices fell. Volumes haven’t followed. Yet. The MFN price cuts landed in late 2025. Medicare obesity coverage just opened. Employer plans are still catching up. Lower prices plus broader coverage equals more patients — but the volume response takes time. The numbers don’t show it yet. The factories do. You don’t commit DKK 60 billion in CAPEX for a market you think is dying.

Lilly’s lead is temporary. Eli Lilly is growing faster today — but partly because Novo has been supply-constrained. That’s a production bottleneck, not a demand problem. As Novo’s 14 fill-finish sites reach full capacity through 2026-2027, the volume gap narrows mechanically.

The guidance was sandbagged. A new CEO inheriting a difficult transition has every incentive to set the bar low and surprise positively. No guidance beyond 2026 isn’t a vacuum — it’s a blank page. The market hates blank pages.

The production moat is the real barrier. 14 fill-finish sites. 5 to 7 years to build and validate a new biologics facility. No challenger with a Phase 2 molecule today reaches scale before 2030. The factory war is won before it starts.

The market stays a duopoly through 2028. No credible third entrant before 2029-2030 — they need both a validated molecule AND industrial capacity. The double lock holds.That’s why the investment horizon stops at 2028: capture the duopoly premium before Big Pharma joins the dance and compresses the multiples.

The numbers. 3.6 million obesity patients treated by Novo in 2025. 12 million in 2028 — our conservative central scenario, anchored in production capacity. That’s a 3x increase in three years, for one company, in one drug category.

And remember what’s behind those numbers: societies that can no longer afford the cost of obesity. Cardiovascular disease, diabetes, cancer, lost productivity — the systemic burden is in the trillions. Governments, insurers, and employers have every incentive to accelerate coverage and access. The tailwind isn’t just commercial. It’s structural, political, and public health driven.

Valuation

I won’t give you a fair value for Novo Nordisk. The concept implies that companies eventually converge to a precise intrinsic number — I don’t believe that. What I believe is that a stock price gravitates around a range of values, constantly pulled between optimism and pessimism, risk perception and opportunity. The PE ratio is the market’s mood ring — not a calculator.

So here is my framework. I build the Bull scenario from the fundamentals — production capacity, pricing, margins, patients treated — as developed in the Bear vs Bull section above. That calculation gives me an EPS anchor for 2028. Bear and Central are discounts to that anchor, reflecting two types of risk: production execution risk and demand disappointment risk. The PE then reflects what story the market tells itself about the company at that moment.

Building The Bull — The Earnings Calculation

12 million obesity patients treated by Novo in 2028 — up from 3.6 million today. 14 fill-finish sites running at full capacity. Wegovy HD is competitive with Zepbound. Oral pill scaling. Total group revenues ~$58 billion. Net margin 33%. EPS ~31 DKK.

This is the scenario where the factories deliver, the volumes follow the price cuts, and the duopoly holds.

Bear and Central — The Discounts

• Central reflects normal execution friction — a ramp-up that takes longer than expected, or some pricing pressure beyond MFN, or Lilly maintaining its lead. 15% of the earnings are discounted as risk provision in this scenario. EPS ~26 DKK.

• Bear reflects a more serious risk control scenario— either a production problem (sites underperforming, FDA validation delays) or a demand disappointment (coverage expansion slower than expected, patient dropout rates higher than modeled). 30% of the earnings are discounted as risk provision in this scenario. EPS ~22 DKK. The thesis is intact but the timeline extends.

The Sentiment — What Story Does The Market Tell?

• PE 15x — The market sees a mature pharma under pressure, losing market share to Lilly, facing patent cliff in 2031. A dividend stock, nothing more.

• PE 22x — The market recognizes a quality compounder, solid second in a structural duopoly, with a manufacturing moat. GARP territory.

• PE 30x — The market prices leadership potential. Wegovy HD closes the efficacy gap, the oral pill scales, CagriSema delivers. Novo challenges for pole position.

The Table

CAGR calculated from 289 DKK to December 31, 2028 (2.6 years), dividends included.

How to read this table: in the central scenario at PE 22x, the price target reaches 572 DKK by December 31, 2028 — a total return of +98% from current price, or a CAGR of 33.1% including dividends. That is my base case.

The full model with all assumptions is available here: https://docs.google.com/spreadsheets/d/12qmrNwYuS3IBPM5ji8JGd4g6ODyW7VDfmSSdcAp3pSc/edit?usp=sharing

The most likely scenario — Central, PE 22x — gives a CAGR of ~33% to December 31, 2028. The bear floor at PE 15x gives ~10% — you underperform the bull case, you don’t lose money. The upside at Bull PE 30x gives ~59% CAGR.

One observation worth noting: Eli Lilly currently trades at PE 36x. The rational duopoly equilibrium — market leader at 30x, solid second at 22x — implies significant re-rating potential for Novo without assuming anything extraordinary.

Portfolio Considerations

Currency Risk

Novo Nordisk is Danish — its stock trades in DKK, which is quasi-fixed to the euro via ERM II. For a European investor, the DKK is a non-issue.

The dollar is a different story. ~60% of Novo’s revenues are in USD. A 10% dollar decline reduces those earnings when converted to DKK. The net impact on EPS depends on the offsetting USD-denominated costs — US manufacturing, R&D, commercial operations — which partially absorb the shock. The exact figure requires a detailed cost structure breakdown, but the order of magnitude is a few percentage points on EPS. Real, but not thesis-altering.

Two channels to monitor: earnings translation (direct) and market sentiment on dollar-exposed European companies (indirect).

Sizing

I entered Novo Nordisk on September 18, 2025, and consolidated to 9% of my portfolio — my maximum position size. That’s a deliberate signal: this is a high-conviction bet, not a toe in the water.

My portfolio runs approximately 10 positions. Sizing Novo at the maximum reflects the asymmetry I see in the risk/reward at current prices — limited downside, meaningful upside, and a thesis I can articulate clearly.

On exit: I’ll let the thesis guide me. The 2028 horizon is a checkpoint, not a hard deadline. When Novo reports in 2027-2028, I’ll reassess based on the volume data, the production ramp, and the competitive landscape. Parallel opportunities in the portfolio will also influence the decision. No mechanical formula — just disciplined reassessment as the facts evolve.

A Defensive Play for European Investors

Beyond the thesis, Novo Nordisk has a structural characteristic worth noting for European investors specifically: it eliminates currency risk. Buying a Danish company in DKK, with the krone pegged to the euro, means your equity exposure is in euros by another name. In a world where the dollar is structurally weakening against the euro, that matters.

It also offers a ~4% dividend yield at current prices — rare for a growth company in this market. And as a quality compounder in healthcare, it behaves defensively during tech corrections. When markets rotate out of high-multiple technology names, capital tends to find its way into exactly this type of asset — a predictable, cash-generative business with a structural growth tailwind.

For a European investor looking to reduce tech concentration while maintaining exposure to a secular growth theme, Novo Nordisk at current prices offers an unusual combination: growth potential, income, and currency neutrality.

Share

Conclusion

Novo Nordisk is not a complicated story. It’s a century-old Danish company that stumbled onto the most important drug class of our generation, built the industrial infrastructure to dominate it, and is now being priced as if the story is over.

It isn’t.

The market is looking at 2026 — a year of declining revenues, a new CEO, and no visibility beyond the guidance. I’m looking at 2028 — 12 million obesity patients, 14 fill-finish sites running at capacity, a weekly oral pill with no needle, and a molecule that now matches its competitor on efficacy.

The bear case is real. The risks are documented. The patent cliff comes in 2031. Lilly is ahead on market share. The pricing environment has changed permanently. None of that is trivial.

But at PE 10x — a valuation that implies 6% perpetual growth for a company in the middle of the largest untreated health crisis on the planet — I think the market is making a mistake.

I’m positioned accordingly. 9% of my portfolio, maximum conviction, eyes open.

The central scenario gives ~33% CAGR to 2028. The downside gives ~10%. That asymmetry is why I’m here — and why I haven’t sold.

Subscribe now

Important Disclosure & Disclaimer:

All content published by JB Peter on this platform is strictly for educational and informational purposes. It does not constitute investment, financial, legal, or tax advice, nor does it represent a personal recommendation or solicitation to buy or sell securities. This research is operated by ORIACON (SASU) and reflects independent corporate analysis. Every reader must conduct their own independent research (Due Diligence) or consult a licensed professional before making any financial decision, as financial markets involve a high risk of capital loss. At the time of writing, ORIACON or the author HOLD shares in the company analyzed in this article. Following this publication, ORIACON and the author reserve the right to buy, sell, or modify positions in any security mentioned at any time, without prior notice to readers or subscribers.